id	sid	tid	token	lemma	pos
bjp-23079	1	1	introduction	introduction	NOUN
bjp-23079	1	2	ovarian	ovarian	ADJ
bjp-23079	1	3	cancer	cancer	NOUN
bjp-23079	1	4	is	be	AUX
bjp-23079	1	5	a	a	DET
bjp-23079	1	6	serious	serious	ADJ
bjp-23079	1	7	disease	disease	NOUN
bjp-23079	1	8	which	which	PRON
bjp-23079	1	9	can	can	AUX
bjp-23079	1	10	threat	threat	VERB
bjp-23079	1	11	women	woman	NOUN
bjp-23079	1	12	's	's	PART
bjp-23079	1	13	life	life	NOUN
bjp-23079	1	14	and	and	CCONJ
bjp-23079	1	15	health	health	NOUN
bjp-23079	1	16	,	,	PUNCT
bjp-23079	1	17	its	its	PRON
bjp-23079	1	18	morbidity	morbidity	NOUN
bjp-23079	1	19	is	be	AUX
bjp-23079	1	20	highest	high	ADJ
bjp-23079	1	21	in	in	ADP
bjp-23079	1	22	the	the	DET
bjp-23079	1	23	disease	disease	NOUN
bjp-23079	1	24	of	of	ADP
bjp-23079	1	25	gynecology	gynecology	NOUN
bjp-23079	1	26	,	,	PUNCT
bjp-23079	1	27	and	and	CCONJ
bjp-23079	1	28	the	the	DET
bjp-23079	1	29	mortality	mortality	NOUN
bjp-23079	1	30	is	be	AUX
bjp-23079	1	31	also	also	ADV
bjp-23079	1	32	high	high	ADJ
bjp-23079	1	33	,	,	PUNCT
bjp-23079	1	34	to	to	ADP
bjp-23079	1	35	the	the	DET
bjp-23079	1	36	end	end	NOUN
bjp-23079	1	37	-	-	PUNCT
bjp-23079	1	38	stage	stage	NOUN
bjp-23079	1	39	ovarian	ovarian	ADJ
bjp-23079	1	40	cancer	cancer	NOUN
bjp-23079	1	41	patients	patient	NOUN
bjp-23079	1	42	,	,	PUNCT
bjp-23079	1	43	long	long	ADJ
bjp-23079	1	44	-	-	PUNCT
bjp-23079	1	45	term	term	NOUN
bjp-23079	1	46	survival	survival	NOUN
bjp-23079	1	47	rate	rate	NOUN
bjp-23079	1	48	is	be	AUX
bjp-23079	1	49	no	no	DET
bjp-23079	1	50	more	more	ADJ
bjp-23079	1	51	than	than	ADP
bjp-23079	1	52	20	20	NUM
bjp-23079	1	53	%	%	NOUN
bjp-23079	1	54	(	(	PUNCT
bjp-23079	1	55	pu	pu	PROPN
bjp-23079	1	56	et	et	PROPN
bjp-23079	1	57	al	al	PROPN
bjp-23079	1	58	.	.	PROPN
bjp-23079	1	59	,	,	PUNCT
bjp-23079	1	60	2014	2014	NUM
bjp-23079	1	61	;	;	PUNCT
bjp-23079	1	62	xie	xie	PROPN
bjp-23079	1	63	et	et	PROPN
bjp-23079	1	64	al	al	PROPN
bjp-23079	1	65	.	.	PROPN
bjp-23079	1	66	,	,	PUNCT
bjp-23079	1	67	2014	2014	NUM
bjp-23079	1	68	)	)	PUNCT
bjp-23079	1	69	.	.	PUNCT
bjp-23079	2	1	ovarian	ovarian	ADJ
bjp-23079	2	2	malignant	malignant	ADJ
bjp-23079	2	3	tumor	tumor	NOUN
bjp-23079	2	4	is	be	AUX
bjp-23079	2	5	one	one	NUM
bjp-23079	2	6	of	of	ADP
bjp-23079	2	7	the	the	DET
bjp-23079	2	8	three	three	NUM
bjp-23079	2	9	malignant	malignant	ADJ
bjp-23079	2	10	tumors	tumor	NOUN
bjp-23079	2	11	in	in	ADP
bjp-23079	2	12	female	female	ADJ
bjp-23079	2	13	reproductive	reproductive	ADJ
bjp-23079	2	14	system	system	NOUN
bjp-23079	2	15	,	,	PUNCT
bjp-23079	2	16	it	it	PRON
bjp-23079	2	17	has	have	VERB
bjp-23079	2	18	high	high	ADJ
bjp-23079	2	19	morbidity	morbidity	NOUN
bjp-23079	2	20	which	which	PRON
bjp-23079	2	21	is	be	AUX
bjp-23079	2	22	secondary	secondary	ADJ
bjp-23079	2	23	to	to	ADP
bjp-23079	2	24	the	the	DET
bjp-23079	2	25	cervical	cervical	ADJ
bjp-23079	2	26	cancer	cancer	NOUN
bjp-23079	2	27	and	and	CCONJ
bjp-23079	2	28	endometrial	endometrial	ADJ
bjp-23079	2	29	carcinoma	carcinoma	NOUN
bjp-23079	2	30	,	,	PUNCT
bjp-23079	2	31	because	because	SCONJ
bjp-23079	2	32	of	of	ADP
bjp-23079	2	33	the	the	DET
bjp-23079	2	34	onset	onset	NOUN
bjp-23079	2	35	of	of	ADP
bjp-23079	2	36	the	the	DET
bjp-23079	2	37	disease	disease	NOUN
bjp-23079	2	38	is	be	AUX
bjp-23079	2	39	hidden	hide	VERB
bjp-23079	2	40	,	,	PUNCT
bjp-23079	2	41	difficult	difficult	ADJ
bjp-23079	2	42	early	early	ADJ
bjp-23079	2	43	diagnosis	diagnosis	NOUN
bjp-23079	2	44	,	,	PUNCT
bjp-23079	2	45	so	so	CCONJ
bjp-23079	2	46	when	when	SCONJ
bjp-23079	2	47	the	the	DET
bjp-23079	2	48	ovarian	ovarian	ADJ
bjp-23079	2	49	cancer	cancer	NOUN
bjp-23079	2	50	is	be	AUX
bjp-23079	2	51	diagnosed	diagnose	VERB
bjp-23079	2	52	,	,	PUNCT
bjp-23079	2	53	70	70	NUM
bjp-23079	2	54	%	%	NOUN
bjp-23079	2	55	of	of	ADP
bjp-23079	2	56	them	they	PRON
bjp-23079	2	57	belong	belong	VERB
bjp-23079	2	58	to	to	ADP
bjp-23079	2	59	the	the	DET
bjp-23079	2	60	end	end	NOUN
bjp-23079	2	61	-	-	PUNCT
bjp-23079	2	62	stage	stage	NOUN
bjp-23079	2	63	(	(	PUNCT
bjp-23079	2	64	chen	chen	PROPN
bjp-23079	2	65	et	et	PROPN
bjp-23079	2	66	al	al	PROPN
bjp-23079	2	67	.	.	PROPN
bjp-23079	2	68	,	,	PUNCT
bjp-23079	2	69	2014	2014	NUM
bjp-23079	2	70	)	)	PUNCT
bjp-23079	2	71	.	.	PUNCT
bjp-23079	3	1	postoperative	postoperative	ADJ
bjp-23079	3	2	relapse	relapse	NOUN
bjp-23079	3	3	may	may	AUX
bjp-23079	3	4	occur	occur	VERB
bjp-23079	3	5	easily	easily	ADV
bjp-23079	3	6	.	.	PUNCT
bjp-23079	4	1	there	there	PRON
bjp-23079	4	2	may	may	AUX
bjp-23079	4	3	be	be	AUX
bjp-23079	4	4	abdominal	abdominal	ADJ
bjp-23079	4	5	and	and	CCONJ
bjp-23079	4	6	pelvic	pelvic	ADJ
bjp-23079	4	7	lymph	lymph	NOUN
bjp-23079	4	8	node	node	NOUN
bjp-23079	4	9	metastasis	metastasis	NOUN
bjp-23079	4	10	.	.	PUNCT
bjp-23079	5	1	patients	patient	NOUN
bjp-23079	5	2	with	with	ADP
bjp-23079	5	3	end	end	NOUN
bjp-23079	5	4	-	-	PUNCT
bjp-23079	5	5	stage	stage	NOUN
bjp-23079	5	6	ovarian	ovarian	ADJ
bjp-23079	5	7	cancer	cancer	NOUN
bjp-23079	5	8	have	have	VERB
bjp-23079	5	9	poor	poor	ADJ
bjp-23079	5	10	prognosis	prognosis	NOUN
bjp-23079	5	11	,	,	PUNCT
bjp-23079	5	12	and	and	CCONJ
bjp-23079	5	13	the	the	DET
bjp-23079	5	14	fatality	fatality	NOUN
bjp-23079	5	15	rate	rate	NOUN
bjp-23079	5	16	is	be	AUX
bjp-23079	5	17	top	top	ADJ
bjp-23079	5	18	among	among	ADP
bjp-23079	5	19	the	the	DET
bjp-23079	5	20	gynecology	gynecology	NOUN
bjp-23079	5	21	malignant	malignant	ADJ
bjp-23079	5	22	tumor	tumor	NOUN
bjp-23079	5	23	(	(	PUNCT
bjp-23079	5	24	robinson	robinson	PROPN
bjp-23079	5	25	et	et	PROPN
bjp-23079	5	26	al	al	PROPN
bjp-23079	5	27	.	.	PROPN
bjp-23079	5	28	,	,	PUNCT
bjp-23079	5	29	2008	2008	NUM
bjp-23079	5	30	)	)	PUNCT
bjp-23079	5	31	.	.	PUNCT
bjp-23079	6	1	so	so	ADV
bjp-23079	6	2	far	far	ADV
bjp-23079	6	3	,	,	PUNCT
bjp-23079	6	4	the	the	DET
bjp-23079	6	5	treatments	treatment	NOUN
bjp-23079	6	6	of	of	ADP
bjp-23079	6	7	ovarian	ovarian	ADJ
bjp-23079	6	8	cancer	cancer	NOUN
bjp-23079	6	9	are	be	AUX
bjp-23079	6	10	still	still	ADV
bjp-23079	6	11	mainly	mainly	ADV
bjp-23079	6	12	operation	operation	NOUN
bjp-23079	6	13	and	and	CCONJ
bjp-23079	6	14	combine	combine	VERB
bjp-23079	6	15	with	with	ADP
bjp-23079	6	16	chemotherapy	chemotherapy	NOUN
bjp-23079	6	17	and	and	CCONJ
bjp-23079	6	18	radiation	radiation	NOUN
bjp-23079	6	19	(	(	PUNCT
bjp-23079	6	20	harano	harano	INTJ
bjp-23079	6	21	et	et	PROPN
bjp-23079	6	22	al	al	PROPN
bjp-23079	6	23	.	.	PROPN
bjp-23079	6	24	,	,	PUNCT
bjp-23079	6	25	2014	2014	NUM
bjp-23079	6	26	)	)	PUNCT
bjp-23079	6	27	.	.	PUNCT
bjp-23079	7	1	the	the	DET
bjp-23079	7	2	epithelial	epithelial	ADJ
bjp-23079	7	3	carcinoma	carcinoma	NOUN
bjp-23079	7	4	is	be	AUX
bjp-23079	7	5	more	more	ADV
bjp-23079	7	6	sensitive	sensitive	ADJ
bjp-23079	7	7	to	to	ADP
bjp-23079	7	8	chemotherapy	chemotherapy	NOUN
bjp-23079	7	9	,	,	PUNCT
bjp-23079	7	10	but	but	CCONJ
bjp-23079	7	11	because	because	SCONJ
bjp-23079	7	12	of	of	ADP
bjp-23079	7	13	the	the	DET
bjp-23079	7	14	diversity	diversity	NOUN
bjp-23079	7	15	of	of	ADP
bjp-23079	7	16	its	its	PRON
bjp-23079	7	17	biological	biological	ADJ
bjp-23079	7	18	characteristics	characteristic	NOUN
bjp-23079	7	19	and	and	CCONJ
bjp-23079	7	20	the	the	DET
bjp-23079	7	21	characteristics	characteristic	NOUN
bjp-23079	7	22	of	of	ADP
bjp-23079	7	23	easy	easy	ADJ
bjp-23079	7	24	recurrence	recurrence	NOUN
bjp-23079	7	25	,	,	PUNCT
bjp-23079	7	26	transfer	transfer	NOUN
bjp-23079	7	27	,	,	PUNCT
bjp-23079	7	28	even	even	ADV
bjp-23079	7	29	get	get	VERB
bjp-23079	7	30	timely	timely	ADJ
bjp-23079	7	31	treatment	treatment	NOUN
bjp-23079	7	32	early	early	ADV
bjp-23079	7	33	or	or	CCONJ
bjp-23079	7	34	late	late	ADJ
bjp-23079	7	35	-	-	PUNCT
bjp-23079	7	36	stage	stage	NOUN
bjp-23079	7	37	ideal	ideal	ADJ
bjp-23079	7	38	tumor	tumor	NOUN
bjp-23079	7	39	cells	cell	NOUN
bjp-23079	7	40	reductive	reductive	ADJ
bjp-23079	7	41	surgery	surgery	NOUN
bjp-23079	7	42	and	and	CCONJ
bjp-23079	7	43	give	give	VERB
bjp-23079	7	44	first	first	ADJ
bjp-23079	7	45	-	-	PUNCT
bjp-23079	7	46	line	line	NOUN
bjp-23079	7	47	chemotherapy	chemotherapy	NOUN
bjp-23079	7	48	and	and	CCONJ
bjp-23079	7	49	get	get	VERB
bjp-23079	7	50	clinical	clinical	ADJ
bjp-23079	7	51	alleviate	alleviate	NOUN
bjp-23079	7	52	,	,	PUNCT
bjp-23079	7	53	still	still	ADV
bjp-23079	7	54	60	60	NUM
bjp-23079	7	55	%	%	NOUN
bjp-23079	7	56	of	of	ADP
bjp-23079	7	57	the	the	DET
bjp-23079	7	58	patients	patient	NOUN
bjp-23079	7	59	have	have	VERB
bjp-23079	7	60	recurrence	recurrence	NOUN
bjp-23079	7	61	and	and	CCONJ
bjp-23079	7	62	metastasis	metastasis	NOUN
bjp-23079	7	63	after	after	ADP
bjp-23079	7	64	a	a	DET
bjp-23079	7	65	period	period	NOUN
bjp-23079	7	66	of	of	ADP
bjp-23079	7	67	time	time	NOUN
bjp-23079	7	68	(	(	PUNCT
bjp-23079	7	69	numazaki	numazaki	PROPN
bjp-23079	7	70	et	et	PROPN
bjp-23079	7	71	al	al	PROPN
bjp-23079	7	72	.	.	PROPN
bjp-23079	7	73	,	,	PUNCT
bjp-23079	7	74	2006	2006	NUM
bjp-23079	7	75	;	;	PUNCT
bjp-23079	7	76	silasi	silasi	NOUN
bjp-23079	7	77	et	et	PROPN
bjp-23079	7	78	al	al	PROPN
bjp-23079	7	79	.	.	PROPN
bjp-23079	7	80	,	,	PUNCT
bjp-23079	7	81	2006	2006	NUM
bjp-23079	7	82	)	)	PUNCT
bjp-23079	7	83	.	.	PUNCT
bjp-23079	8	1	conventional	conventional	ADJ
bjp-23079	8	2	chemothe	chemothe	ADJ
bjp-23079	8	3	-	-	PUNCT
bjp-23079	8	4	rapy	rapy	NOUN
bjp-23079	8	5	regimens	regimen	NOUN
bjp-23079	8	6	of	of	ADP
bjp-23079	8	7	epithelial	epithelial	ADJ
bjp-23079	8	8	ovarian	ovarian	ADJ
bjp-23079	8	9	cancer	cancer	NOUN
bjp-23079	8	10	is	be	AUX
bjp-23079	8	11	the	the	DET
bjp-23079	8	12	combine	combine	PROPN
bjp-23079	8	13	chemotherapy	chemotherapy	NOUN
bjp-23079	8	14	based	base	VERB
bjp-23079	8	15	on	on	ADP
bjp-23079	8	16	platinum	platinum	NOUN
bjp-23079	8	17	,	,	PUNCT
bjp-23079	8	18	in	in	ADP
bjp-23079	8	19	the	the	DET
bjp-23079	8	20	platinum	platinum	NOUN
bjp-23079	8	21	,	,	PUNCT
bjp-23079	8	22	cisplatin	cisplatin	NOUN
bjp-23079	8	23	and	and	CCONJ
bjp-23079	8	24	carboplatin	carboplatin	NOUN
bjp-23079	8	25	have	have	VERB
bjp-23079	8	26	a	a	DET
bjp-23079	8	27	similar	similar	ADJ
bjp-23079	8	28	curative	curative	ADJ
bjp-23079	8	29	effect	effect	NOUN
bjp-23079	8	30	,	,	PUNCT
bjp-23079	8	31	but	but	CCONJ
bjp-23079	8	32	the	the	DET
bjp-23079	8	33	adverse	adverse	ADJ
bjp-23079	8	34	reaction	reaction	NOUN
bjp-23079	8	35	is	be	AUX
bjp-23079	8	36	different	different	ADJ
bjp-23079	8	37	,	,	PUNCT
bjp-23079	8	38	as	as	ADP
bjp-23079	8	39	neurotoxicity	neurotoxicity	NOUN
bjp-23079	8	40	adverse	adverse	ADJ
bjp-23079	8	41	reaction	reaction	NOUN
bjp-23079	8	42	of	of	ADP
bjp-23079	8	43	cisplatin	cisplatin	NOUN
bjp-23079	8	44	overlap	overlap	NOUN
bjp-23079	8	45	paclitaxel	paclitaxel	NOUN
bjp-23079	8	46	,	,	PUNCT
bjp-23079	8	47	but	but	CCONJ
bjp-23079	8	48	the	the	DET
bjp-23079	8	49	renal	renal	ADJ
bjp-23079	8	50	toxicity	toxicity	NOUN
bjp-23079	8	51	,	,	PUNCT
bjp-23079	8	52	gastrointestinal	gastrointestinal	ADJ
bjp-23079	8	53	reaction	reaction	NOUN
bjp-23079	8	54	and	and	CCONJ
bjp-23079	8	55	neurotoxicity	neurotoxicity	NOUN
bjp-23079	8	56	of	of	ADP
bjp-23079	8	57	carboplatin	carboplatin	NOUN
bjp-23079	8	58	are	be	AUX
bjp-23079	8	59	all	all	ADV
bjp-23079	8	60	less	less	ADJ
bjp-23079	8	61	than	than	ADP
bjp-23079	8	62	cisplatin	cisplatin	NOUN
bjp-23079	8	63	,	,	PUNCT
bjp-23079	8	64	so	so	CCONJ
bjp-23079	8	65	the	the	DET
bjp-23079	8	66	ovarian	ovarian	ADJ
bjp-23079	8	67	cancer	cancer	NOUN
bjp-23079	8	68	treatment	treatment	NOUN
bjp-23079	8	69	guidelines	guideline	NOUN
bjp-23079	8	70	make	make	VERB
bjp-23079	8	71	by	by	ADP
bjp-23079	8	72	most	most	ADJ
bjp-23079	8	73	of	of	ADP
bjp-23079	8	74	the	the	DET
bjp-23079	8	75	gynecological	gynecological	ADJ
bjp-23079	8	76	cancer	cancer	NOUN
bjp-23079	8	77	center	center	NOUN
bjp-23079	8	78	and	and	CCONJ
bjp-23079	8	79	authority	authority	NOUN
bjp-23079	8	80	of	of	ADP
bjp-23079	8	81	the	the	DET
bjp-23079	8	82	gynecological	gynecological	ADJ
bjp-23079	8	83	tumors	tumor	NOUN
bjp-23079	8	84	,	,	PUNCT
bjp-23079	8	85	recommend	recommend	VERB
bjp-23079	8	86	paclitaxel	paclitaxel	PROPN
bjp-23079	8	87	and	and	CCONJ
bjp-23079	8	88	carboa	carboa	PROPN
bjp-23079	8	89	journal	journal	PROPN
bjp-23079	8	90	of	of	ADP
bjp-23079	8	91	the	the	DET
bjp-23079	8	92	bangladesh	bangladesh	NOUN
bjp-23079	8	93	pharmacological	pharmacological	ADJ
bjp-23079	8	94	society	society	NOUN
bjp-23079	8	95	(	(	PUNCT
bjp-23079	8	96	bdps	bdps	NOUN
bjp-23079	8	97	)	)	PUNCT
bjp-23079	8	98	bangladesh	bangladesh	PROPN
bjp-23079	8	99	j	j	PROPN
bjp-23079	8	100	pharmacol	pharmacol	PROPN
bjp-23079	8	101	2015	2015	NUM
bjp-23079	8	102	;	;	PUNCT
bjp-23079	8	103	10	10	NUM
bjp-23079	8	104	:	:	PUNCT
bjp-23079	8	105	489	489	NUM
bjp-23079	8	106	-	-	PUNCT
bjp-23079	8	107	493	493	NUM
bjp-23079	8	108	journal	journal	NOUN
bjp-23079	8	109	homepage	homepage	NOUN
bjp-23079	8	110	:	:	PUNCT
bjp-23079	8	111	www.banglajol.info	www.banglajol.info	PROPN
bjp-23079	8	112	abstracted	abstract	VERB
bjp-23079	8	113	/	/	SYM
bjp-23079	8	114	indexed	index	VERB
bjp-23079	8	115	in	in	ADP
bjp-23079	8	116	academic	academic	ADJ
bjp-23079	8	117	search	search	NOUN
bjp-23079	8	118	complete	complete	ADJ
bjp-23079	8	119	,	,	PUNCT
bjp-23079	8	120	agroforestry	agroforestry	NOUN
bjp-23079	8	121	abstracts	abstract	NOUN
bjp-23079	8	122	,	,	PUNCT
bjp-23079	8	123	asia	asia	PROPN
bjp-23079	8	124	journals	journal	NOUN
bjp-23079	8	125	online	online	ADV
bjp-23079	8	126	,	,	PUNCT
bjp-23079	8	127	bangladesh	bangladesh	NOUN
bjp-23079	8	128	journals	journal	NOUN
bjp-23079	8	129	online	online	ADV
bjp-23079	8	130	,	,	PUNCT
bjp-23079	8	131	biological	biological	ADJ
bjp-23079	8	132	abstracts	abstract	NOUN
bjp-23079	8	133	,	,	PUNCT
bjp-23079	8	134	biosis	biosis	NOUN
bjp-23079	8	135	previews	preview	NOUN
bjp-23079	8	136	,	,	PUNCT
bjp-23079	8	137	cab	cab	NOUN
bjp-23079	8	138	abstracts	abstract	NOUN
bjp-23079	8	139	,	,	PUNCT
bjp-23079	8	140	current	current	ADJ
bjp-23079	8	141	abstracts	abstract	NOUN
bjp-23079	8	142	,	,	PUNCT
bjp-23079	8	143	directory	directory	NOUN
bjp-23079	8	144	of	of	ADP
bjp-23079	8	145	open	open	ADJ
bjp-23079	8	146	access	access	NOUN
bjp-23079	8	147	journals	journal	NOUN
bjp-23079	8	148	,	,	PUNCT
bjp-23079	8	149	embase	embase	NOUN
bjp-23079	8	150	/	/	SYM
bjp-23079	8	151	excerpta	excerpta	NOUN
bjp-23079	8	152	medica	medica	NOUN
bjp-23079	8	153	,	,	PUNCT
bjp-23079	8	154	google	google	PROPN
bjp-23079	8	155	scholar	scholar	NOUN
bjp-23079	8	156	,	,	PUNCT
bjp-23079	8	157	hinari	hinari	X
bjp-23079	8	158	(	(	PUNCT
bjp-23079	8	159	who	who	PRON
bjp-23079	8	160	)	)	PUNCT
bjp-23079	8	161	,	,	PUNCT
bjp-23079	8	162	international	international	ADJ
bjp-23079	8	163	pharmaceutical	pharmaceutical	ADJ
bjp-23079	8	164	abstracts	abstract	NOUN
bjp-23079	8	165	,	,	PUNCT
bjp-23079	8	166	open	open	ADJ
bjp-23079	8	167	j	j	PROPN
bjp-23079	8	168	-	-	PUNCT
bjp-23079	8	169	gate	gate	NOUN
bjp-23079	8	170	,	,	PUNCT
bjp-23079	8	171	science	science	NOUN
bjp-23079	8	172	citation	citation	NOUN
bjp-23079	8	173	index	index	NOUN
bjp-23079	8	174	expanded	expand	VERB
bjp-23079	8	175	,	,	PUNCT
bjp-23079	8	176	scopus	scopus	NOUN
bjp-23079	8	177	and	and	CCONJ
bjp-23079	8	178	social	social	ADJ
bjp-23079	8	179	sciences	sciences	PROPN
bjp-23079	8	180	citation	citation	NOUN
bjp-23079	8	181	index	index	NOUN
bjp-23079	8	182	;	;	PUNCT
bjp-23079	8	183	issn	issn	PROPN
bjp-23079	8	184	:	:	PUNCT
bjp-23079	8	185	1991	1991	NUM
bjp-23079	8	186	-	-	SYM
bjp-23079	8	187	0088	0088	NUM
bjp-23079	8	188	abstract	abstract	NOUN
bjp-23079	8	189	we	we	PRON
bjp-23079	8	190	investigated	investigate	VERB
bjp-23079	8	191	dose	dose	NOUN
bjp-23079	8	192	-	-	PUNCT
bjp-23079	8	193	dense	dense	ADJ
bjp-23079	8	194	weekly	weekly	ADJ
bjp-23079	8	195	paclitaxel	paclitaxel	NOUN
bjp-23079	8	196	and	and	CCONJ
bjp-23079	8	197	carboplatin	carboplatin	NOUN
bjp-23079	8	198	compared	compare	VERB
bjp-23079	8	199	with	with	ADP
bjp-23079	8	200	conventional	conventional	ADJ
bjp-23079	8	201	paclitaxel	paclitaxel	NOUN
bjp-23079	8	202	and	and	CCONJ
bjp-23079	8	203	carboplatin	carboplatin	NOUN
bjp-23079	8	204	treatment	treatment	NOUN
bjp-23079	8	205	on	on	ADP
bjp-23079	8	206	stage	stage	NOUN
bjp-23079	8	207	ii	ii	PROPN
bjp-23079	8	208	-	-	PUNCT
bjp-23079	8	209	iv	iv	ADJ
bjp-23079	8	210	ovarian	ovarian	ADJ
bjp-23079	8	211	cancer	cancer	NOUN
bjp-23079	8	212	patients	patient	NOUN
bjp-23079	8	213	.	.	PUNCT
bjp-23079	9	1	between	between	ADP
bjp-23079	9	2	july	july	PROPN
bjp-23079	9	3	,	,	PUNCT
bjp-23079	9	4	2011	2011	NUM
bjp-23079	9	5	,	,	PUNCT
bjp-23079	9	6	and	and	CCONJ
bjp-23079	9	7	october	october	PROPN
bjp-23079	9	8	,	,	PUNCT
bjp-23079	9	9	2014	2014	NUM
bjp-23079	9	10	,	,	PUNCT
bjp-23079	9	11	a	a	DET
bjp-23079	9	12	total	total	NOUN
bjp-23079	9	13	of	of	ADP
bjp-23079	9	14	221	221	NUM
bjp-23079	9	15	patients	patient	NOUN
bjp-23079	9	16	was	be	AUX
bjp-23079	9	17	randomly	randomly	ADV
bjp-23079	9	18	assigned	assign	VERB
bjp-23079	9	19	to	to	PART
bjp-23079	9	20	receive	receive	VERB
bjp-23079	9	21	dose	dose	NOUN
bjp-23079	9	22	-	-	PUNCT
bjp-23079	9	23	dense	dense	ADJ
bjp-23079	9	24	weekly	weekly	ADJ
bjp-23079	9	25	paclitaxel	paclitaxel	NOUN
bjp-23079	9	26	and	and	CCONJ
bjp-23079	9	27	carboplatin	carboplatin	PROPN
bjp-23079	9	28	group	group	NOUN
bjp-23079	9	29	(	(	PUNCT
bjp-23079	9	30	n	n	NOUN
bjp-23079	9	31	=	=	SYM
bjp-23079	9	32	109	109	NUM
bjp-23079	9	33	)	)	PUNCT
bjp-23079	9	34	and	and	CCONJ
bjp-23079	9	35	conventional	conventional	ADJ
bjp-23079	9	36	paclitaxel	paclitaxel	NOUN
bjp-23079	9	37	and	and	CCONJ
bjp-23079	9	38	carboplatin	carboplatin	PROPN
bjp-23079	9	39	group	group	NOUN
bjp-23079	9	40	(	(	PUNCT
bjp-23079	9	41	n	n	NOUN
bjp-23079	9	42	=	=	SYM
bjp-23079	9	43	112	112	NUM
bjp-23079	9	44	)	)	PUNCT
bjp-23079	9	45	,	,	PUNCT
bjp-23079	9	46	just	just	ADV
bjp-23079	9	47	after	after	ADP
bjp-23079	9	48	the	the	DET
bjp-23079	9	49	sixth	sixth	ADJ
bjp-23079	9	50	chemotherapy	chemotherapy	NOUN
bjp-23079	9	51	cycles	cycle	NOUN
bjp-23079	9	52	,	,	PUNCT
bjp-23079	9	53	and	and	CCONJ
bjp-23079	9	54	at	at	ADP
bjp-23079	9	55	12	12	NUM
bjp-23079	9	56	months	month	NOUN
bjp-23079	9	57	after	after	ADP
bjp-23079	9	58	randomization	randomization	NOUN
bjp-23079	9	59	.	.	PUNCT
bjp-23079	10	1	median	median	ADJ
bjp-23079	10	2	progression	progression	NOUN
bjp-23079	10	3	-	-	PUNCT
bjp-23079	10	4	free	free	ADJ
bjp-23079	10	5	survival	survival	NOUN
bjp-23079	10	6	(	(	PUNCT
bjp-23079	10	7	pfs	pfs	PROPN
bjp-23079	10	8	)	)	PUNCT
bjp-23079	10	9	was	be	AUX
bjp-23079	10	10	16.8	16.8	NUM
bjp-23079	10	11	months	month	NOUN
bjp-23079	10	12	(	(	PUNCT
bjp-23079	10	13	range	range	NOUN
bjp-23079	10	14	3.3	3.3	NUM
bjp-23079	10	15	-	-	SYM
bjp-23079	10	16	48	48	NUM
bjp-23079	10	17	+	+	NUM
bjp-23079	10	18	months	month	NOUN
bjp-23079	10	19	)	)	PUNCT
bjp-23079	10	20	of	of	ADP
bjp-23079	10	21	conventional	conventional	ADJ
bjp-23079	10	22	paclitaxel	paclitaxel	PROPN
bjp-23079	10	23	and	and	CCONJ
bjp-23079	10	24	carboplatin	carboplatin	PROPN
bjp-23079	10	25	group	group	NOUN
bjp-23079	10	26	was	be	AUX
bjp-23079	10	27	lower	low	ADJ
bjp-23079	10	28	than	than	ADP
bjp-23079	10	29	that	that	PRON
bjp-23079	10	30	of	of	ADP
bjp-23079	10	31	dose	dose	NOUN
bjp-23079	10	32	-	-	PUNCT
bjp-23079	10	33	dense	dense	ADJ
bjp-23079	10	34	weekly	weekly	ADJ
bjp-23079	10	35	paclitaxel	paclitaxel	NOUN
bjp-23079	10	36	and	and	CCONJ
bjp-23079	10	37	carboplatin	carboplatin	PROPN
bjp-23079	10	38	group	group	NOUN
bjp-23079	10	39	27.6	27.6	NUM
bjp-23079	10	40	months	month	NOUN
bjp-23079	10	41	(	(	PUNCT
bjp-23079	10	42	range	range	NOUN
bjp-23079	10	43	4.2	4.2	NUM
bjp-23079	10	44	-	-	SYM
bjp-23079	10	45	51	51	NUM
bjp-23079	10	46	+	+	NUM
bjp-23079	10	47	months	month	NOUN
bjp-23079	10	48	)	)	PUNCT
bjp-23079	10	49	.	.	PUNCT
bjp-23079	11	1	but	but	CCONJ
bjp-23079	11	2	,	,	PUNCT
bjp-23079	11	3	these	these	DET
bjp-23079	11	4	clinical	clinical	ADJ
bjp-23079	11	5	responses	response	NOUN
bjp-23079	11	6	were	be	AUX
bjp-23079	11	7	not	not	PART
bjp-23079	11	8	statistical	statistical	ADJ
bjp-23079	11	9	significance	significance	NOUN
bjp-23079	11	10	in	in	ADP
bjp-23079	11	11	each	each	DET
bjp-23079	11	12	group	group	NOUN
bjp-23079	11	13	.	.	PUNCT
bjp-23079	12	1	in	in	ADP
bjp-23079	12	2	conclusion	conclusion	NOUN
bjp-23079	12	3	,	,	PUNCT
bjp-23079	12	4	dose	dose	NOUN
bjp-23079	12	5	-	-	PUNCT
bjp-23079	12	6	dense	dense	ADJ
bjp-23079	12	7	weekly	weekly	ADJ
bjp-23079	12	8	paclitaxel	paclitaxel	NOUN
bjp-23079	12	9	and	and	CCONJ
bjp-23079	12	10	carboplatin	carboplatin	NOUN
bjp-23079	12	11	treatment	treatment	NOUN
bjp-23079	12	12	improves	improve	VERB
bjp-23079	12	13	survival	survival	NOUN
bjp-23079	12	14	compared	compare	VERB
bjp-23079	12	15	with	with	ADP
bjp-23079	12	16	conventional	conventional	ADJ
bjp-23079	12	17	paclitaxel	paclitaxel	NOUN
bjp-23079	12	18	and	and	CCONJ
bjp-23079	12	19	carboplatin	carboplatin	NOUN
bjp-23079	12	20	treatment	treatment	NOUN
bjp-23079	12	21	.	.	PUNCT
bjp-23079	13	1	article	article	NOUN
bjp-23079	13	2	info	info	NOUN
bjp-23079	13	3	received	receive	VERB
bjp-23079	13	4	:	:	PUNCT
bjp-23079	13	5	24	24	NUM
bjp-23079	13	6	april	april	PROPN
bjp-23079	13	7	2015	2015	NUM
bjp-23079	13	8	accepted	accept	VERB
bjp-23079	13	9	:	:	PUNCT
bjp-23079	13	10	21	21	NUM
bjp-23079	13	11	may	may	PROPN
bjp-23079	13	12	2015	2015	NUM
bjp-23079	13	13	available	available	ADJ
bjp-23079	13	14	online	online	ADV
bjp-23079	13	15	:	:	PUNCT
bjp-23079	13	16	1	1	NUM
bjp-23079	13	17	july	july	PROPN
bjp-23079	13	18	2015	2015	NUM
bjp-23079	13	19	doi	doi	NOUN
bjp-23079	13	20	:	:	PUNCT
bjp-23079	13	21	10.3329	10.3329	NUM
bjp-23079	13	22	/	/	SYM
bjp-23079	13	23	bjp.v10i3.23079	bjp.v10i3.23079	PROPN
bjp-23079	13	24	cite	cite	VERB
bjp-23079	13	25	this	this	DET
bjp-23079	13	26	article	article	NOUN
bjp-23079	13	27	:	:	PUNCT
bjp-23079	13	28	du	du	PROPN
bjp-23079	13	29	z	z	PROPN
bjp-23079	13	30	,	,	PUNCT
bjp-23079	13	31	ma	ma	PROPN
bjp-23079	13	32	x.	x.	PROPN
bjp-23079	13	33	dose	dose	PROPN
bjp-23079	13	34	-	-	PUNCT
bjp-23079	13	35	dense	dense	ADJ
bjp-23079	13	36	weekly	weekly	ADJ
bjp-23079	13	37	paclitaxel	paclitaxel	NOUN
bjp-23079	13	38	and	and	CCONJ
bjp-23079	13	39	carboplatin	carboplatin	NOUN
bjp-23079	13	40	compared	compare	VERB
bjp-23079	13	41	with	with	ADP
bjp-23079	13	42	conventional	conventional	ADJ
bjp-23079	13	43	paclitaxel	paclitaxel	NOUN
bjp-23079	13	44	and	and	CCONJ
bjp-23079	13	45	carboplatin	carboplatin	NOUN
bjp-23079	13	46	treatment	treatment	NOUN
bjp-23079	13	47	for	for	ADP
bjp-23079	13	48	stage	stage	NOUN
bjp-23079	13	49	ii	ii	PROPN
bjp-23079	13	50	-	-	PUNCT
bjp-23079	13	51	iv	iv	ADJ
bjp-23079	13	52	ovarian	ovarian	ADJ
bjp-23079	13	53	cancer	cancer	NOUN
bjp-23079	13	54	patients	patient	NOUN
bjp-23079	13	55	.	.	PUNCT
bjp-23079	14	1	bangladesh	bangladesh	PROPN
bjp-23079	14	2	j	j	PROPN
bjp-23079	14	3	pharmacol	pharmacol	PROPN
bjp-23079	14	4	.	.	PROPN
bjp-23079	15	1	2015	2015	NUM
bjp-23079	15	2	;	;	PUNCT
bjp-23079	15	3	10	10	NUM
bjp-23079	15	4	:	:	SYM
bjp-23079	15	5	489	489	NUM
bjp-23079	15	6	-	-	SYM
bjp-23079	15	7	93	93	NUM
bjp-23079	15	8	.	.	PUNCT
bjp-23079	16	1	this	this	DET
bjp-23079	16	2	work	work	NOUN
bjp-23079	16	3	is	be	AUX
bjp-23079	16	4	licensed	license	VERB
bjp-23079	16	5	under	under	ADP
bjp-23079	16	6	a	a	DET
bjp-23079	16	7	creative	creative	ADJ
bjp-23079	16	8	commons	common	NOUN
bjp-23079	16	9	attribution	attribution	NOUN
bjp-23079	16	10	3.0	3.0	NUM
bjp-23079	16	11	license	license	NOUN
bjp-23079	16	12	.	.	PUNCT
bjp-23079	17	1	you	you	PRON
bjp-23079	17	2	are	be	AUX
bjp-23079	17	3	free	free	ADJ
bjp-23079	17	4	to	to	PART
bjp-23079	17	5	copy	copy	VERB
bjp-23079	17	6	,	,	PUNCT
bjp-23079	17	7	distribute	distribute	VERB
bjp-23079	17	8	and	and	CCONJ
bjp-23079	17	9	perform	perform	VERB
bjp-23079	17	10	the	the	DET
bjp-23079	17	11	work	work	NOUN
bjp-23079	17	12	.	.	PUNCT
bjp-23079	18	1	you	you	PRON
bjp-23079	18	2	must	must	AUX
bjp-23079	18	3	attribute	attribute	VERB
bjp-23079	18	4	the	the	DET
bjp-23079	18	5	work	work	NOUN
bjp-23079	18	6	in	in	ADP
bjp-23079	18	7	the	the	DET
bjp-23079	18	8	manner	manner	NOUN
bjp-23079	18	9	specified	specify	VERB
bjp-23079	18	10	by	by	ADP
bjp-23079	18	11	the	the	DET
bjp-23079	18	12	author	author	NOUN
bjp-23079	18	13	or	or	CCONJ
bjp-23079	18	14	licensor	licensor	NOUN
bjp-23079	18	15	.	.	PUNCT
bjp-23079	19	1	dose	dose	NOUN
bjp-23079	19	2	-	-	PUNCT
bjp-23079	19	3	dense	dense	ADJ
bjp-23079	19	4	weekly	weekly	ADJ
bjp-23079	19	5	paclitaxel	paclitaxel	NOUN
bjp-23079	19	6	and	and	CCONJ
bjp-23079	19	7	carboplatin	carboplatin	NOUN
bjp-23079	19	8	compared	compare	VERB
bjp-23079	19	9	with	with	ADP
bjp-23079	19	10	conventional	conventional	ADJ
bjp-23079	19	11	paclitaxel	paclitaxel	NOUN
bjp-23079	19	12	and	and	CCONJ
bjp-23079	19	13	carboplatin	carboplatin	NOUN
bjp-23079	19	14	treatment	treatment	NOUN
bjp-23079	19	15	for	for	ADP
bjp-23079	19	16	stage	stage	NOUN
bjp-23079	19	17	ii	ii	PROPN
bjp-23079	19	18	-	-	PUNCT
bjp-23079	19	19	iv	iv	ADJ
bjp-23079	19	20	ovarian	ovarian	ADJ
bjp-23079	19	21	cancer	cancer	NOUN
bjp-23079	19	22	patients	patient	NOUN
bjp-23079	19	23	zhenhua	zhenhua	PROPN
bjp-23079	19	24	du	du	PROPN
bjp-23079	19	25	and	and	CCONJ
bjp-23079	19	26	xiaolin	xiaolin	PROPN
bjp-23079	19	27	ma	ma	PROPN
bjp-23079	19	28	department	department	PROPN
bjp-23079	19	29	of	of	ADP
bjp-23079	19	30	obstetrics	obstetric	NOUN
bjp-23079	19	31	and	and	CCONJ
bjp-23079	19	32	gynecology	gynecology	NOUN
bjp-23079	19	33	,	,	PUNCT
bjp-23079	19	34	sheng	sheng	PROPN
bjp-23079	19	35	jing	jing	PROPN
bjp-23079	19	36	hospital	hospital	PROPN
bjp-23079	19	37	of	of	ADP
bjp-23079	19	38	china	china	PROPN
bjp-23079	19	39	medical	medical	PROPN
bjp-23079	19	40	university	university	PROPN
bjp-23079	19	41	,	,	PUNCT
bjp-23079	19	42	shenyang	shenyang	PROPN
bjp-23079	19	43	,	,	PUNCT
bjp-23079	19	44	liaoning	liaone	VERB
bjp-23079	19	45	110	110	NUM
bjp-23079	19	46	022	022	NUM
bjp-23079	19	47	,	,	PUNCT
bjp-23079	19	48	china	china	PROPN
bjp-23079	19	49	.	.	PUNCT
bjp-23079	20	1	c	c	PROPN
bjp-23079	20	2	lin	lin	PROPN
bjp-23079	20	3	ic	ic	PROPN
bjp-23079	20	4	al	al	PROPN
bjp-23079	20	5	t	t	PROPN
bjp-23079	20	6	ria	ria	PROPN
bjp-23079	20	7	l	l	PROPN
bjp-23079	20	8	platin	platin	PROPN
bjp-23079	20	9	program	program	NOUN
bjp-23079	20	10	as	as	ADP
bjp-23079	20	11	the	the	DET
bjp-23079	20	12	post	post	ADJ
bjp-23079	20	13	-	-	ADJ
bjp-23079	20	14	surgery	surgery	ADJ
bjp-23079	20	15	first	first	ADJ
bjp-23079	20	16	-	-	PUNCT
bjp-23079	20	17	line	line	NOUN
bjp-23079	20	18	chemotherapy	chemotherapy	NOUN
bjp-23079	20	19	of	of	ADP
bjp-23079	20	20	the	the	DET
bjp-23079	20	21	epithelial	epithelial	ADJ
bjp-23079	20	22	ovarian	ovarian	ADJ
bjp-23079	20	23	cancer	cancer	NOUN
bjp-23079	20	24	,	,	PUNCT
bjp-23079	20	25	alleviate	alleviate	VERB
bjp-23079	20	26	the	the	DET
bjp-23079	20	27	adverse	adverse	ADJ
bjp-23079	20	28	reaction	reaction	NOUN
bjp-23079	20	29	of	of	ADP
bjp-23079	20	30	chemotherapy	chemotherapy	NOUN
bjp-23079	20	31	to	to	ADP
bjp-23079	20	32	a	a	DET
bjp-23079	20	33	certain	certain	ADJ
bjp-23079	20	34	extent	extent	NOUN
bjp-23079	20	35	,	,	PUNCT
bjp-23079	20	36	and	and	CCONJ
bjp-23079	20	37	improve	improve	VERB
bjp-23079	20	38	the	the	DET
bjp-23079	20	39	patient	patient	NOUN
bjp-23079	20	40	's	's	PART
bjp-23079	20	41	quality	quality	NOUN
bjp-23079	20	42	of	of	ADP
bjp-23079	20	43	life	life	NOUN
bjp-23079	20	44	(	(	PUNCT
bjp-23079	20	45	chen	chen	PROPN
bjp-23079	20	46	et	et	PROPN
bjp-23079	20	47	al	al	PROPN
bjp-23079	20	48	.	.	PROPN
bjp-23079	20	49	,	,	PUNCT
bjp-23079	20	50	2013	2013	NUM
bjp-23079	20	51	;	;	PUNCT
bjp-23079	20	52	katsumata	katsumata	NOUN
bjp-23079	20	53	et	et	PROPN
bjp-23079	20	54	al	al	PROPN
bjp-23079	20	55	.	.	PROPN
bjp-23079	20	56	,	,	PUNCT
bjp-23079	20	57	2013	2013	NUM
bjp-23079	20	58	;	;	PUNCT
bjp-23079	20	59	katsumata	katsumata	NOUN
bjp-23079	20	60	et	et	PROPN
bjp-23079	20	61	al	al	PROPN
bjp-23079	20	62	.	.	PROPN
bjp-23079	20	63	,	,	PUNCT
bjp-23079	20	64	2009	2009	NUM
bjp-23079	20	65	)	)	PUNCT
bjp-23079	20	66	.	.	PUNCT
bjp-23079	21	1	in	in	ADP
bjp-23079	21	2	the	the	DET
bjp-23079	21	3	present	present	ADJ
bjp-23079	21	4	study	study	NOUN
bjp-23079	21	5	,	,	PUNCT
bjp-23079	21	6	we	we	PRON
bjp-23079	21	7	investigated	investigate	VERB
bjp-23079	21	8	dose	dose	NOUN
bjp-23079	21	9	-	-	PUNCT
bjp-23079	21	10	dense	dense	ADJ
bjp-23079	21	11	weekly	weekly	ADJ
bjp-23079	21	12	paclitaxel	paclitaxel	NOUN
bjp-23079	21	13	and	and	CCONJ
bjp-23079	21	14	carboplatin	carboplatin	NOUN
bjp-23079	21	15	compared	compare	VERB
bjp-23079	21	16	with	with	ADP
bjp-23079	21	17	conventional	conventional	ADJ
bjp-23079	21	18	paclitaxel	paclitaxel	NOUN
bjp-23079	21	19	and	and	CCONJ
bjp-23079	21	20	carboplatin	carboplatin	NOUN
bjp-23079	21	21	treatment	treatment	NOUN
bjp-23079	21	22	on	on	ADP
bjp-23079	21	23	stage	stage	NOUN
bjp-23079	21	24	ii	ii	PROPN
bjp-23079	21	25	-	-	PUNCT
bjp-23079	21	26	iv	iv	ADJ
bjp-23079	21	27	ovarian	ovarian	ADJ
bjp-23079	21	28	cancer	cancer	NOUN
bjp-23079	21	29	patients	patient	NOUN
bjp-23079	21	30	.	.	PUNCT
bjp-23079	22	1	materials	material	NOUN
bjp-23079	22	2	and	and	CCONJ
bjp-23079	22	3	methods	method	NOUN
bjp-23079	22	4	patients	patient	NOUN
bjp-23079	22	5	and	and	CCONJ
bjp-23079	22	6	eligibility	eligibility	NOUN
bjp-23079	22	7	:	:	PUNCT
bjp-23079	22	8	between	between	ADP
bjp-23079	22	9	july	july	PROPN
bjp-23079	22	10	,	,	PUNCT
bjp-23079	22	11	2011	2011	NUM
bjp-23079	22	12	,	,	PUNCT
bjp-23079	22	13	and	and	CCONJ
bjp-23079	22	14	october	october	PROPN
bjp-23079	22	15	,	,	PUNCT
bjp-23079	22	16	2014	2014	NUM
bjp-23079	22	17	,	,	PUNCT
bjp-23079	22	18	a	a	DET
bjp-23079	22	19	total	total	NOUN
bjp-23079	22	20	of	of	ADP
bjp-23079	22	21	221	221	NUM
bjp-23079	22	22	patients	patient	NOUN
bjp-23079	22	23	were	be	AUX
bjp-23079	22	24	randomly	randomly	ADV
bjp-23079	22	25	assigned	assign	VERB
bjp-23079	22	26	to	to	PART
bjp-23079	22	27	receive	receive	VERB
bjp-23079	22	28	dose	dose	NOUN
bjp-23079	22	29	-	-	PUNCT
bjp-23079	22	30	dense	dense	ADJ
bjp-23079	22	31	weekly	weekly	ADJ
bjp-23079	22	32	paclitaxel	paclitaxel	NOUN
bjp-23079	22	33	and	and	CCONJ
bjp-23079	22	34	carboplatin	carboplatin	PROPN
bjp-23079	22	35	group	group	NOUN
bjp-23079	22	36	(	(	PUNCT
bjp-23079	22	37	n	n	NOUN
bjp-23079	22	38	=	=	SYM
bjp-23079	22	39	109	109	NUM
bjp-23079	22	40	)	)	PUNCT
bjp-23079	22	41	and	and	CCONJ
bjp-23079	22	42	conventional	conventional	ADJ
bjp-23079	22	43	paclitaxel	paclitaxel	NOUN
bjp-23079	22	44	and	and	CCONJ
bjp-23079	22	45	carboplatin	carboplatin	PROPN
bjp-23079	22	46	group	group	NOUN
bjp-23079	22	47	(	(	PUNCT
bjp-23079	22	48	n	n	NOUN
bjp-23079	22	49	=	=	SYM
bjp-23079	22	50	112	112	NUM
bjp-23079	22	51	)	)	PUNCT
bjp-23079	22	52	,	,	PUNCT
bjp-23079	22	53	just	just	ADV
bjp-23079	22	54	after	after	ADP
bjp-23079	22	55	the	the	DET
bjp-23079	22	56	sixth	sixth	ADJ
bjp-23079	22	57	chemotherapy	chemotherapy	NOUN
bjp-23079	22	58	cycles	cycle	NOUN
bjp-23079	22	59	,	,	PUNCT
bjp-23079	22	60	and	and	CCONJ
bjp-23079	22	61	at	at	ADP
bjp-23079	22	62	12	12	NUM
bjp-23079	22	63	months	month	NOUN
bjp-23079	22	64	after	after	ADP
bjp-23079	22	65	randomization	randomization	NOUN
bjp-23079	22	66	(	(	PUNCT
bjp-23079	22	67	harano	harano	INTJ
bjp-23079	22	68	et	et	PROPN
bjp-23079	22	69	al	al	PROPN
bjp-23079	22	70	.	.	PROPN
bjp-23079	22	71	,	,	PUNCT
bjp-23079	22	72	2014	2014	NUM
bjp-23079	22	73	)	)	PUNCT
bjp-23079	22	74	.	.	PUNCT
bjp-23079	23	1	the	the	DET
bjp-23079	23	2	specific	specific	ADJ
bjp-23079	23	3	information	information	NOUN
bjp-23079	23	4	of	of	ADP
bjp-23079	23	5	the	the	DET
bjp-23079	23	6	trial	trial	NOUN
bjp-23079	23	7	has	have	AUX
bjp-23079	23	8	been	be	AUX
bjp-23079	23	9	already	already	ADV
bjp-23079	23	10	covered	cover	VERB
bjp-23079	23	11	.	.	PUNCT
bjp-23079	24	1	to	to	PART
bjp-23079	24	2	put	put	VERB
bjp-23079	24	3	it	it	PRON
bjp-23079	24	4	in	in	ADP
bjp-23079	24	5	a	a	DET
bjp-23079	24	6	nutshell	nutshell	NOUN
bjp-23079	24	7	,	,	PUNCT
bjp-23079	24	8	it	it	PRON
bjp-23079	24	9	was	be	AUX
bjp-23079	24	10	confirmed	confirm	VERB
bjp-23079	24	11	that	that	SCONJ
bjp-23079	24	12	the	the	DET
bjp-23079	24	13	suitable	suitable	ADJ
bjp-23079	24	14	patients	patient	NOUN
bjp-23079	24	15	were	be	AUX
bjp-23079	24	16	diagnosed	diagnose	VERB
bjp-23079	24	17	with	with	ADP
bjp-23079	24	18	stage	stage	NOUN
bjp-23079	24	19	ii	ii	PROPN
bjp-23079	24	20	-	-	PUNCT
bjp-23079	24	21	iv	iv	ADJ
bjp-23079	24	22	epithelial	epithelial	ADJ
bjp-23079	24	23	ovarian	ovarian	ADJ
bjp-23079	24	24	cancer	cancer	NOUN
bjp-23079	24	25	,	,	PUNCT
bjp-23079	24	26	primary	primary	ADJ
bjp-23079	24	27	peritoneal	peritoneal	ADJ
bjp-23079	24	28	cancer	cancer	NOUN
bjp-23079	24	29	,	,	PUNCT
bjp-23079	24	30	or	or	CCONJ
bjp-23079	24	31	fallopian	fallopian	ADJ
bjp-23079	24	32	tube	tube	NOUN
bjp-23079	24	33	cancer	cancer	NOUN
bjp-23079	24	34	in	in	ADP
bjp-23079	24	35	histological	histological	ADJ
bjp-23079	24	36	or	or	CCONJ
bjp-23079	24	37	cytological	cytological	ADJ
bjp-23079	24	38	terms	term	NOUN
bjp-23079	24	39	.	.	PUNCT
bjp-23079	25	1	additional	additional	ADJ
bjp-23079	25	2	criteria	criterion	NOUN
bjp-23079	25	3	for	for	ADP
bjp-23079	25	4	inclusion	inclusion	NOUN
bjp-23079	25	5	consisted	consist	VERB
bjp-23079	25	6	of	of	ADP
bjp-23079	25	7	age	age	NOUN
bjp-23079	25	8	of	of	ADP
bjp-23079	25	9	20	20	NUM
bjp-23079	25	10	years	year	NOUN
bjp-23079	25	11	or	or	CCONJ
bjp-23079	25	12	more	more	ADJ
bjp-23079	25	13	,	,	PUNCT
bjp-23079	25	14	an	an	DET
bjp-23079	25	15	eastern	eastern	ADJ
bjp-23079	25	16	cooperative	cooperative	ADJ
bjp-23079	25	17	oncology	oncology	NOUN
bjp-23079	25	18	group	group	NOUN
bjp-23079	25	19	performance	performance	NOUN
bjp-23079	25	20	status	status	NOUN
bjp-23079	25	21	of	of	ADP
bjp-23079	25	22	03	03	NUM
bjp-23079	25	23	,	,	PUNCT
bjp-23079	25	24	and	and	CCONJ
bjp-23079	25	25	satisfactory	satisfactory	ADJ
bjp-23079	25	26	bone	bone	NOUN
bjp-23079	25	27	marrow	marrow	NOUN
bjp-23079	25	28	,	,	PUNCT
bjp-23079	25	29	renal	renal	ADJ
bjp-23079	25	30	,	,	PUNCT
bjp-23079	25	31	and	and	CCONJ
bjp-23079	25	32	hepatic	hepatic	ADJ
bjp-23079	25	33	function	function	NOUN
bjp-23079	25	34	.	.	PUNCT
bjp-23079	26	1	patients	patient	NOUN
bjp-23079	26	2	who	who	PRON
bjp-23079	26	3	suffered	suffer	VERB
bjp-23079	26	4	from	from	ADP
bjp-23079	26	5	an	an	DET
bjp-23079	26	6	ovarian	ovarian	ADJ
bjp-23079	26	7	tumor	tumor	NOUN
bjp-23079	26	8	with	with	ADP
bjp-23079	26	9	a	a	DET
bjp-23079	26	10	low	low	ADJ
bjp-23079	26	11	malignant	malignant	ADJ
bjp-23079	26	12	potential	potential	NOUN
bjp-23079	26	13	or	or	CCONJ
bjp-23079	26	14	a	a	DET
bjp-23079	26	15	synchronous	synchronous	ADJ
bjp-23079	26	16	or	or	CCONJ
bjp-23079	26	17	metachronous	metachronous	ADJ
bjp-23079	26	18	(	(	PUNCT
bjp-23079	26	19	within	within	ADP
bjp-23079	26	20	5	5	NUM
bjp-23079	26	21	years	year	NOUN
bjp-23079	26	22	)	)	PUNCT
bjp-23079	26	23	malignancies	malignancy	NOUN
bjp-23079	26	24	other	other	ADJ
bjp-23079	26	25	than	than	ADP
bjp-23079	26	26	carcinoma	carcinoma	NOUN
bjp-23079	26	27	in	in	ADP
bjp-23079	26	28	situ	situ	NOUN
bjp-23079	26	29	were	be	AUX
bjp-23079	26	30	barred	bar	VERB
bjp-23079	26	31	from	from	ADP
bjp-23079	26	32	participation	participation	NOUN
bjp-23079	26	33	.	.	PUNCT
bjp-23079	27	1	informed	informed	ADJ
bjp-23079	27	2	consent	consent	NOUN
bjp-23079	27	3	was	be	AUX
bjp-23079	27	4	provided	provide	VERB
bjp-23079	27	5	by	by	ADP
bjp-23079	27	6	all	all	DET
bjp-23079	27	7	patients	patient	NOUN
bjp-23079	27	8	before	before	SCONJ
bjp-23079	27	9	they	they	PRON
bjp-23079	27	10	took	take	VERB
bjp-23079	27	11	part	part	NOUN
bjp-23079	27	12	in	in	ADP
bjp-23079	27	13	the	the	DET
bjp-23079	27	14	study	study	NOUN
bjp-23079	27	15	.	.	PUNCT
bjp-23079	28	1	the	the	DET
bjp-23079	28	2	study	study	NOUN
bjp-23079	28	3	protocol	protocol	NOUN
bjp-23079	28	4	gained	gain	VERB
bjp-23079	28	5	approval	approval	NOUN
bjp-23079	28	6	from	from	ADP
bjp-23079	28	7	the	the	DET
bjp-23079	28	8	institutional	institutional	ADJ
bjp-23079	28	9	review	review	NOUN
bjp-23079	28	10	boards	board	NOUN
bjp-23079	28	11	at	at	ADP
bjp-23079	28	12	each	each	PRON
bjp-23079	28	13	and	and	CCONJ
bjp-23079	28	14	every	every	DET
bjp-23079	28	15	participating	participate	VERB
bjp-23079	28	16	center	center	NOUN
bjp-23079	28	17	.	.	PUNCT
bjp-23079	29	1	the	the	DET
bjp-23079	29	2	protocol	protocol	NOUN
bjp-23079	29	3	was	be	AUX
bjp-23079	29	4	coordinated	coordinate	VERB
bjp-23079	29	5	by	by	ADP
bjp-23079	29	6	the	the	DET
bjp-23079	29	7	shengjing	shengjing	NOUN
bjp-23079	29	8	hospital	hospital	NOUN
bjp-23079	29	9	of	of	ADP
bjp-23079	29	10	china	china	PROPN
bjp-23079	29	11	medical	medical	PROPN
bjp-23079	29	12	university	university	PROPN
bjp-23079	29	13	(	(	PUNCT
bjp-23079	29	14	protocol	protocol	NOUN
bjp-23079	29	15	number	number	NOUN
bjp-23079	29	16	sjcmu3013	sjcmu3013	PROPN
bjp-23079	29	17	)	)	PUNCT
bjp-23079	29	18	.	.	PUNCT
bjp-23079	30	1	treatment	treatment	NOUN
bjp-23079	30	2	plan	plan	NOUN
bjp-23079	30	3	:	:	PUNCT
bjp-23079	30	4	patients	patient	NOUN
bjp-23079	30	5	were	be	AUX
bjp-23079	30	6	expected	expect	VERB
bjp-23079	30	7	to	to	PART
bjp-23079	30	8	receive	receive	VERB
bjp-23079	30	9	paclitaxel	paclitaxel	PROPN
bjp-23079	30	10	(	(	PUNCT
bjp-23079	30	11	taxol	taxol	PROPN
bjp-23079	30	12	)	)	PUNCT
bjp-23079	30	13	and	and	CCONJ
bjp-23079	30	14	carboplatin	carboplatin	NOUN
bjp-23079	30	15	as	as	ADP
bjp-23079	30	16	part	part	NOUN
bjp-23079	30	17	of	of	ADP
bjp-23079	30	18	either	either	CCONJ
bjp-23079	30	19	an	an	DET
bjp-23079	30	20	conventional	conventional	ADJ
bjp-23079	30	21	paclitaxel	paclitaxel	NOUN
bjp-23079	30	22	and	and	CCONJ
bjp-23079	30	23	carboplatin	carboplatin	NOUN
bjp-23079	30	24	treatment	treatment	NOUN
bjp-23079	30	25	(	(	PUNCT
bjp-23079	30	26	group	group	NOUN
bjp-23079	30	27	)	)	PUNCT
bjp-23079	30	28	or	or	CCONJ
bjp-23079	30	29	dose	dose	NOUN
bjp-23079	30	30	-	-	PUNCT
bjp-23079	30	31	dense	dense	ADJ
bjp-23079	30	32	weekly	weekly	ADJ
bjp-23079	30	33	paclitaxel	paclitaxel	NOUN
bjp-23079	30	34	and	and	CCONJ
bjp-23079	30	35	carboplatin	carboplatin	NOUN
bjp-23079	30	36	treatment	treatment	NOUN
bjp-23079	30	37	(	(	PUNCT
bjp-23079	30	38	group	group	NOUN
bjp-23079	30	39	)	)	PUNCT
bjp-23079	30	40	at	at	ADP
bjp-23079	30	41	random	random	ADJ
bjp-23079	30	42	.	.	PUNCT
bjp-23079	31	1	the	the	DET
bjp-23079	31	2	two	two	NUM
bjp-23079	31	3	groups	group	NOUN
bjp-23079	31	4	were	be	AUX
bjp-23079	31	5	provided	provide	VERB
bjp-23079	31	6	with	with	ADP
bjp-23079	31	7	carboplatin	carboplatin	NOUN
bjp-23079	31	8	at	at	ADP
bjp-23079	31	9	a	a	DET
bjp-23079	31	10	dose	dose	NOUN
bjp-23079	31	11	intended	intend	VERB
bjp-23079	31	12	to	to	PART
bjp-23079	31	13	bring	bring	VERB
bjp-23079	31	14	about	about	ADP
bjp-23079	31	15	an	an	DET
bjp-23079	31	16	area	area	NOUN
bjp-23079	31	17	under	under	ADP
bjp-23079	31	18	the	the	DET
bjp-23079	31	19	plasma	plasma	NOUN
bjp-23079	31	20	concentration	concentration	NOUN
bjp-23079	31	21	-	-	PUNCT
bjp-23079	31	22	time	time	NOUN
bjp-23079	31	23	curve	curve	NOUN
bjp-23079	31	24	of	of	ADP
bjp-23079	31	25	6	6	NUM
bjp-23079	31	26	mg/	mg/	NOUN
bjp-23079	31	27	ml	ml	NOUN
bjp-23079	31	28	/	/	SYM
bjp-23079	31	29	min	min	NOUN
bjp-23079	31	30	on	on	ADP
bjp-23079	31	31	the	the	DET
bjp-23079	31	32	first	first	ADJ
bjp-23079	31	33	day	day	NOUN
bjp-23079	31	34	of	of	ADP
bjp-23079	31	35	a	a	DET
bjp-23079	31	36	21	21	NUM
bjp-23079	31	37	-	-	PUNCT
bjp-23079	31	38	day	day	NOUN
bjp-23079	31	39	cycle	cycle	NOUN
bjp-23079	31	40	.	.	PUNCT
bjp-23079	32	1	carboplatin	carboplatin	PROPN
bjp-23079	32	2	was	be	AUX
bjp-23079	32	3	dispensed	dispense	VERB
bjp-23079	32	4	as	as	ADP
bjp-23079	32	5	intravenous	intravenous	ADJ
bjp-23079	32	6	infusion	infusion	NOUN
bjp-23079	32	7	during	during	ADP
bjp-23079	32	8	the	the	DET
bjp-23079	32	9	course	course	NOUN
bjp-23079	32	10	of	of	ADP
bjp-23079	32	11	1	1	NUM
bjp-23079	32	12	hour	hour	NOUN
bjp-23079	32	13	.	.	PUNCT
bjp-23079	33	1	in	in	ADP
bjp-23079	33	2	addition	addition	NOUN
bjp-23079	33	3	,	,	PUNCT
bjp-23079	33	4	the	the	DET
bjp-23079	33	5	conventional	conventional	ADJ
bjp-23079	33	6	paclitaxel	paclitaxel	NOUN
bjp-23079	33	7	and	and	CCONJ
bjp-23079	33	8	carboplatin	carboplatin	PROPN
bjp-23079	33	9	group	group	NOUN
bjp-23079	33	10	received	receive	VERB
bjp-23079	33	11	paclitaxel	paclitaxel	PROPN
bjp-23079	33	12	as	as	ADP
bjp-23079	33	13	intravenous	intravenous	ADJ
bjp-23079	33	14	infusion	infusion	NOUN
bjp-23079	33	15	for	for	ADP
bjp-23079	33	16	3	3	NUM
bjp-23079	33	17	hours	hour	NOUN
bjp-23079	33	18	at	at	ADP
bjp-23079	33	19	a	a	DET
bjp-23079	33	20	dose	dose	NOUN
bjp-23079	33	21	of	of	ADP
bjp-23079	33	22	180	180	NUM
bjp-23079	33	23	mg	mg	PROPN
bjp-23079	33	24	/	/	SYM
bjp-23079	33	25	m2	m2	PROPN
bjp-23079	33	26	on	on	ADP
bjp-23079	33	27	the	the	DET
bjp-23079	33	28	first	first	ADJ
bjp-23079	33	29	day	day	NOUN
bjp-23079	33	30	.	.	PUNCT
bjp-23079	34	1	in	in	ADP
bjp-23079	34	2	dose	dose	NOUN
bjp-23079	34	3	-	-	PUNCT
bjp-23079	34	4	dense	dense	ADJ
bjp-23079	34	5	weekly	weekly	ADJ
bjp-23079	34	6	paclitaxel	paclitaxel	NOUN
bjp-23079	34	7	and	and	CCONJ
bjp-23079	34	8	carboplatin	carboplatin	PROPN
bjp-23079	34	9	group	group	NOUN
bjp-23079	34	10	,	,	PUNCT
bjp-23079	34	11	paclitaxel	paclitaxel	PROPN
bjp-23079	34	12	was	be	AUX
bjp-23079	34	13	dispensed	dispense	VERB
bjp-23079	34	14	as	as	ADP
bjp-23079	34	15	intravenous	intravenous	ADJ
bjp-23079	34	16	infusion	infusion	NOUN
bjp-23079	34	17	over	over	ADP
bjp-23079	34	18	1	1	NUM
bjp-23079	34	19	hour	hour	NOUN
bjp-23079	34	20	at	at	ADP
bjp-23079	34	21	a	a	DET
bjp-23079	34	22	dose	dose	NOUN
bjp-23079	34	23	of	of	ADP
bjp-23079	34	24	80	80	NUM
bjp-23079	34	25	mg	mg	PROPN
bjp-23079	34	26	/	/	SYM
bjp-23079	34	27	m2	m2	PROPN
bjp-23079	34	28	on	on	ADP
bjp-23079	34	29	the	the	DET
bjp-23079	34	30	first	first	ADJ
bjp-23079	34	31	,	,	PUNCT
bjp-23079	34	32	eighth	eighth	ADJ
bjp-23079	34	33	and	and	CCONJ
bjp-23079	34	34	15th	15th	ADJ
bjp-23079	34	35	day	day	NOUN
bjp-23079	34	36	respectively	respectively	ADV
bjp-23079	34	37	.	.	PUNCT
bjp-23079	35	1	the	the	DET
bjp-23079	35	2	treatments	treatment	NOUN
bjp-23079	35	3	were	be	AUX
bjp-23079	35	4	replicated	replicate	VERB
bjp-23079	35	5	every	every	DET
bjp-23079	35	6	3	3	NUM
bjp-23079	35	7	weeks	week	NOUN
bjp-23079	35	8	for	for	ADP
bjp-23079	35	9	six	six	NUM
bjp-23079	35	10	cycles	cycle	NOUN
bjp-23079	35	11	.	.	PUNCT
bjp-23079	36	1	for	for	ADP
bjp-23079	36	2	those	those	DET
bjp-23079	36	3	patients	patient	NOUN
bjp-23079	36	4	with	with	ADP
bjp-23079	36	5	measurable	measurable	ADJ
bjp-23079	36	6	lesions	lesion	NOUN
bjp-23079	36	7	and	and	CCONJ
bjp-23079	36	8	a	a	DET
bjp-23079	36	9	partial	partial	ADJ
bjp-23079	36	10	or	or	CCONJ
bjp-23079	36	11	complete	complete	ADJ
bjp-23079	36	12	response	response	NOUN
bjp-23079	36	13	,	,	PUNCT
bjp-23079	36	14	three	three	NUM
bjp-23079	36	15	extra	extra	ADJ
bjp-23079	36	16	cycles	cycle	NOUN
bjp-23079	36	17	of	of	ADP
bjp-23079	36	18	chemotherapy	chemotherapy	NOUN
bjp-23079	36	19	were	be	AUX
bjp-23079	36	20	provided	provide	VERB
bjp-23079	36	21	.	.	PUNCT
bjp-23079	37	1	curative	curative	ADJ
bjp-23079	37	2	effect	effect	NOUN
bjp-23079	37	3	analysis	analysis	NOUN
bjp-23079	37	4	:	:	PUNCT
bjp-23079	37	5	assessment	assessment	NOUN
bjp-23079	37	6	of	of	ADP
bjp-23079	37	7	the	the	DET
bjp-23079	37	8	response	response	NOUN
bjp-23079	37	9	was	be	AUX
bjp-23079	37	10	scheduled	schedule	VERB
bjp-23079	37	11	for	for	ADP
bjp-23079	37	12	the	the	DET
bjp-23079	37	13	56th	56th	ADJ
bjp-23079	37	14	day	day	NOUN
bjp-23079	37	15	.	.	PUNCT
bjp-23079	38	1	patients	patient	NOUN
bjp-23079	38	2	who	who	PRON
bjp-23079	38	3	were	be	AUX
bjp-23079	38	4	given	give	VERB
bjp-23079	38	5	cisplatin	cisplatin	NOUN
bjp-23079	38	6	at	at	ADP
bjp-23079	38	7	least	least	ADV
bjp-23079	38	8	three	three	NUM
bjp-23079	38	9	times	time	NOUN
bjp-23079	38	10	a	a	DET
bjp-23079	38	11	week	week	NOUN
bjp-23079	38	12	were	be	AUX
bjp-23079	38	13	deemed	deem	VERB
bjp-23079	38	14	evaluable	evaluable	ADJ
bjp-23079	38	15	for	for	ADP
bjp-23079	38	16	response	response	NOUN
bjp-23079	38	17	.	.	PUNCT
bjp-23079	39	1	definitions	definition	NOUN
bjp-23079	39	2	of	of	ADP
bjp-23079	39	3	the	the	DET
bjp-23079	39	4	response	response	NOUN
bjp-23079	39	5	were	be	AUX
bjp-23079	39	6	in	in	ADP
bjp-23079	39	7	accordance	accordance	NOUN
bjp-23079	39	8	with	with	ADP
bjp-23079	39	9	who	who	PRON
bjp-23079	39	10	criteria	criterion	NOUN
bjp-23079	39	11	;	;	PUNCT
bjp-23079	39	12	responses	response	NOUN
bjp-23079	39	13	was	be	AUX
bjp-23079	39	14	supposed	suppose	VERB
bjp-23079	39	15	to	to	PART
bjp-23079	39	16	be	be	AUX
bjp-23079	39	17	validated	validate	VERB
bjp-23079	39	18	by	by	ADP
bjp-23079	39	19	two	two	NUM
bjp-23079	39	20	observations	observation	NOUN
bjp-23079	39	21	at	at	ADP
bjp-23079	39	22	an	an	DET
bjp-23079	39	23	interval	interval	NOUN
bjp-23079	39	24	of	of	ADP
bjp-23079	39	25	at	at	ADV
bjp-23079	39	26	least	least	ADV
bjp-23079	39	27	4	4	NUM
bjp-23079	39	28	weeks	week	NOUN
bjp-23079	39	29	.	.	PUNCT
bjp-23079	40	1	all	all	DET
bjp-23079	40	2	responses	response	NOUN
bjp-23079	40	3	were	be	AUX
bjp-23079	40	4	reviewed	review	VERB
bjp-23079	40	5	by	by	ADP
bjp-23079	40	6	an	an	DET
bjp-23079	40	7	experienced	experienced	ADJ
bjp-23079	40	8	medical	medical	ADJ
bjp-23079	40	9	member	member	NOUN
bjp-23079	40	10	who	who	PRON
bjp-23079	40	11	did	do	AUX
bjp-23079	40	12	not	not	PART
bjp-23079	40	13	participate	participate	VERB
bjp-23079	40	14	in	in	ADP
bjp-23079	40	15	the	the	DET
bjp-23079	40	16	study	study	NOUN
bjp-23079	40	17	.	.	PUNCT
bjp-23079	41	1	providing	provide	VERB
bjp-23079	41	2	some	some	DET
bjp-23079	41	3	difference	difference	NOUN
bjp-23079	41	4	existed	exist	VERB
bjp-23079	41	5	in	in	ADP
bjp-23079	41	6	the	the	DET
bjp-23079	41	7	response	response	NOUN
bjp-23079	41	8	assessment	assessment	NOUN
bjp-23079	41	9	between	between	ADP
bjp-23079	41	10	investigator	investigator	NOUN
bjp-23079	41	11	and	and	CCONJ
bjp-23079	41	12	independent	independent	ADJ
bjp-23079	41	13	reviewer	reviewer	NOUN
bjp-23079	41	14	,	,	PUNCT
bjp-23079	41	15	the	the	DET
bjp-23079	41	16	worst	bad	ADJ
bjp-23079	41	17	response	response	NOUN
bjp-23079	41	18	was	be	AUX
bjp-23079	41	19	regarded	regard	VERB
bjp-23079	41	20	as	as	ADP
bjp-23079	41	21	the	the	DET
bjp-23079	41	22	actual	actual	ADJ
bjp-23079	41	23	response	response	NOUN
bjp-23079	41	24	.	.	PUNCT
bjp-23079	42	1	disease	disease	NOUN
bjp-23079	42	2	worsening	worsen	VERB
bjp-23079	42	3	was	be	AUX
bjp-23079	42	4	interpreted	interpret	VERB
bjp-23079	42	5	as	as	ADP
bjp-23079	42	6	the	the	DET
bjp-23079	42	7	emergence	emergence	NOUN
bjp-23079	42	8	of	of	ADP
bjp-23079	42	9	a	a	DET
bjp-23079	42	10	new	new	ADJ
bjp-23079	42	11	lesion	lesion	NOUN
bjp-23079	42	12	and/or	and/or	CCONJ
bjp-23079	42	13	>	>	NUM
bjp-23079	42	14	25	25	NUM
bjp-23079	42	15	%	%	NOUN
bjp-23079	42	16	increase	increase	NOUN
bjp-23079	42	17	of	of	ADP
bjp-23079	42	18	measurable	measurable	ADJ
bjp-23079	42	19	lesions	lesion	NOUN
bjp-23079	42	20	.	.	PUNCT
bjp-23079	43	1	ca-125	ca-125	NOUN
bjp-23079	43	2	elevation	elevation	NOUN
bjp-23079	43	3	itself	itself	PRON
bjp-23079	43	4	was	be	AUX
bjp-23079	43	5	not	not	PART
bjp-23079	43	6	thought	think	VERB
bjp-23079	43	7	of	of	ADP
bjp-23079	43	8	as	as	ADP
bjp-23079	43	9	sufficient	sufficient	ADJ
bjp-23079	43	10	evidence	evidence	NOUN
bjp-23079	43	11	for	for	ADP
bjp-23079	43	12	disease	disease	NOUN
bjp-23079	43	13	progression	progression	NOUN
bjp-23079	43	14	or	or	CCONJ
bjp-23079	43	15	recurrence	recurrence	NOUN
bjp-23079	43	16	.	.	PUNCT
bjp-23079	44	1	figure	figure	VERB
bjp-23079	44	2	1	1	NUM
bjp-23079	44	3	:	:	PUNCT
bjp-23079	44	4	trial	trial	NOUN
bjp-23079	44	5	profile	profile	NOUN
bjp-23079	44	6	490	490	NUM
bjp-23079	44	7	bangladesh	bangladesh	PROPN
bjp-23079	44	8	j	j	PROPN
bjp-23079	44	9	pharmacol	pharmacol	PROPN
bjp-23079	44	10	2015	2015	NUM
bjp-23079	44	11	;	;	PUNCT
bjp-23079	44	12	10	10	NUM
bjp-23079	44	13	:	:	PUNCT
bjp-23079	44	14	489	489	NUM
bjp-23079	44	15	-	-	SYM
bjp-23079	44	16	493	493	NUM
bjp-23079	44	17	measurement	measurement	NOUN
bjp-23079	44	18	was	be	AUX
bjp-23079	44	19	taken	take	VERB
bjp-23079	44	20	in	in	ADP
bjp-23079	44	21	relation	relation	NOUN
bjp-23079	44	22	to	to	ADP
bjp-23079	44	23	patient	patient	ADJ
bjp-23079	44	24	survival	survival	NOUN
bjp-23079	44	25	from	from	ADP
bjp-23079	44	26	the	the	DET
bjp-23079	44	27	first	first	ADJ
bjp-23079	44	28	day	day	NOUN
bjp-23079	44	29	of	of	ADP
bjp-23079	44	30	the	the	DET
bjp-23079	44	31	present	present	ADJ
bjp-23079	44	32	treatment	treatment	NOUN
bjp-23079	44	33	.	.	PUNCT
bjp-23079	45	1	the	the	DET
bjp-23079	45	2	progression	progression	NOUN
bjp-23079	45	3	-	-	PUNCT
bjp-23079	45	4	free	free	ADJ
bjp-23079	45	5	survival	survival	NOUN
bjp-23079	45	6	(	(	PUNCT
bjp-23079	45	7	pfs	pfs	PROPN
bjp-23079	45	8	)	)	PUNCT
bjp-23079	45	9	probabilities	probability	NOUN
bjp-23079	45	10	were	be	AUX
bjp-23079	45	11	worked	work	VERB
bjp-23079	45	12	out	out	ADP
bjp-23079	45	13	by	by	ADP
bjp-23079	45	14	making	make	VERB
bjp-23079	45	15	use	use	NOUN
bjp-23079	45	16	of	of	ADP
bjp-23079	45	17	the	the	DET
bjp-23079	45	18	kaplan	kaplan	PROPN
bjp-23079	45	19	-	-	PUNCT
bjp-23079	45	20	meier	meier	PROPN
bjp-23079	45	21	method	method	NOUN
bjp-23079	45	22	,	,	PUNCT
bjp-23079	45	23	with	with	ADP
bjp-23079	45	24	survival	survival	NOUN
bjp-23079	45	25	times	time	NOUN
bjp-23079	45	26	for	for	ADP
bjp-23079	45	27	survivors	survivor	NOUN
bjp-23079	45	28	determined	determine	VERB
bjp-23079	45	29	.	.	PUNCT
bjp-23079	46	1	a	a	DET
bjp-23079	46	2	non	non	ADJ
bjp-23079	46	3	-	-	ADJ
bjp-23079	46	4	parametric	parametric	ADJ
bjp-23079	46	5	log	log	NOUN
bjp-23079	46	6	-	-	PUNCT
bjp-23079	46	7	rank	rank	NOUN
bjp-23079	46	8	test	test	NOUN
bjp-23079	46	9	was	be	AUX
bjp-23079	46	10	put	put	VERB
bjp-23079	46	11	to	to	PART
bjp-23079	46	12	use	use	VERB
bjp-23079	46	13	for	for	ADP
bjp-23079	46	14	the	the	DET
bjp-23079	46	15	purpose	purpose	NOUN
bjp-23079	46	16	of	of	ADP
bjp-23079	46	17	testing	test	VERB
bjp-23079	46	18	the	the	DET
bjp-23079	46	19	null	null	ADJ
bjp-23079	46	20	hypothesis	hypothesis	NOUN
bjp-23079	46	21	that	that	PRON
bjp-23079	46	22	groups	group	NOUN
bjp-23079	46	23	to	to	PART
bjp-23079	46	24	be	be	AUX
bjp-23079	46	25	set	set	VERB
bjp-23079	46	26	side	side	NOUN
bjp-23079	46	27	by	by	ADP
bjp-23079	46	28	side	side	NOUN
bjp-23079	46	29	came	come	VERB
bjp-23079	46	30	from	from	ADP
bjp-23079	46	31	the	the	DET
bjp-23079	46	32	same	same	ADJ
bjp-23079	46	33	population	population	NOUN
bjp-23079	46	34	with	with	ADP
bjp-23079	46	35	regard	regard	NOUN
bjp-23079	46	36	to	to	ADP
bjp-23079	46	37	survival	survival	NOUN
bjp-23079	46	38	experience	experience	NOUN
bjp-23079	46	39	.	.	PUNCT
bjp-23079	47	1	ncss	ncss	PROPN
bjp-23079	47	2	v5.x	v5.x	PROPN
bjp-23079	47	3	(	(	PUNCT
bjp-23079	47	4	j.l	j.l	PROPN
bjp-23079	47	5	.	.	PROPN
bjp-23079	47	6	hintze	hintze	PROPN
bjp-23079	47	7	,	,	PUNCT
bjp-23079	47	8	east	east	PROPN
bjp-23079	47	9	kayesville	kayesville	PROPN
bjp-23079	47	10	,	,	PUNCT
bjp-23079	47	11	ut	ut	PROPN
bjp-23079	47	12	,	,	PUNCT
bjp-23079	47	13	usa	usa	PROPN
bjp-23079	47	14	)	)	PUNCT
bjp-23079	47	15	was	be	AUX
bjp-23079	47	16	taken	take	VERB
bjp-23079	47	17	advantage	advantage	NOUN
bjp-23079	47	18	of	of	ADP
bjp-23079	47	19	for	for	ADP
bjp-23079	47	20	analysis	analysis	NOUN
bjp-23079	47	21	of	of	ADP
bjp-23079	47	22	relevant	relevant	ADJ
bjp-23079	47	23	statistics	statistic	NOUN
bjp-23079	47	24	.	.	PUNCT
bjp-23079	48	1	statistical	statistical	ADJ
bjp-23079	48	2	analysis	analysis	NOUN
bjp-23079	48	3	:	:	PUNCT
bjp-23079	48	4	the	the	DET
bjp-23079	48	5	spss	spss	PROPN
bjp-23079	48	6	17.0	17.0	NUM
bjp-23079	48	7	software	software	NOUN
bjp-23079	48	8	was	be	AUX
bjp-23079	48	9	applied	apply	VERB
bjp-23079	48	10	to	to	PART
bjp-23079	48	11	complete	complete	VERB
bjp-23079	48	12	data	datum	NOUN
bjp-23079	48	13	processing	processing	NOUN
bjp-23079	48	14	.	.	PUNCT
bjp-23079	49	1	all	all	DET
bjp-23079	49	2	quantitative	quantitative	ADJ
bjp-23079	49	3	values	value	NOUN
bjp-23079	49	4	are	be	AUX
bjp-23079	49	5	performed	perform	VERB
bjp-23079	49	6	at	at	ADP
bjp-23079	49	7	least	least	ADV
bjp-23079	49	8	three	three	NUM
bjp-23079	49	9	times	time	NOUN
bjp-23079	49	10	and	and	CCONJ
bjp-23079	49	11	given	give	VERB
bjp-23079	49	12	as	as	ADP
bjp-23079	49	13	mean	mean	PROPN
bjp-23079	49	14	±	±	NUM
bjp-23079	49	15	s.d	s.d	PROPN
bjp-23079	49	16	.	.	PUNCT
bjp-23079	50	1	statistical	statistical	ADJ
bjp-23079	50	2	significance	significance	NOUN
bjp-23079	50	3	was	be	AUX
bjp-23079	50	4	analyzed	analyze	VERB
bjp-23079	50	5	by	by	ADP
bjp-23079	50	6	student	student	NOUN
bjp-23079	50	7	’s	’s	PART
bjp-23079	50	8	t	t	PROPN
bjp-23079	50	9	-	-	PUNCT
bjp-23079	50	10	test	test	NOUN
bjp-23079	50	11	.	.	PUNCT
bjp-23079	51	1	values	value	NOUN
bjp-23079	51	2	of	of	ADP
bjp-23079	51	3	p<0.05	p<0.05	NOUN
bjp-23079	51	4	were	be	AUX
bjp-23079	51	5	considered	consider	VERB
bjp-23079	51	6	statistically	statistically	ADV
bjp-23079	51	7	significant	significant	ADJ
bjp-23079	51	8	.	.	PUNCT
bjp-23079	52	1	results	result	VERB
bjp-23079	52	2	patient	patient	ADJ
bjp-23079	52	3	characteristics	characteristic	NOUN
bjp-23079	52	4	:	:	PUNCT
bjp-23079	52	5	between	between	ADP
bjp-23079	52	6	july	july	PROPN
bjp-23079	52	7	,	,	PUNCT
bjp-23079	52	8	2011	2011	NUM
bjp-23079	52	9	,	,	PUNCT
bjp-23079	52	10	and	and	CCONJ
bjp-23079	52	11	october	october	PROPN
bjp-23079	52	12	,	,	PUNCT
bjp-23079	52	13	2014	2014	NUM
bjp-23079	52	14	,	,	PUNCT
bjp-23079	52	15	a	a	DET
bjp-23079	52	16	total	total	NOUN
bjp-23079	52	17	of	of	ADP
bjp-23079	52	18	221	221	NUM
bjp-23079	52	19	patients	patient	NOUN
bjp-23079	52	20	was	be	AUX
bjp-23079	52	21	randomly	randomly	ADV
bjp-23079	52	22	assigned	assign	VERB
bjp-23079	52	23	to	to	PART
bjp-23079	52	24	receive	receive	VERB
bjp-23079	52	25	dose	dose	NOUN
bjp-23079	52	26	-	-	PUNCT
bjp-23079	52	27	dense	dense	ADJ
bjp-23079	52	28	weekly	weekly	ADJ
bjp-23079	52	29	paclitaxel	paclitaxel	NOUN
bjp-23079	52	30	and	and	CCONJ
bjp-23079	52	31	carboplatin	carboplatin	PROPN
bjp-23079	52	32	group	group	NOUN
bjp-23079	52	33	(	(	PUNCT
bjp-23079	52	34	n	n	NOUN
bjp-23079	52	35	=	=	SYM
bjp-23079	52	36	109	109	NUM
bjp-23079	52	37	)	)	PUNCT
bjp-23079	52	38	and	and	CCONJ
bjp-23079	52	39	conventional	conventional	ADJ
bjp-23079	52	40	paclitaxel	paclitaxel	NOUN
bjp-23079	52	41	and	and	CCONJ
bjp-23079	52	42	carboplatin	carboplatin	PROPN
bjp-23079	52	43	group	group	NOUN
bjp-23079	52	44	(	(	PUNCT
bjp-23079	52	45	n	n	NOUN
bjp-23079	52	46	=	=	SYM
bjp-23079	52	47	112	112	NUM
bjp-23079	52	48	)	)	PUNCT
bjp-23079	52	49	,	,	PUNCT
bjp-23079	52	50	just	just	ADV
bjp-23079	52	51	after	after	ADP
bjp-23079	52	52	the	the	DET
bjp-23079	52	53	sixth	sixth	ADJ
bjp-23079	52	54	chemotherapy	chemotherapy	NOUN
bjp-23079	52	55	cycles	cycle	NOUN
bjp-23079	52	56	,	,	PUNCT
bjp-23079	52	57	and	and	CCONJ
bjp-23079	52	58	at	at	ADP
bjp-23079	52	59	12	12	NUM
bjp-23079	52	60	months	month	NOUN
bjp-23079	52	61	after	after	ADP
bjp-23079	52	62	randomization	randomization	NOUN
bjp-23079	52	63	.	.	PUNCT
bjp-23079	53	1	figure	figure	NOUN
bjp-23079	53	2	1	1	NUM
bjp-23079	53	3	showed	show	VERB
bjp-23079	53	4	the	the	DET
bjp-23079	53	5	trial	trial	NOUN
bjp-23079	53	6	profile	profile	NOUN
bjp-23079	53	7	.	.	PUNCT
bjp-23079	54	1	of	of	ADP
bjp-23079	54	2	these	these	PRON
bjp-23079	54	3	,	,	PUNCT
bjp-23079	54	4	109	109	NUM
bjp-23079	54	5	patients	patient	NOUN
bjp-23079	54	6	were	be	AUX
bjp-23079	54	7	randomized	randomize	VERB
bjp-23079	54	8	to	to	ADP
bjp-23079	54	9	the	the	DET
bjp-23079	54	10	dose	dose	NOUN
bjp-23079	54	11	-	-	PUNCT
bjp-23079	54	12	dense	dense	ADJ
bjp-23079	54	13	weekly	weekly	ADJ
bjp-23079	54	14	paclitaxel	paclitaxel	NOUN
bjp-23079	54	15	and	and	CCONJ
bjp-23079	54	16	carboplatin	carboplatin	NOUN
bjp-23079	54	17	group	group	NOUN
bjp-23079	54	18	and	and	CCONJ
bjp-23079	54	19	112	112	NUM
bjp-23079	54	20	were	be	AUX
bjp-23079	54	21	randomized	randomize	VERB
bjp-23079	54	22	to	to	ADP
bjp-23079	54	23	the	the	DET
bjp-23079	54	24	conventional	conventional	ADJ
bjp-23079	54	25	paclitaxel	paclitaxel	NOUN
bjp-23079	54	26	and	and	CCONJ
bjp-23079	54	27	carboplatin	carboplatin	PROPN
bjp-23079	54	28	group	group	NOUN
bjp-23079	54	29	.	.	PUNCT
bjp-23079	55	1	baseline	baseline	PROPN
bjp-23079	55	2	characteristics	characteristic	NOUN
bjp-23079	55	3	in	in	ADP
bjp-23079	55	4	our	our	PRON
bjp-23079	55	5	study	study	NOUN
bjp-23079	55	6	did	do	AUX
bjp-23079	55	7	not	not	PART
bjp-23079	55	8	differ	differ	VERB
bjp-23079	55	9	significantly	significantly	ADV
bjp-23079	55	10	between	between	ADP
bjp-23079	55	11	the	the	DET
bjp-23079	55	12	two	two	NUM
bjp-23079	55	13	treatment	treatment	NOUN
bjp-23079	55	14	groups	group	NOUN
bjp-23079	55	15	(	(	PUNCT
bjp-23079	55	16	table	table	NOUN
bjp-23079	55	17	i	i	NOUN
bjp-23079	55	18	)	)	PUNCT
bjp-23079	55	19	.	.	PUNCT
bjp-23079	56	1	progression	progression	NOUN
bjp-23079	56	2	-	-	PUNCT
bjp-23079	56	3	free	free	ADJ
bjp-23079	56	4	survival	survival	NOUN
bjp-23079	56	5	:	:	PUNCT
bjp-23079	57	1	in	in	ADP
bjp-23079	57	2	dose	dose	NOUN
bjp-23079	57	3	-	-	PUNCT
bjp-23079	57	4	dense	dense	ADJ
bjp-23079	57	5	weekly	weekly	ADJ
bjp-23079	57	6	paclitaxel	paclitaxel	NOUN
bjp-23079	57	7	and	and	CCONJ
bjp-23079	57	8	carboplatin	carboplatin	PROPN
bjp-23079	57	9	group	group	NOUN
bjp-23079	57	10	,	,	PUNCT
bjp-23079	57	11	median	median	PROPN
bjp-23079	57	12	pfs	pfs	PROPN
bjp-23079	57	13	was	be	AUX
bjp-23079	57	14	27.6	27.6	NUM
bjp-23079	57	15	months	month	NOUN
bjp-23079	57	16	(	(	PUNCT
bjp-23079	57	17	range	range	NOUN
bjp-23079	57	18	4.2	4.2	NUM
bjp-23079	57	19	-	-	SYM
bjp-23079	57	20	51	51	NUM
bjp-23079	57	21	+	+	NUM
bjp-23079	57	22	months	month	NOUN
bjp-23079	57	23	)	)	PUNCT
bjp-23079	57	24	.	.	PUNCT
bjp-23079	58	1	median	median	PROPN
bjp-23079	58	2	pfs	pfs	PROPN
bjp-23079	58	3	was	be	AUX
bjp-23079	58	4	16.8	16.8	NUM
bjp-23079	58	5	months	month	NOUN
bjp-23079	58	6	(	(	PUNCT
bjp-23079	58	7	range	range	NOUN
bjp-23079	58	8	3.3	3.3	NUM
bjp-23079	58	9	-	-	SYM
bjp-23079	58	10	48	48	NUM
bjp-23079	58	11	+	+	NUM
bjp-23079	58	12	months	month	NOUN
bjp-23079	58	13	)	)	PUNCT
bjp-23079	58	14	in	in	ADP
bjp-23079	58	15	conventional	conventional	ADJ
bjp-23079	58	16	paclitaxel	paclitaxel	NOUN
bjp-23079	58	17	and	and	CCONJ
bjp-23079	58	18	carboplatin	carboplatin	NOUN
bjp-23079	58	19	group	group	NOUN
bjp-23079	58	20	and	and	CCONJ
bjp-23079	58	21	lower	low	ADJ
bjp-23079	58	22	than	than	ADP
bjp-23079	58	23	that	that	PRON
bjp-23079	58	24	of	of	ADP
bjp-23079	58	25	dose	dose	NOUN
bjp-23079	58	26	-	-	PUNCT
bjp-23079	58	27	dense	dense	ADJ
bjp-23079	58	28	weekly	weekly	ADJ
bjp-23079	58	29	paclitaxel	paclitaxel	NOUN
bjp-23079	58	30	and	and	CCONJ
bjp-23079	58	31	carboplatin	carboplatin	PROPN
bjp-23079	58	32	group	group	NOUN
bjp-23079	58	33	.	.	PUNCT
bjp-23079	59	1	clinical	clinical	ADJ
bjp-23079	59	2	response	response	NOUN
bjp-23079	59	3	:	:	PUNCT
bjp-23079	59	4	table	table	NOUN
bjp-23079	59	5	ii	ii	PROPN
bjp-23079	59	6	showed	show	VERB
bjp-23079	59	7	that	that	SCONJ
bjp-23079	59	8	selected	select	VERB
bjp-23079	59	9	patients	patient	NOUN
bjp-23079	59	10	appeared	appear	VERB
bjp-23079	59	11	complete	complete	ADJ
bjp-23079	59	12	response	response	NOUN
bjp-23079	59	13	(	(	PUNCT
bjp-23079	59	14	22/109	22/109	NUM
bjp-23079	59	15	,	,	PUNCT
bjp-23079	59	16	20.2	20.2	NUM
bjp-23079	59	17	%	%	NOUN
bjp-23079	59	18	)	)	PUNCT
bjp-23079	59	19	,	,	PUNCT
bjp-23079	59	20	partial	partial	ADJ
bjp-23079	59	21	response	response	NOUN
bjp-23079	59	22	(	(	PUNCT
bjp-23079	59	23	41/109	41/109	NUM
bjp-23079	59	24	,	,	PUNCT
bjp-23079	59	25	37.6	37.6	NUM
bjp-23079	59	26	%	%	NOUN
bjp-23079	59	27	)	)	PUNCT
bjp-23079	59	28	,	,	PUNCT
bjp-23079	59	29	stable	stable	ADJ
bjp-23079	59	30	disease	disease	NOUN
bjp-23079	59	31	(	(	PUNCT
bjp-23079	59	32	32/109	32/109	NUM
bjp-23079	59	33	,	,	PUNCT
bjp-23079	59	34	29.4	29.4	NUM
bjp-23079	59	35	%	%	NOUN
bjp-23079	59	36	)	)	PUNCT
bjp-23079	59	37	,	,	PUNCT
bjp-23079	59	38	progressive	progressive	ADJ
bjp-23079	59	39	disease	disease	NOUN
bjp-23079	59	40	(	(	PUNCT
bjp-23079	59	41	3/109	3/109	NUM
bjp-23079	59	42	,	,	PUNCT
bjp-23079	59	43	2.8	2.8	NUM
bjp-23079	59	44	%	%	NOUN
bjp-23079	59	45	)	)	PUNCT
bjp-23079	59	46	and	and	CCONJ
bjp-23079	59	47	not	not	PART
bjp-23079	59	48	evaluable	evaluable	ADJ
bjp-23079	59	49	(	(	PUNCT
bjp-23079	59	50	11/109	11/109	NUM
bjp-23079	59	51	,	,	PUNCT
bjp-23079	59	52	10.1	10.1	NUM
bjp-23079	59	53	%	%	NOUN
bjp-23079	59	54	)	)	PUNCT
bjp-23079	59	55	in	in	ADP
bjp-23079	59	56	dose	dose	NOUN
bjp-23079	59	57	-	-	PUNCT
bjp-23079	59	58	dense	dense	ADJ
bjp-23079	59	59	weekly	weekly	ADJ
bjp-23079	59	60	paclitaxel	paclitaxel	NOUN
bjp-23079	59	61	and	and	CCONJ
bjp-23079	59	62	carboplatin	carboplatin	PROPN
bjp-23079	59	63	group	group	NOUN
bjp-23079	59	64	.	.	PUNCT
bjp-23079	60	1	there	there	ADV
bjp-23079	60	2	24/112	24/112	NUM
bjp-23079	60	3	(	(	PUNCT
bjp-23079	60	4	21.4	21.4	NUM
bjp-23079	60	5	%	%	NOUN
bjp-23079	60	6	)	)	PUNCT
bjp-23079	60	7	patients	patient	NOUN
bjp-23079	60	8	,	,	PUNCT
bjp-23079	60	9	43/112	43/112	NUM
bjp-23079	60	10	(	(	PUNCT
bjp-23079	60	11	38.5	38.5	NUM
bjp-23079	60	12	%	%	NOUN
bjp-23079	60	13	)	)	PUNCT
bjp-23079	60	14	patients	patient	NOUN
bjp-23079	60	15	,	,	PUNCT
bjp-23079	60	16	30/112	30/112	NUM
bjp-23079	60	17	(	(	PUNCT
bjp-23079	60	18	26.5	26.5	NUM
bjp-23079	60	19	%	%	NOUN
bjp-23079	60	20	)	)	PUNCT
bjp-23079	60	21	patients	patient	NOUN
bjp-23079	60	22	,	,	PUNCT
bjp-23079	60	23	4/112	4/112	NUM
bjp-23079	60	24	(	(	PUNCT
bjp-23079	60	25	3.5	3.5	NUM
bjp-23079	60	26	%	%	NOUN
bjp-23079	60	27	)	)	PUNCT
bjp-23079	60	28	patients	patient	NOUN
bjp-23079	60	29	and	and	CCONJ
bjp-23079	60	30	11/112	11/112	NUM
bjp-23079	60	31	(	(	PUNCT
bjp-23079	60	32	9.8	9.8	NUM
bjp-23079	60	33	%	%	NOUN
bjp-23079	60	34	)	)	PUNCT
bjp-23079	60	35	patients	patient	NOUN
bjp-23079	60	36	were	be	AUX
bjp-23079	60	37	surveyed	survey	VERB
bjp-23079	60	38	complete	complete	ADJ
bjp-23079	60	39	response	response	NOUN
bjp-23079	60	40	,	,	PUNCT
bjp-23079	60	41	partial	partial	ADJ
bjp-23079	60	42	response	response	NOUN
bjp-23079	60	43	,	,	PUNCT
bjp-23079	60	44	stable	stable	ADJ
bjp-23079	60	45	disease	disease	NOUN
bjp-23079	60	46	,	,	PUNCT
bjp-23079	60	47	progressive	progressive	ADJ
bjp-23079	60	48	disease	disease	NOUN
bjp-23079	60	49	and	and	CCONJ
bjp-23079	60	50	not	not	PART
bjp-23079	60	51	evaluable	evaluable	ADJ
bjp-23079	60	52	in	in	ADP
bjp-23079	60	53	conventional	conventional	ADJ
bjp-23079	60	54	paclitaxel	paclitaxel	NOUN
bjp-23079	60	55	and	and	CCONJ
bjp-23079	60	56	carboplatin	carboplatin	PROPN
bjp-23079	60	57	group	group	NOUN
bjp-23079	60	58	,	,	PUNCT
bjp-23079	60	59	respectively	respectively	ADV
bjp-23079	60	60	.	.	PUNCT
bjp-23079	61	1	these	these	DET
bjp-23079	61	2	clinical	clinical	ADJ
bjp-23079	61	3	responses	response	NOUN
bjp-23079	61	4	were	be	AUX
bjp-23079	61	5	not	not	PART
bjp-23079	61	6	statistical	statistical	ADJ
bjp-23079	61	7	significance	significance	NOUN
bjp-23079	61	8	(	(	PUNCT
bjp-23079	61	9	table	table	NOUN
bjp-23079	61	10	ii	ii	NOUN
bjp-23079	61	11	)	)	PUNCT
bjp-23079	61	12	.	.	PUNCT
bjp-23079	62	1	adverse	adverse	ADJ
bjp-23079	62	2	events	event	NOUN
bjp-23079	62	3	:	:	PUNCT
bjp-23079	62	4	table	table	NOUN
bjp-23079	62	5	iii	iii	NOUN
bjp-23079	62	6	showed	show	VERB
bjp-23079	62	7	there	there	PRON
bjp-23079	62	8	was	be	VERB
bjp-23079	62	9	statistical	statistical	ADJ
bjp-23079	62	10	significance	significance	NOUN
bjp-23079	62	11	in	in	ADP
bjp-23079	62	12	neutropenia	neutropenia	NOUN
bjp-23079	62	13	and	and	CCONJ
bjp-23079	62	14	anemia	anemia	NOUN
bjp-23079	62	15	of	of	ADP
bjp-23079	62	16	ovarian	ovarian	ADJ
bjp-23079	62	17	cancer	cancer	NOUN
bjp-23079	62	18	patients	patient	NOUN
bjp-23079	62	19	between	between	ADP
bjp-23079	62	20	dose	dose	NOUN
bjp-23079	62	21	-	-	PUNCT
bjp-23079	62	22	dense	dense	ADJ
bjp-23079	62	23	weekly	weekly	ADJ
bjp-23079	62	24	paclitaxel	paclitaxel	NOUN
bjp-23079	62	25	and	and	CCONJ
bjp-23079	62	26	carboplatin	carboplatin	NOUN
bjp-23079	62	27	group	group	NOUN
bjp-23079	62	28	and	and	CCONJ
bjp-23079	62	29	conventional	conventional	ADJ
bjp-23079	62	30	paclitaxel	paclitaxel	NOUN
bjp-23079	62	31	and	and	CCONJ
bjp-23079	62	32	carboplatin	carboplatin	PROPN
bjp-23079	62	33	group	group	NOUN
bjp-23079	62	34	.	.	PUNCT
bjp-23079	63	1	meanwhile	meanwhile	ADV
bjp-23079	63	2	,	,	PUNCT
bjp-23079	63	3	thrombocytopenia	thrombocytopenia	PROPN
bjp-23079	63	4	,	,	PUNCT
bjp-23079	63	5	febrile	febrile	NOUN
bjp-23079	63	6	neutropenia	neutropenia	NOUN
bjp-23079	63	7	,	,	PUNCT
bjp-23079	63	8	nausea	nausea	NOUN
bjp-23079	63	9	,	,	PUNCT
bjp-23079	63	10	vomiting	vomiting	NOUN
bjp-23079	63	11	,	,	PUNCT
bjp-23079	63	12	diarrhea	diarrhea	PROPN
bjp-23079	63	13	,	,	PUNCT
bjp-23079	63	14	fatigue	fatigue	NOUN
bjp-23079	63	15	,	,	PUNCT
bjp-23079	63	16	neuropathy	neuropathy	ADJ
bjp-23079	63	17	(	(	PUNCT
bjp-23079	63	18	motor	motor	NOUN
bjp-23079	63	19	)	)	PUNCT
bjp-23079	63	20	and	and	CCONJ
bjp-23079	63	21	neuropathy	neuropathy	ADJ
bjp-23079	63	22	(	(	PUNCT
bjp-23079	63	23	sensory	sensory	NOUN
bjp-23079	63	24	)	)	PUNCT
bjp-23079	63	25	of	of	ADP
bjp-23079	63	26	selected	select	VERB
bjp-23079	63	27	patients	patient	NOUN
bjp-23079	63	28	were	be	AUX
bjp-23079	63	29	observed	observe	VERB
bjp-23079	63	30	in	in	ADP
bjp-23079	63	31	dose	dose	NOUN
bjp-23079	63	32	-	-	PUNCT
bjp-23079	63	33	dense	dense	ADJ
bjp-23079	63	34	weekly	weekly	ADJ
bjp-23079	63	35	paclitaxel	paclitaxel	NOUN
bjp-23079	63	36	and	and	CCONJ
bjp-23079	63	37	carboplatin	carboplatin	NOUN
bjp-23079	63	38	group	group	NOUN
bjp-23079	63	39	and	and	CCONJ
bjp-23079	63	40	conventional	conventional	ADJ
bjp-23079	63	41	paclitaxel	paclitaxel	NOUN
bjp-23079	63	42	and	and	CCONJ
bjp-23079	63	43	carboplatin	carboplatin	PROPN
bjp-23079	63	44	group	group	NOUN
bjp-23079	63	45	,	,	PUNCT
bjp-23079	63	46	these	these	DET
bjp-23079	63	47	differences	difference	NOUN
bjp-23079	63	48	were	be	AUX
bjp-23079	63	49	not	not	PART
bjp-23079	63	50	statistical	statistical	ADJ
bjp-23079	63	51	significance	significance	NOUN
bjp-23079	63	52	.	.	PUNCT
bjp-23079	64	1	discussion	discussion	NOUN
bjp-23079	64	2	ovarian	ovarian	ADJ
bjp-23079	64	3	cancer	cancer	NOUN
bjp-23079	64	4	is	be	AUX
bjp-23079	64	5	one	one	NUM
bjp-23079	64	6	of	of	ADP
bjp-23079	64	7	the	the	DET
bjp-23079	64	8	three	three	NUM
bjp-23079	64	9	most	most	ADV
bjp-23079	64	10	famous	famous	ADJ
bjp-23079	64	11	malignant	malignant	ADJ
bjp-23079	64	12	tumor	tumor	NOUN
bjp-23079	64	13	in	in	ADP
bjp-23079	64	14	women	woman	NOUN
bjp-23079	64	15	,	,	PUNCT
bjp-23079	64	16	mainly	mainly	ADV
bjp-23079	64	17	epithelial	epithelial	ADJ
bjp-23079	64	18	ovarian	ovarian	ADJ
bjp-23079	64	19	cancer	cancer	NOUN
bjp-23079	64	20	,	,	PUNCT
bjp-23079	64	21	80	80	NUM
bjp-23079	64	22	-	-	SYM
bjp-23079	64	23	90	90	NUM
bjp-23079	64	24	%	%	NOUN
bjp-23079	64	25	of	of	ADP
bjp-23079	64	26	ovarian	ovarian	ADJ
bjp-23079	64	27	malignant	malignant	ADJ
bjp-23079	64	28	tumors	tumor	NOUN
bjp-23079	64	29	.	.	PUNCT
bjp-23079	65	1	due	due	ADP
bjp-23079	65	2	to	to	ADP
bjp-23079	65	3	the	the	DET
bjp-23079	65	4	ovaries	ovary	NOUN
bjp-23079	65	5	deep	deep	ADV
bjp-23079	65	6	in	in	ADP
bjp-23079	65	7	the	the	DET
bjp-23079	65	8	pelvic	pelvic	ADJ
bjp-23079	65	9	cavity	cavity	NOUN
bjp-23079	65	10	,	,	PUNCT
bjp-23079	65	11	concealment	concealment	NOUN
bjp-23079	65	12	,	,	PUNCT
bjp-23079	65	13	it	it	PRON
bjp-23079	65	14	brings	bring	VERB
bjp-23079	65	15	table	table	NOUN
bjp-23079	65	16	i	i	PRON
bjp-23079	65	17	patient	patient	ADJ
bjp-23079	65	18	characteristics	characteristic	NOUN
bjp-23079	65	19	dose	dose	NOUN
bjp-23079	65	20	-	-	PUNCT
bjp-23079	65	21	dense	dense	ADJ
bjp-23079	65	22	treatment	treatment	NOUN
bjp-23079	65	23	(	(	PUNCT
bjp-23079	65	24	n=109	n=109	NUM
bjp-23079	65	25	)	)	PUNCT
bjp-23079	65	26	conventional	conventional	ADJ
bjp-23079	65	27	treatment	treatment	NOUN
bjp-23079	65	28	(	(	PUNCT
bjp-23079	65	29	n=112	n=112	NOUN
bjp-23079	65	30	)	)	PUNCT
bjp-23079	65	31	p	p	NOUN
bjp-23079	65	32	value	value	NOUN
bjp-23079	65	33	age	age	NOUN
bjp-23079	65	34	(	(	PUNCT
bjp-23079	65	35	range	range	NOUN
bjp-23079	65	36	)	)	PUNCT
bjp-23079	65	37	in	in	ADP
bjp-23079	65	38	year	year	NOUN
bjp-23079	65	39	57	57	NUM
bjp-23079	65	40	(	(	PUNCT
bjp-23079	65	41	27	27	NUM
bjp-23079	65	42	-	-	SYM
bjp-23079	65	43	76	76	NUM
bjp-23079	65	44	)	)	PUNCT
bjp-23079	65	45	58	58	NUM
bjp-23079	65	46	(	(	PUNCT
bjp-23079	65	47	28	28	NUM
bjp-23079	65	48	-	-	SYM
bjp-23079	65	49	75	75	NUM
bjp-23079	65	50	)	)	PUNCT
bjp-23079	65	51	0.71	0.71	NUM
bjp-23079	65	52	ecog	ecog	VERB
bjp-23079	65	53	ps	ps	PROPN
bjp-23079	65	54	0	0	NUM
bjp-23079	65	55	-	-	SYM
bjp-23079	65	56	1	1	NUM
bjp-23079	65	57	99	99	NUM
bjp-23079	65	58	(	(	PUNCT
bjp-23079	65	59	90.8	90.8	NUM
bjp-23079	65	60	)	)	PUNCT
bjp-23079	65	61	101	101	NUM
bjp-23079	65	62	(	(	PUNCT
bjp-23079	65	63	90.2	90.2	NUM
bjp-23079	65	64	)	)	PUNCT
bjp-23079	65	65	0.56	0.56	NUM
bjp-23079	65	66	2	2	NUM
bjp-23079	65	67	7	7	NUM
bjp-23079	65	68	(	(	PUNCT
bjp-23079	65	69	6.4	6.4	NUM
bjp-23079	65	70	)	)	PUNCT
bjp-23079	65	71	9	9	NUM
bjp-23079	65	72	(	(	PUNCT
bjp-23079	65	73	8.0	8.0	NUM
bjp-23079	65	74	)	)	PUNCT
bjp-23079	65	75	3	3	NUM
bjp-23079	65	76	3	3	NUM
bjp-23079	65	77	(	(	PUNCT
bjp-23079	65	78	2.8	2.8	NUM
bjp-23079	65	79	)	)	PUNCT
bjp-23079	65	80	2(1.8	2(1.8	NUM
bjp-23079	65	81	)	)	PUNCT
bjp-23079	65	82	figo	figo	ADJ
bjp-23079	65	83	stage	stage	NOUN
bjp-23079	65	84	20	20	NUM
bjp-23079	65	85	(	(	PUNCT
bjp-23079	65	86	18.3	18.3	NUM
bjp-23079	65	87	)	)	PUNCT
bjp-23079	65	88	22	22	NUM
bjp-23079	65	89	(	(	PUNCT
bjp-23079	65	90	19.6	19.6	NUM
bjp-23079	65	91	)	)	PUNCT
bjp-23079	65	92	0.77	0.77	NUM
bjp-23079	65	93	5	5	NUM
bjp-23079	65	94	(	(	PUNCT
bjp-23079	65	95	4.6	4.6	NUM
bjp-23079	65	96	)	)	PUNCT
bjp-23079	65	97	6	6	NUM
bjp-23079	65	98	(	(	PUNCT
bjp-23079	65	99	5.4	5.4	NUM
bjp-23079	65	100	)	)	PUNCT
bjp-23079	65	101	8	8	NUM
bjp-23079	65	102	(	(	PUNCT
bjp-23079	65	103	7.3	7.3	NUM
bjp-23079	65	104	)	)	PUNCT
bjp-23079	65	105	7	7	NUM
bjp-23079	65	106	(	(	PUNCT
bjp-23079	65	107	6.3	6.3	NUM
bjp-23079	65	108	)	)	PUNCT
bjp-23079	65	109	53	53	NUM
bjp-23079	65	110	(	(	PUNCT
bjp-23079	65	111	48.6	48.6	NUM
bjp-23079	65	112	)	)	PUNCT
bjp-23079	65	113	55	55	NUM
bjp-23079	65	114	(	(	PUNCT
bjp-23079	65	115	49.1	49.1	NUM
bjp-23079	65	116	)	)	PUNCT
bjp-23079	65	117	23	23	NUM
bjp-23079	65	118	(	(	PUNCT
bjp-23079	65	119	21.2	21.2	NUM
bjp-23079	65	120	)	)	PUNCT
bjp-23079	65	121	22	22	NUM
bjp-23079	65	122	(	(	PUNCT
bjp-23079	65	123	19.6	19.6	NUM
bjp-23079	65	124	)	)	PUNCT
bjp-23079	65	125	histological	histological	ADJ
bjp-23079	65	126	type	type	NOUN
bjp-23079	65	127	serous	serous	ADJ
bjp-23079	65	128	/	/	SYM
bjp-23079	65	129	others	other	NOUN
bjp-23079	65	130	92	92	NUM
bjp-23079	65	131	(	(	PUNCT
bjp-23079	65	132	84.4	84.4	NUM
bjp-23079	65	133	)	)	PUNCT
bjp-23079	65	134	94	94	NUM
bjp-23079	65	135	(	(	PUNCT
bjp-23079	65	136	83.9	83.9	NUM
bjp-23079	65	137	)	)	PUNCT
bjp-23079	65	138	0.43	0.43	NUM
bjp-23079	65	139	clear	clear	ADJ
bjp-23079	65	140	cell/	cell/	NUM
bjp-23079	65	141	mucinous	mucinous	ADJ
bjp-23079	65	142	17	17	NUM
bjp-23079	65	143	(	(	PUNCT
bjp-23079	65	144	15.6	15.6	NUM
bjp-23079	65	145	)	)	SYM
bjp-23079	65	146	18	18	NUM
bjp-23079	65	147	(	(	PUNCT
bjp-23079	65	148	16.1	16.1	NUM
bjp-23079	65	149	)	)	PUNCT
bjp-23079	65	150	residual	residual	ADJ
bjp-23079	65	151	disease	disease	NOUN
bjp-23079	65	152	0.56	0.56	NUM
bjp-23079	65	153	≤1	≤1	PROPN
bjp-23079	65	154	cm	cm	PROPN
bjp-23079	65	155	53	53	NUM
bjp-23079	65	156	(	(	PUNCT
bjp-23079	65	157	48.6	48.6	NUM
bjp-23079	65	158	)	)	PUNCT
bjp-23079	65	159	55	55	NUM
bjp-23079	65	160	(	(	PUNCT
bjp-23079	65	161	49.1	49.1	NUM
bjp-23079	65	162	)	)	PUNCT
bjp-23079	65	163	>	>	PUNCT
bjp-23079	65	164	1	1	NUM
bjp-23079	65	165	cm	cm	NUM
bjp-23079	65	166	56	56	NUM
bjp-23079	65	167	(	(	PUNCT
bjp-23079	65	168	51.4	51.4	NUM
bjp-23079	65	169	)	)	PUNCT
bjp-23079	65	170	57	57	NUM
bjp-23079	65	171	(	(	PUNCT
bjp-23079	65	172	50.9	50.9	NUM
bjp-23079	65	173	)	)	PUNCT
bjp-23079	65	174	table	table	NOUN
bjp-23079	65	175	ii	ii	PROPN
bjp-23079	65	176	clinical	clinical	ADJ
bjp-23079	65	177	responses	response	NOUN
bjp-23079	65	178	dose	dose	NOUN
bjp-23079	65	179	-	-	PUNCT
bjp-23079	65	180	dense	dense	ADJ
bjp-23079	65	181	treatment	treatment	NOUN
bjp-23079	65	182	(	(	PUNCT
bjp-23079	65	183	n=109	n=109	NUM
bjp-23079	65	184	)	)	PUNCT
bjp-23079	65	185	conventional	conventional	ADJ
bjp-23079	65	186	treatment	treatment	NOUN
bjp-23079	65	187	(	(	PUNCT
bjp-23079	65	188	n=112	n=112	NOUN
bjp-23079	65	189	)	)	PUNCT
bjp-23079	65	190	p	p	NOUN
bjp-23079	65	191	value	value	NOUN
bjp-23079	65	192	complete	complete	ADJ
bjp-23079	65	193	response	response	NOUN
bjp-23079	65	194	22	22	NUM
bjp-23079	65	195	(	(	PUNCT
bjp-23079	65	196	20.2	20.2	NUM
bjp-23079	65	197	)	)	PUNCT
bjp-23079	65	198	24	24	NUM
bjp-23079	65	199	(	(	PUNCT
bjp-23079	65	200	21.4	21.4	NUM
bjp-23079	65	201	)	)	PUNCT
bjp-23079	65	202	0.56	0.56	NUM
bjp-23079	65	203	partial	partial	ADJ
bjp-23079	65	204	response	response	NOUN
bjp-23079	65	205	41	41	NUM
bjp-23079	65	206	(	(	PUNCT
bjp-23079	65	207	37.6	37.6	NUM
bjp-23079	65	208	)	)	PUNCT
bjp-23079	65	209	43	43	NUM
bjp-23079	65	210	(	(	PUNCT
bjp-23079	65	211	38.4	38.4	NUM
bjp-23079	65	212	)	)	PUNCT
bjp-23079	65	213	0.73	0.73	NUM
bjp-23079	65	214	stable	stable	ADJ
bjp-23079	65	215	disease	disease	NOUN
bjp-23079	65	216	32	32	NUM
bjp-23079	65	217	(	(	PUNCT
bjp-23079	65	218	29.4	29.4	NUM
bjp-23079	65	219	)	)	SYM
bjp-23079	65	220	30	30	NUM
bjp-23079	65	221	(	(	PUNCT
bjp-23079	65	222	26.5	26.5	NUM
bjp-23079	65	223	)	)	PUNCT
bjp-23079	65	224	0.32	0.32	NUM
bjp-23079	65	225	progressive	progressive	ADJ
bjp-23079	65	226	disease	disease	NOUN
bjp-23079	65	227	3	3	NUM
bjp-23079	65	228	(	(	PUNCT
bjp-23079	65	229	2.8	2.8	NUM
bjp-23079	65	230	)	)	PUNCT
bjp-23079	65	231	4	4	NUM
bjp-23079	65	232	(	(	PUNCT
bjp-23079	65	233	3.5	3.5	NUM
bjp-23079	65	234	)	)	PUNCT
bjp-23079	65	235	0.88	0.88	NUM
bjp-23079	65	236	not	not	PART
bjp-23079	65	237	evaluable	evaluable	ADJ
bjp-23079	65	238	11	11	NUM
bjp-23079	65	239	(	(	PUNCT
bjp-23079	65	240	10.1	10.1	NUM
bjp-23079	65	241	)	)	PUNCT
bjp-23079	65	242	11	11	NUM
bjp-23079	65	243	(	(	PUNCT
bjp-23079	65	244	9.8	9.8	NUM
bjp-23079	65	245	)	)	PUNCT
bjp-23079	65	246	0.90	0.90	NUM
bjp-23079	65	247	bangladesh	bangladesh	NOUN
bjp-23079	65	248	j	j	PROPN
bjp-23079	65	249	pharmacol	pharmacol	PROPN
bjp-23079	65	250	2015	2015	NUM
bjp-23079	65	251	;	;	PUNCT
bjp-23079	65	252	10	10	NUM
bjp-23079	65	253	:	:	PUNCT
bjp-23079	65	254	489	489	NUM
bjp-23079	65	255	-	-	SYM
bjp-23079	65	256	493	493	NUM
bjp-23079	65	257	491	491	NUM
bjp-23079	65	258	the	the	DET
bjp-23079	65	259	late	late	ADJ
bjp-23079	65	260	phase	phase	NOUN
bjp-23079	65	261	(	(	PUNCT
bjp-23079	65	262	januchowski	januchowski	NOUN
bjp-23079	65	263	et	et	PROPN
bjp-23079	65	264	al	al	PROPN
bjp-23079	65	265	.	.	PROPN
bjp-23079	65	266	,	,	PUNCT
bjp-23079	65	267	2014	2014	NUM
bjp-23079	65	268	)	)	PUNCT
bjp-23079	65	269	.	.	PUNCT
bjp-23079	66	1	ovarian	ovarian	ADJ
bjp-23079	66	2	cancer	cancer	NOUN
bjp-23079	66	3	also	also	ADV
bjp-23079	66	4	prone	prone	ADJ
bjp-23079	66	5	to	to	PART
bjp-23079	66	6	spread	spread	VERB
bjp-23079	66	7	planting	planting	NOUN
bjp-23079	66	8	and	and	CCONJ
bjp-23079	66	9	lymph	lymph	NOUN
bjp-23079	66	10	node	node	ADJ
bjp-23079	66	11	metastasis	metastasis	NOUN
bjp-23079	66	12	in	in	ADP
bjp-23079	66	13	pelvic	pelvic	ADJ
bjp-23079	66	14	or	or	CCONJ
bjp-23079	66	15	abdominal	abdominal	ADJ
bjp-23079	66	16	cavity	cavity	NOUN
bjp-23079	66	17	,	,	PUNCT
bjp-23079	66	18	although	although	SCONJ
bjp-23079	66	19	the	the	DET
bjp-23079	66	20	tumor	tumor	NOUN
bjp-23079	66	21	cells	cell	NOUN
bjp-23079	66	22	destroy	destroy	VERB
bjp-23079	66	23	combine	combine	VERB
bjp-23079	66	24	the	the	DET
bjp-23079	66	25	treatment	treatment	NOUN
bjp-23079	66	26	of	of	ADP
bjp-23079	66	27	radiotherapy	radiotherapy	NOUN
bjp-23079	66	28	and	and	CCONJ
bjp-23079	66	29	chemotherapy	chemotherapy	NOUN
bjp-23079	66	30	scheme	scheme	NOUN
bjp-23079	66	31	has	have	VERB
bjp-23079	66	32	a	a	DET
bjp-23079	66	33	great	great	ADJ
bjp-23079	66	34	improvement	improvement	NOUN
bjp-23079	66	35	,	,	PUNCT
bjp-23079	66	36	but	but	CCONJ
bjp-23079	66	37	ovarian	ovarian	ADJ
bjp-23079	66	38	cancer	cancer	NOUN
bjp-23079	66	39	recurrence	recurrence	NOUN
bjp-23079	66	40	rate	rate	NOUN
bjp-23079	66	41	is	be	AUX
bjp-23079	66	42	still	still	ADV
bjp-23079	66	43	high	high	ADJ
bjp-23079	66	44	,	,	PUNCT
bjp-23079	66	45	with	with	ADP
bjp-23079	66	46	poor	poor	ADJ
bjp-23079	66	47	prognosis	prognosis	NOUN
bjp-23079	66	48	,	,	PUNCT
bjp-23079	66	49	5	5	NUM
bjp-23079	66	50	years	year	NOUN
bjp-23079	66	51	of	of	ADP
bjp-23079	66	52	survival	survival	NOUN
bjp-23079	66	53	rate	rate	NOUN
bjp-23079	66	54	below	below	ADP
bjp-23079	66	55	30	30	NUM
bjp-23079	66	56	%	%	NOUN
bjp-23079	66	57	(	(	PUNCT
bjp-23079	66	58	liu	liu	PROPN
bjp-23079	66	59	et	et	PROPN
bjp-23079	66	60	al	al	PROPN
bjp-23079	66	61	.	.	PROPN
bjp-23079	66	62	,	,	PUNCT
bjp-23079	66	63	2014	2014	NUM
bjp-23079	66	64	)	)	PUNCT
bjp-23079	66	65	.	.	PUNCT
bjp-23079	67	1	so	so	ADV
bjp-23079	67	2	,	,	PUNCT
bjp-23079	67	3	in	in	ADP
bjp-23079	67	4	the	the	DET
bjp-23079	67	5	tumor	tumor	NOUN
bjp-23079	67	6	of	of	ADP
bjp-23079	67	7	female	female	ADJ
bjp-23079	67	8	reproductive	reproductive	ADJ
bjp-23079	67	9	system	system	NOUN
bjp-23079	67	10	,	,	PUNCT
bjp-23079	67	11	ovarian	ovarian	ADJ
bjp-23079	67	12	cancer	cancer	NOUN
bjp-23079	67	13	has	have	VERB
bjp-23079	67	14	the	the	DET
bjp-23079	67	15	highest	high	ADJ
bjp-23079	67	16	fatality	fatality	NOUN
bjp-23079	67	17	rate	rate	NOUN
bjp-23079	67	18	in	in	ADP
bjp-23079	67	19	malignant	malignant	ADJ
bjp-23079	67	20	tumors	tumor	NOUN
bjp-23079	67	21	.	.	PUNCT
bjp-23079	68	1	in	in	ADP
bjp-23079	68	2	our	our	PRON
bjp-23079	68	3	study	study	NOUN
bjp-23079	68	4	,	,	PUNCT
bjp-23079	68	5	from	from	ADP
bjp-23079	68	6	july	july	PROPN
bjp-23079	68	7	,	,	PUNCT
bjp-23079	68	8	2011	2011	NUM
bjp-23079	68	9	to	to	ADP
bjp-23079	68	10	october	october	PROPN
bjp-23079	68	11	,	,	PUNCT
bjp-23079	68	12	2014	2014	NUM
bjp-23079	68	13	,	,	PUNCT
bjp-23079	68	14	221	221	NUM
bjp-23079	68	15	patients	patient	NOUN
bjp-23079	68	16	were	be	AUX
bjp-23079	68	17	randomly	randomly	ADV
bjp-23079	68	18	assigned	assign	VERB
bjp-23079	68	19	to	to	ADP
bjp-23079	68	20	the	the	DET
bjp-23079	68	21	dose	dose	NOUN
bjp-23079	68	22	-	-	PUNCT
bjp-23079	68	23	dense	dense	ADJ
bjp-23079	68	24	weekly	weekly	ADJ
bjp-23079	68	25	paclitaxel	paclitaxel	NOUN
bjp-23079	68	26	and	and	CCONJ
bjp-23079	68	27	carboplatin	carboplatin	PROPN
bjp-23079	68	28	group	group	NOUN
bjp-23079	68	29	(	(	PUNCT
bjp-23079	68	30	n	n	NOUN
bjp-23079	68	31	=	=	SYM
bjp-23079	68	32	109	109	NUM
bjp-23079	68	33	)	)	PUNCT
bjp-23079	68	34	and	and	CCONJ
bjp-23079	68	35	conventional	conventional	ADJ
bjp-23079	68	36	paclitaxel	paclitaxel	NOUN
bjp-23079	68	37	and	and	CCONJ
bjp-23079	68	38	carboplatin	carboplatin	PROPN
bjp-23079	68	39	group	group	NOUN
bjp-23079	68	40	(	(	PUNCT
bjp-23079	68	41	n	n	NOUN
bjp-23079	68	42	=	=	SYM
bjp-23079	68	43	112	112	NUM
bjp-23079	68	44	)	)	PUNCT
bjp-23079	68	45	.	.	PUNCT
bjp-23079	69	1	baseline	baseline	PROPN
bjp-23079	69	2	characteristics	characteristic	NOUN
bjp-23079	69	3	in	in	ADP
bjp-23079	69	4	our	our	PRON
bjp-23079	69	5	study	study	NOUN
bjp-23079	69	6	did	do	AUX
bjp-23079	69	7	not	not	PART
bjp-23079	69	8	differ	differ	VERB
bjp-23079	69	9	significantly	significantly	ADV
bjp-23079	69	10	between	between	ADP
bjp-23079	69	11	the	the	DET
bjp-23079	69	12	two	two	NUM
bjp-23079	69	13	treatment	treatment	NOUN
bjp-23079	69	14	groups	group	NOUN
bjp-23079	69	15	.	.	PUNCT
bjp-23079	70	1	epithelial	epithelial	ADJ
bjp-23079	70	2	ovarian	ovarian	ADJ
bjp-23079	70	3	carcinoma	carcinoma	NOUN
bjp-23079	70	4	is	be	AUX
bjp-23079	70	5	difficult	difficult	ADJ
bjp-23079	70	6	to	to	PART
bjp-23079	70	7	be	be	AUX
bjp-23079	70	8	diagnosed	diagnose	VERB
bjp-23079	70	9	early	early	ADV
bjp-23079	70	10	,	,	PUNCT
bjp-23079	70	11	rapid	rapid	ADJ
bjp-23079	70	12	progress	progress	NOUN
bjp-23079	70	13	,	,	PUNCT
bjp-23079	70	14	high	high	ADJ
bjp-23079	70	15	malignant	malignant	ADJ
bjp-23079	70	16	degree	degree	NOUN
bjp-23079	70	17	,	,	PUNCT
bjp-23079	70	18	easily	easily	ADV
bjp-23079	70	19	abdominopelvic	abdominopelvic	ADJ
bjp-23079	70	20	cavity	cavity	NOUN
bjp-23079	70	21	metastasis	metastasis	NOUN
bjp-23079	70	22	,	,	PUNCT
bjp-23079	70	23	and	and	CCONJ
bjp-23079	70	24	prone	prone	ADJ
bjp-23079	70	25	to	to	ADP
bjp-23079	70	26	resistance	resistance	NOUN
bjp-23079	70	27	to	to	ADP
bjp-23079	70	28	chemotherapy	chemotherapy	NOUN
bjp-23079	70	29	and	and	CCONJ
bjp-23079	70	30	treatment	treatment	NOUN
bjp-23079	70	31	effect	effect	NOUN
bjp-23079	70	32	is	be	AUX
bjp-23079	70	33	poor	poor	ADJ
bjp-23079	70	34	,	,	PUNCT
bjp-23079	70	35	mortality	mortality	NOUN
bjp-23079	70	36	is	be	AUX
bjp-23079	70	37	highest	high	ADJ
bjp-23079	70	38	in	in	ADP
bjp-23079	70	39	malignant	malignant	ADJ
bjp-23079	70	40	tumor	tumor	NOUN
bjp-23079	70	41	(	(	PUNCT
bjp-23079	70	42	inoue	inoue	PROPN
bjp-23079	70	43	et	et	PROPN
bjp-23079	70	44	al	al	PROPN
bjp-23079	70	45	.	.	PROPN
bjp-23079	70	46	,	,	PUNCT
bjp-23079	70	47	2006	2006	NUM
bjp-23079	70	48	)	)	PUNCT
bjp-23079	70	49	.	.	PUNCT
bjp-23079	71	1	in	in	ADP
bjp-23079	71	2	the	the	DET
bjp-23079	71	3	past	past	ADJ
bjp-23079	71	4	30	30	NUM
bjp-23079	71	5	years	year	NOUN
bjp-23079	71	6	,	,	PUNCT
bjp-23079	71	7	the	the	DET
bjp-23079	71	8	surgery	surgery	NOUN
bjp-23079	71	9	treatment	treatment	NOUN
bjp-23079	71	10	and	and	CCONJ
bjp-23079	71	11	radical	radical	ADJ
bjp-23079	71	12	tumor	tumor	NOUN
bjp-23079	71	13	cells	cell	NOUN
bjp-23079	71	14	destroy	destroy	VERB
bjp-23079	71	15	in	in	ADP
bjp-23079	71	16	the	the	DET
bjp-23079	71	17	early	early	ADJ
bjp-23079	71	18	phase	phase	NOUN
bjp-23079	71	19	ovarian	ovarian	ADJ
bjp-23079	71	20	cancer	cancer	NOUN
bjp-23079	71	21	(	(	PUNCT
bjp-23079	71	22	phase	phase	NOUN
bjp-23079	71	23	i	i	PRON
bjp-23079	71	24	and	and	CCONJ
bjp-23079	71	25	ii	ii	NOUN
bjp-23079	71	26	)	)	PUNCT
bjp-23079	71	27	or	or	CCONJ
bjp-23079	71	28	advanced	advanced	ADJ
bjp-23079	71	29	cases	case	NOUN
bjp-23079	71	30	(	(	PUNCT
bjp-23079	71	31	phase	phase	NOUN
bjp-23079	71	32	iii	iii	NOUN
bjp-23079	71	33	and	and	CCONJ
bjp-23079	71	34	phase	phase	NOUN
bjp-23079	71	35	iv	iv	NUM
bjp-23079	71	36	)	)	PUNCT
bjp-23079	71	37	using	use	VERB
bjp-23079	71	38	combined	combined	ADJ
bjp-23079	71	39	chemotherapy	chemotherapy	NOUN
bjp-23079	71	40	based	base	VERB
bjp-23079	71	41	on	on	ADP
bjp-23079	71	42	cisplatin	cisplatin	NOUN
bjp-23079	71	43	make	make	VERB
bjp-23079	71	44	the	the	DET
bjp-23079	71	45	patients	patient	NOUN
bjp-23079	71	46	have	have	VERB
bjp-23079	71	47	better	well	ADJ
bjp-23079	71	48	prognosis	prognosis	NOUN
bjp-23079	71	49	,	,	PUNCT
bjp-23079	71	50	but	but	CCONJ
bjp-23079	71	51	the	the	DET
bjp-23079	71	52	5	5	NUM
bjp-23079	71	53	-	-	PUNCT
bjp-23079	71	54	year	year	NOUN
bjp-23079	71	55	survival	survival	NOUN
bjp-23079	71	56	rate	rate	NOUN
bjp-23079	71	57	is	be	AUX
bjp-23079	71	58	still	still	ADV
bjp-23079	71	59	around	around	ADV
bjp-23079	71	60	5	5	NUM
bjp-23079	71	61	-	-	SYM
bjp-23079	71	62	30	30	NUM
bjp-23079	71	63	%	%	NOUN
bjp-23079	71	64	.	.	PUNCT
bjp-23079	72	1	into	into	ADP
bjp-23079	72	2	the	the	DET
bjp-23079	72	3	1990s	1990	NOUN
bjp-23079	72	4	,	,	PUNCT
bjp-23079	72	5	as	as	SCONJ
bjp-23079	72	6	the	the	DET
bjp-23079	72	7	clinical	clinical	ADJ
bjp-23079	72	8	application	application	NOUN
bjp-23079	72	9	of	of	ADP
bjp-23079	72	10	paclitaxel	paclitaxel	PROPN
bjp-23079	72	11	,	,	PUNCT
bjp-23079	72	12	paclitaxel	paclitaxel	NOUN
bjp-23079	72	13	,	,	PUNCT
bjp-23079	72	14	cisplatin	cisplatin	NOUN
bjp-23079	72	15	replace	replace	NOUN
bjp-23079	72	16	cisplatin	cisplatin	NOUN
bjp-23079	72	17	,	,	PUNCT
bjp-23079	72	18	cyclophosphamide	cyclophosphamide	NOUN
bjp-23079	72	19	combined	combine	VERB
bjp-23079	72	20	chemotherapy	chemotherapy	NOUN
bjp-23079	72	21	as	as	ADP
bjp-23079	72	22	the	the	DET
bjp-23079	72	23	post	post	ADJ
bjp-23079	72	24	-	-	ADJ
bjp-23079	72	25	surgery	surgery	ADJ
bjp-23079	72	26	first	first	ADJ
bjp-23079	72	27	-	-	PUNCT
bjp-23079	72	28	line	line	NOUN
bjp-23079	72	29	treatment	treatment	NOUN
bjp-23079	72	30	of	of	ADP
bjp-23079	72	31	ovarian	ovarian	ADJ
bjp-23079	72	32	cancer	cancer	NOUN
bjp-23079	72	33	,	,	PUNCT
bjp-23079	72	34	prolongs	prolong	VERB
bjp-23079	72	35	the	the	DET
bjp-23079	72	36	median	median	ADJ
bjp-23079	72	37	survival	survival	NOUN
bjp-23079	72	38	time	time	NOUN
bjp-23079	72	39	in	in	ADP
bjp-23079	72	40	advanced	advanced	ADJ
bjp-23079	72	41	cases	case	NOUN
bjp-23079	72	42	,	,	PUNCT
bjp-23079	72	43	to	to	PART
bjp-23079	72	44	decrease	decrease	VERB
bjp-23079	72	45	the	the	DET
bjp-23079	72	46	poisonousness	poisonousness	NOUN
bjp-23079	72	47	of	of	ADP
bjp-23079	72	48	the	the	DET
bjp-23079	72	49	pt	pt	PROPN
bjp-23079	72	50	scheme	scheme	NOUN
bjp-23079	72	51	,	,	PUNCT
bjp-23079	72	52	carboplatin	carboplatin	NOUN
bjp-23079	72	53	was	be	AUX
bjp-23079	72	54	used	use	VERB
bjp-23079	72	55	to	to	PART
bjp-23079	72	56	replace	replace	VERB
bjp-23079	72	57	cisplatin	cisplatin	NOUN
bjp-23079	72	58	combine	combine	NOUN
bjp-23079	72	59	paclitaxel	paclitaxel	PROPN
bjp-23079	72	60	therapy	therapy	NOUN
bjp-23079	72	61	,	,	PUNCT
bjp-23079	72	62	carboplatin	carboplatin	PROPN
bjp-23079	72	63	is	be	AUX
bjp-23079	72	64	the	the	DET
bjp-23079	72	65	second	second	ADJ
bjp-23079	72	66	generation	generation	NOUN
bjp-23079	72	67	of	of	ADP
bjp-23079	72	68	platinum	platinum	NOUN
bjp-23079	72	69	antitumor	antitumor	PROPN
bjp-23079	72	70	drugs	drug	NOUN
bjp-23079	72	71	,	,	PUNCT
bjp-23079	72	72	it	it	PRON
bjp-23079	72	73	’s	’	VERB
bjp-23079	72	74	mechanism	mechanism	NOUN
bjp-23079	72	75	of	of	ADP
bjp-23079	72	76	action	action	NOUN
bjp-23079	72	77	is	be	AUX
bjp-23079	72	78	the	the	DET
bjp-23079	72	79	same	same	ADJ
bjp-23079	72	80	with	with	ADP
bjp-23079	72	81	cisplatin	cisplatin	NOUN
bjp-23079	72	82	,	,	PUNCT
bjp-23079	72	83	but	but	CCONJ
bjp-23079	72	84	the	the	DET
bjp-23079	72	85	reaction	reaction	NOUN
bjp-23079	72	86	of	of	ADP
bjp-23079	72	87	gastrointestinal	gastrointestinal	ADJ
bjp-23079	72	88	tract	tract	NOUN
bjp-23079	72	89	and	and	CCONJ
bjp-23079	72	90	renal	renal	ADJ
bjp-23079	72	91	toxicity	toxicity	NOUN
bjp-23079	72	92	is	be	AUX
bjp-23079	72	93	lower	low	ADJ
bjp-23079	72	94	than	than	ADP
bjp-23079	72	95	cisplatin	cisplatin	NOUN
bjp-23079	72	96	(	(	PUNCT
bjp-23079	72	97	burris	burris	PROPN
bjp-23079	72	98	et	et	PROPN
bjp-23079	72	99	al	al	PROPN
bjp-23079	72	100	.	.	PROPN
bjp-23079	72	101	,	,	PUNCT
bjp-23079	72	102	2012	2012	NUM
bjp-23079	72	103	;	;	PUNCT
bjp-23079	72	104	kumagai	kumagai	NOUN
bjp-23079	72	105	et	et	PROPN
bjp-23079	72	106	al	al	PROPN
bjp-23079	72	107	.	.	PROPN
bjp-23079	72	108	,	,	PUNCT
bjp-23079	72	109	2011	2011	NUM
bjp-23079	72	110	;	;	PUNCT
bjp-23079	72	111	mundhenke	mundhenke	PROPN
bjp-23079	72	112	et	et	PROPN
bjp-23079	72	113	al	al	PROPN
bjp-23079	72	114	.	.	PROPN
bjp-23079	72	115	,	,	PUNCT
bjp-23079	72	116	2008	2008	NUM
bjp-23079	72	117	)	)	PUNCT
bjp-23079	72	118	.	.	PUNCT
bjp-23079	73	1	because	because	SCONJ
bjp-23079	73	2	of	of	ADP
bjp-23079	73	3	the	the	DET
bjp-23079	73	4	advantages	advantage	NOUN
bjp-23079	73	5	of	of	ADP
bjp-23079	73	6	patient	patient	ADJ
bjp-23079	73	7	tolerance	tolerance	NOUN
bjp-23079	73	8	,	,	PUNCT
bjp-23079	73	9	do	do	AUX
bjp-23079	73	10	not	not	PART
bjp-23079	73	11	need	need	VERB
bjp-23079	73	12	to	to	PART
bjp-23079	73	13	be	be	AUX
bjp-23079	73	14	hydrated	hydrate	VERB
bjp-23079	73	15	,	,	PUNCT
bjp-23079	73	16	currently	currently	ADV
bjp-23079	73	17	accepted	accept	VERB
bjp-23079	73	18	by	by	ADP
bjp-23079	73	19	a	a	DET
bjp-23079	73	20	lot	lot	NOUN
bjp-23079	73	21	of	of	ADP
bjp-23079	73	22	doctors	doctor	NOUN
bjp-23079	73	23	and	and	CCONJ
bjp-23079	73	24	patients	patient	NOUN
bjp-23079	73	25	,	,	PUNCT
bjp-23079	73	26	at	at	ADP
bjp-23079	73	27	present	present	ADJ
bjp-23079	73	28	the	the	DET
bjp-23079	73	29	paclitaxel	paclitaxel	PROPN
bjp-23079	73	30	combine	combine	VERB
bjp-23079	73	31	carboplatin	carboplatin	NOUN
bjp-23079	73	32	therapy	therapy	NOUN
bjp-23079	73	33	is	be	AUX
bjp-23079	73	34	the	the	DET
bjp-23079	73	35	postsurgery	postsurgery	NOUN
bjp-23079	73	36	first	first	ADJ
bjp-23079	73	37	-	-	PUNCT
bjp-23079	73	38	line	line	NOUN
bjp-23079	73	39	treatment	treatment	NOUN
bjp-23079	73	40	of	of	ADP
bjp-23079	73	41	ovarian	ovarian	ADJ
bjp-23079	73	42	epithelial	epithelial	ADJ
bjp-23079	73	43	carcinoma	carcinoma	NOUN
bjp-23079	73	44	at	at	ADP
bjp-23079	73	45	home	home	ADV
bjp-23079	73	46	and	and	CCONJ
bjp-23079	73	47	abroad	abroad	ADV
bjp-23079	73	48	(	(	PUNCT
bjp-23079	73	49	harano	harano	INTJ
bjp-23079	73	50	et	et	PROPN
bjp-23079	73	51	al	al	PROPN
bjp-23079	73	52	.	.	PROPN
bjp-23079	73	53	,	,	PUNCT
bjp-23079	73	54	2014	2014	NUM
bjp-23079	73	55	)	)	PUNCT
bjp-23079	73	56	.	.	PUNCT
bjp-23079	74	1	we	we	PRON
bjp-23079	74	2	found	find	VERB
bjp-23079	74	3	that	that	SCONJ
bjp-23079	74	4	dose	dose	NOUN
bjp-23079	74	5	-	-	PUNCT
bjp-23079	74	6	dense	dense	ADJ
bjp-23079	74	7	weekly	weekly	ADJ
bjp-23079	74	8	paclitaxel	paclitaxel	NOUN
bjp-23079	74	9	and	and	CCONJ
bjp-23079	74	10	carboplatin	carboplatin	NOUN
bjp-23079	74	11	increased	increase	VERB
bjp-23079	74	12	median	median	ADJ
bjp-23079	74	13	pfs	pf	NOUN
bjp-23079	74	14	of	of	ADP
bjp-23079	74	15	stage	stage	PROPN
bjp-23079	74	16	ii	ii	PROPN
bjp-23079	74	17	-	-	PUNCT
bjp-23079	74	18	iv	iv	ADJ
bjp-23079	74	19	ovarian	ovarian	ADJ
bjp-23079	74	20	cancer	cancer	NOUN
bjp-23079	74	21	patients	patient	NOUN
bjp-23079	74	22	,	,	PUNCT
bjp-23079	74	23	in	in	ADP
bjp-23079	74	24	comparison	comparison	NOUN
bjp-23079	74	25	to	to	ADP
bjp-23079	74	26	that	that	PRON
bjp-23079	74	27	of	of	ADP
bjp-23079	74	28	conventional	conventional	ADJ
bjp-23079	74	29	paclitaxel	paclitaxel	NOUN
bjp-23079	74	30	and	and	CCONJ
bjp-23079	74	31	carboplatin	carboplatin	NOUN
bjp-23079	74	32	treatment	treatment	NOUN
bjp-23079	74	33	.	.	PUNCT
bjp-23079	75	1	nevertheless	nevertheless	ADV
bjp-23079	75	2	,	,	PUNCT
bjp-23079	75	3	the	the	DET
bjp-23079	75	4	occurrence	occurrence	NOUN
bjp-23079	75	5	rate	rate	NOUN
bjp-23079	75	6	of	of	ADP
bjp-23079	75	7	neutropenia	neutropenia	NOUN
bjp-23079	75	8	and	and	CCONJ
bjp-23079	75	9	anemia	anemia	NOUN
bjp-23079	75	10	were	be	AUX
bjp-23079	75	11	effectively	effectively	ADV
bjp-23079	75	12	activated	activate	VERB
bjp-23079	75	13	in	in	ADP
bjp-23079	75	14	dose	dose	NOUN
bjp-23079	75	15	-	-	PUNCT
bjp-23079	75	16	dense	dense	ADJ
bjp-23079	75	17	weekly	weekly	ADJ
bjp-23079	75	18	paclitaxel	paclitaxel	NOUN
bjp-23079	75	19	and	and	CCONJ
bjp-23079	75	20	carboplatin	carboplatin	NOUN
bjp-23079	75	21	treatment	treatment	NOUN
bjp-23079	75	22	,	,	PUNCT
bjp-23079	75	23	comparied	comparie	VERB
bjp-23079	75	24	with	with	ADP
bjp-23079	75	25	those	those	PRON
bjp-23079	75	26	of	of	ADP
bjp-23079	75	27	conventional	conventional	ADJ
bjp-23079	75	28	paclitaxel	paclitaxel	NOUN
bjp-23079	75	29	and	and	CCONJ
bjp-23079	75	30	carboplatin	carboplatin	NOUN
bjp-23079	75	31	treatment	treatment	NOUN
bjp-23079	75	32	.	.	PUNCT
bjp-23079	76	1	in	in	ADP
bjp-23079	76	2	conclusion	conclusion	NOUN
bjp-23079	76	3	,	,	PUNCT
bjp-23079	76	4	these	these	DET
bjp-23079	76	5	results	result	NOUN
bjp-23079	76	6	of	of	ADP
bjp-23079	76	7	our	our	PRON
bjp-23079	76	8	study	study	NOUN
bjp-23079	76	9	displayed	display	VERB
bjp-23079	76	10	that	that	SCONJ
bjp-23079	76	11	pfs	pfs	PROPN
bjp-23079	76	12	of	of	ADP
bjp-23079	76	13	dose	dose	NOUN
bjp-23079	76	14	-	-	PUNCT
bjp-23079	76	15	dense	dense	ADJ
bjp-23079	76	16	weekly	weekly	ADJ
bjp-23079	76	17	paclitaxel	paclitaxel	NOUN
bjp-23079	76	18	and	and	CCONJ
bjp-23079	76	19	carboplatin	carboplatin	NOUN
bjp-23079	76	20	is	be	AUX
bjp-23079	76	21	associated	associate	VERB
bjp-23079	76	22	with	with	ADP
bjp-23079	76	23	longer	long	ADJ
bjp-23079	76	24	than	than	ADP
bjp-23079	76	25	a	a	DET
bjp-23079	76	26	conventional	conventional	ADJ
bjp-23079	76	27	regimen	regiman	NOUN
bjp-23079	76	28	of	of	ADP
bjp-23079	76	29	paclitaxel	paclitaxel	PROPN
bjp-23079	76	30	and	and	CCONJ
bjp-23079	76	31	carboplatin	carboplatin	NOUN
bjp-23079	76	32	in	in	ADP
bjp-23079	76	33	epithelial	epithelial	ADJ
bjp-23079	76	34	ovarian	ovarian	ADJ
bjp-23079	76	35	cancer	cancer	NOUN
bjp-23079	76	36	.	.	PUNCT
bjp-23079	77	1	references	reference	NOUN
bjp-23079	77	2	burris	burris	PROPN
bjp-23079	77	3	ha	ha	INTJ
bjp-23079	77	4	,	,	PUNCT
bjp-23079	77	5	3rd	3rd	NOUN
bjp-23079	77	6	,	,	PUNCT
bjp-23079	77	7	dowlati	dowlati	PROPN
bjp-23079	77	8	a	a	PROPN
bjp-23079	77	9	,	,	PUNCT
bjp-23079	77	10	moss	moss	PROPN
bjp-23079	77	11	ra	ra	PROPN
bjp-23079	77	12	,	,	PUNCT
bjp-23079	77	13	infante	infante	PROPN
bjp-23079	77	14	jr	jr	PROPN
bjp-23079	77	15	,	,	PUNCT
bjp-23079	77	16	jones	jones	PROPN
bjp-23079	77	17	sf	sf	PROPN
bjp-23079	77	18	,	,	PUNCT
bjp-23079	77	19	spigel	spigel	NOUN
bjp-23079	77	20	dr	dr	PROPN
bjp-23079	77	21	,	,	PUNCT
bjp-23079	77	22	levinson	levinson	PROPN
bjp-23079	77	23	kt	kt	PROPN
bjp-23079	77	24	,	,	PUNCT
bjp-23079	77	25	lindquist	lindquist	PROPN
bjp-23079	77	26	d	d	PROPN
bjp-23079	77	27	,	,	PUNCT
bjp-23079	77	28	gainer	gainer	PROPN
bjp-23079	77	29	sd	sd	PROPN
bjp-23079	77	30	,	,	PUNCT
bjp-23079	77	31	dar	dar	PROPN
bjp-23079	77	32	mm	mm	PROPN
bjp-23079	77	33	,	,	PUNCT
bjp-23079	77	34	suttle	suttle	PROPN
bjp-23079	77	35	ab	ab	PROPN
bjp-23079	77	36	,	,	PUNCT
bjp-23079	77	37	ball	ball	PROPN
bjp-23079	77	38	ha	ha	INTJ
bjp-23079	77	39	,	,	PUNCT
bjp-23079	77	40	tan	tan	PROPN
bjp-23079	77	41	ar	ar	PROPN
bjp-23079	77	42	.	.	PROPN
bjp-23079	77	43	phase	phase	NOUN
bjp-23079	77	44	i	i	PRON
bjp-23079	77	45	study	study	NOUN
bjp-23079	77	46	of	of	ADP
bjp-23079	77	47	pazopanib	pazopanib	NOUN
bjp-23079	77	48	in	in	ADP
bjp-23079	77	49	combination	combination	NOUN
bjp-23079	77	50	with	with	ADP
bjp-23079	77	51	paclitaxel	paclitaxel	PROPN
bjp-23079	77	52	and	and	CCONJ
bjp-23079	77	53	carboplatin	carboplatin	NOUN
bjp-23079	77	54	given	give	VERB
bjp-23079	77	55	every	every	DET
bjp-23079	77	56	21	21	NUM
bjp-23079	77	57	days	day	NOUN
bjp-23079	77	58	in	in	ADP
bjp-23079	77	59	patients	patient	NOUN
bjp-23079	77	60	with	with	ADP
bjp-23079	77	61	advanced	advanced	ADJ
bjp-23079	77	62	solid	solid	ADJ
bjp-23079	77	63	tumors	tumor	NOUN
bjp-23079	77	64	.	.	PUNCT
bjp-23079	78	1	mol	mol	ADP
bjp-23079	78	2	cancer	cancer	NOUN
bjp-23079	78	3	ther	ther	ADV
bjp-23079	78	4	.	.	PUNCT
bjp-23079	79	1	2012	2012	NUM
bjp-23079	79	2	;	;	PUNCT
bjp-23079	79	3	11	11	NUM
bjp-23079	79	4	:	:	SYM
bjp-23079	79	5	1820	1820	NUM
bjp-23079	79	6	-	-	SYM
bjp-23079	79	7	28	28	NUM
bjp-23079	79	8	.	.	PUNCT
bjp-23079	80	1	chen	chen	PROPN
bjp-23079	80	2	d	d	PROPN
bjp-23079	80	3	,	,	PUNCT
bjp-23079	80	4	cheng	cheng	PROPN
bjp-23079	80	5	j	j	PROPN
bjp-23079	80	6	,	,	PUNCT
bjp-23079	80	7	yang	yang	PROPN
bjp-23079	80	8	k	k	PROPN
bjp-23079	80	9	,	,	PUNCT
bjp-23079	80	10	ma	ma	PROPN
bjp-23079	80	11	y	y	PROPN
bjp-23079	80	12	,	,	PUNCT
bjp-23079	80	13	yang	yang	PROPN
bjp-23079	80	14	f.	f.	PROPN
bjp-23079	80	15	retrospective	retrospective	ADJ
bjp-23079	80	16	analysis	analysis	NOUN
bjp-23079	80	17	of	of	ADP
bjp-23079	80	18	chronomodulated	chronomodulate	VERB
bjp-23079	80	19	chemotherapy	chemotherapy	NOUN
bjp-23079	80	20	versus	versus	ADP
bjp-23079	80	21	conventional	conventional	ADJ
bjp-23079	80	22	chemotherapy	chemotherapy	NOUN
bjp-23079	80	23	with	with	ADP
bjp-23079	80	24	paclitaxel	paclitaxel	PROPN
bjp-23079	80	25	,	,	PUNCT
bjp-23079	80	26	carboplatin	carboplatin	NOUN
bjp-23079	80	27	,	,	PUNCT
bjp-23079	80	28	and	and	CCONJ
bjp-23079	80	29	5	5	NUM
bjp-23079	80	30	-	-	PUNCT
bjp-23079	80	31	fluorouracil	fluorouracil	NOUN
bjp-23079	80	32	in	in	ADP
bjp-23079	80	33	patients	patient	NOUN
bjp-23079	80	34	with	with	ADP
bjp-23079	80	35	recurrent	recurrent	ADJ
bjp-23079	80	36	and/or	and/or	CCONJ
bjp-23079	80	37	metastatic	metastatic	ADJ
bjp-23079	80	38	head	head	NOUN
bjp-23079	80	39	and	and	CCONJ
bjp-23079	80	40	neck	neck	VERB
bjp-23079	80	41	squamous	squamous	ADJ
bjp-23079	80	42	cell	cell	NOUN
bjp-23079	80	43	carcinoma	carcinoma	NOUN
bjp-23079	80	44	.	.	PUNCT
bjp-23079	81	1	onco	onco	NOUN
bjp-23079	81	2	targets	target	NOUN
bjp-23079	81	3	ther	ther	ADV
bjp-23079	81	4	.	.	PUNCT
bjp-23079	82	1	2013	2013	NUM
bjp-23079	82	2	;	;	PUNCT
bjp-23079	82	3	6	6	NUM
bjp-23079	82	4	:	:	SYM
bjp-23079	82	5	1507	1507	NUM
bjp-23079	82	6	-	-	SYM
bjp-23079	82	7	14	14	NUM
bjp-23079	82	8	.	.	PUNCT
bjp-23079	83	1	chen	chen	PROPN
bjp-23079	83	2	k	k	PROPN
bjp-23079	83	3	,	,	PUNCT
bjp-23079	83	4	wei	wei	PROPN
bjp-23079	83	5	h	h	PROPN
bjp-23079	83	6	,	,	PUNCT
bjp-23079	83	7	ling	ling	PROPN
bjp-23079	83	8	s	s	PROPN
bjp-23079	83	9	,	,	PUNCT
bjp-23079	83	10	yi	yi	PROPN
bjp-23079	83	11	c.	c.	NOUN
bjp-23079	83	12	expression	expression	NOUN
bjp-23079	83	13	and	and	CCONJ
bjp-23079	83	14	significance	significance	NOUN
bjp-23079	83	15	of	of	ADP
bjp-23079	83	16	transforming	transform	VERB
bjp-23079	83	17	growth	growth	NOUN
bjp-23079	83	18	factor	factor	NOUN
bjp-23079	83	19	-	-	PUNCT
bjp-23079	83	20	beta1	beta1	NOUN
bjp-23079	83	21	in	in	ADP
bjp-23079	83	22	epithelial	epithelial	ADJ
bjp-23079	83	23	ovarian	ovarian	ADJ
bjp-23079	83	24	cancer	cancer	NOUN
bjp-23079	83	25	and	and	CCONJ
bjp-23079	83	26	its	its	PRON
bjp-23079	83	27	extracellular	extracellular	ADJ
bjp-23079	83	28	matrix	matrix	NOUN
bjp-23079	83	29	.	.	PUNCT
bjp-23079	84	1	oncol	oncol	ADJ
bjp-23079	84	2	lett	lett	PROPN
bjp-23079	84	3	.	.	PUNCT
bjp-23079	85	1	2014	2014	NUM
bjp-23079	85	2	;	;	PUNCT
bjp-23079	85	3	8	8	NUM
bjp-23079	85	4	:	:	SYM
bjp-23079	85	5	217174	217174	NUM
bjp-23079	85	6	.	.	PUNCT
bjp-23079	86	1	harano	harano	PROPN
bjp-23079	87	1	k	k	NOUN
bjp-23079	87	2	,	,	PUNCT
bjp-23079	87	3	terauchi	terauchi	ADV
bjp-23079	87	4	f	f	X
bjp-23079	87	5	,	,	PUNCT
bjp-23079	87	6	katsumata	katsumata	NOUN
bjp-23079	87	7	n	n	CCONJ
bjp-23079	87	8	,	,	PUNCT
bjp-23079	87	9	takahashi	takahashi	PROPN
bjp-23079	87	10	f	f	PROPN
bjp-23079	87	11	,	,	PUNCT
bjp-23079	87	12	yasuda	yasuda	PROPN
bjp-23079	87	13	m	m	PROPN
bjp-23079	87	14	,	,	PUNCT
bjp-23079	87	15	takakura	takakura	PROPN
bjp-23079	87	16	s	s	PROPN
bjp-23079	87	17	,	,	PUNCT
bjp-23079	87	18	takano	takano	PROPN
bjp-23079	87	19	m	m	PROPN
bjp-23079	87	20	,	,	PUNCT
bjp-23079	87	21	yamamoto	yamamoto	PROPN
bjp-23079	87	22	y	y	PROPN
bjp-23079	87	23	,	,	PUNCT
bjp-23079	87	24	sugiyama	sugiyama	NOUN
bjp-23079	87	25	t.	t.	PROPN
bjp-23079	87	26	qualityof	qualityof	PROPN
bjp-23079	87	27	-	-	PUNCT
bjp-23079	87	28	life	life	NOUN
bjp-23079	87	29	outcomes	outcome	NOUN
bjp-23079	87	30	from	from	ADP
bjp-23079	87	31	a	a	DET
bjp-23079	87	32	randomized	randomized	ADJ
bjp-23079	87	33	phase	phase	NOUN
bjp-23079	87	34	iii	iii	NOUN
bjp-23079	87	35	trial	trial	NOUN
bjp-23079	87	36	of	of	ADP
bjp-23079	87	37	dosedense	dosedense	NOUN
bjp-23079	87	38	weekly	weekly	ADJ
bjp-23079	87	39	paclitaxel	paclitaxel	NOUN
bjp-23079	87	40	and	and	CCONJ
bjp-23079	87	41	carboplatin	carboplatin	NOUN
bjp-23079	87	42	compared	compare	VERB
bjp-23079	87	43	with	with	ADP
bjp-23079	87	44	conventional	conventional	ADJ
bjp-23079	87	45	paclitaxel	paclitaxel	NOUN
bjp-23079	87	46	and	and	CCONJ
bjp-23079	87	47	carboplatin	carboplatin	NOUN
bjp-23079	87	48	as	as	ADP
bjp-23079	87	49	a	a	DET
bjp-23079	87	50	first	first	ADJ
bjp-23079	87	51	-	-	PUNCT
bjp-23079	87	52	line	line	NOUN
bjp-23079	87	53	treatment	treatment	NOUN
bjp-23079	87	54	for	for	ADP
bjp-23079	87	55	stage	stage	NOUN
bjp-23079	87	56	ii	ii	PROPN
bjp-23079	87	57	-	-	PUNCT
bjp-23079	87	58	iv	iv	ADJ
bjp-23079	87	59	ovarian	ovarian	ADJ
bjp-23079	87	60	cancer	cancer	NOUN
bjp-23079	87	61	:	:	PUNCT
bjp-23079	87	62	japanese	japanese	ADJ
bjp-23079	87	63	gynecologic	gynecologic	ADJ
bjp-23079	87	64	oncology	oncology	NOUN
bjp-23079	87	65	group	group	NOUN
bjp-23079	87	66	trial	trial	NOUN
bjp-23079	87	67	(	(	PUNCT
bjp-23079	87	68	jgog3016	jgog3016	PROPN
bjp-23079	87	69	)	)	PUNCT
bjp-23079	87	70	.	.	PUNCT
bjp-23079	88	1	ann	ann	PROPN
bjp-23079	88	2	oncol	oncol	PROPN
bjp-23079	88	3	.	.	PUNCT
bjp-23079	89	1	2014	2014	NUM
bjp-23079	89	2	;	;	PUNCT
bjp-23079	89	3	25	25	NUM
bjp-23079	89	4	:	:	SYM
bjp-23079	89	5	251	251	NUM
bjp-23079	89	6	-57	-57	NUM
bjp-23079	89	7	.	.	PUNCT
bjp-23079	90	1	inoue	inoue	PROPN
bjp-23079	90	2	a	a	PRON
bjp-23079	90	3	,	,	PUNCT
bjp-23079	90	4	usui	usui	NOUN
bjp-23079	90	5	k	k	PROPN
bjp-23079	90	6	,	,	PUNCT
bjp-23079	90	7	ishimoto	ishimoto	PROPN
bjp-23079	90	8	o	o	NOUN
bjp-23079	90	9	,	,	PUNCT
bjp-23079	90	10	matsubara	matsubara	PROPN
bjp-23079	90	11	n	n	CCONJ
bjp-23079	90	12	,	,	PUNCT
bjp-23079	90	13	tanaka	tanaka	PROPN
bjp-23079	90	14	m	m	PROPN
bjp-23079	90	15	,	,	PUNCT
bjp-23079	90	16	kanbe	kanbe	PROPN
bjp-23079	90	17	m	m	PROPN
bjp-23079	90	18	,	,	PUNCT
bjp-23079	90	19	gomi	gomi	PROPN
bjp-23079	90	20	k	k	PROPN
bjp-23079	90	21	,	,	PUNCT
bjp-23079	90	22	koinumaru	koinumaru	PROPN
bjp-23079	90	23	s	s	PROPN
bjp-23079	90	24	,	,	PUNCT
bjp-23079	90	25	saijo	saijo	PROPN
bjp-23079	90	26	y	y	PROPN
bjp-23079	90	27	,	,	PUNCT
bjp-23079	90	28	nukiwa	nukiwa	PROPN
bjp-23079	90	29	t.	t.	PROPN
bjp-23079	90	30	a	a	DET
bjp-23079	90	31	phase	phase	NOUN
bjp-23079	90	32	ii	ii	NOUN
bjp-23079	90	33	study	study	NOUN
bjp-23079	90	34	of	of	ADP
bjp-23079	90	35	weekly	weekly	ADJ
bjp-23079	90	36	paclitaxel	paclitaxel	NOUN
bjp-23079	90	37	combined	combine	VERB
bjp-23079	90	38	with	with	ADP
bjp-23079	90	39	carboplatin	carboplatin	NOUN
bjp-23079	90	40	for	for	ADP
bjp-23079	90	41	elderly	elderly	ADJ
bjp-23079	90	42	patients	patient	NOUN
bjp-23079	90	43	with	with	ADP
bjp-23079	90	44	advanced	advanced	ADJ
bjp-23079	90	45	non	non	ADJ
bjp-23079	90	46	-	-	ADJ
bjp-23079	90	47	small	small	ADJ
bjp-23079	90	48	cell	cell	NOUN
bjp-23079	90	49	lung	lung	NOUN
bjp-23079	90	50	cancer	cancer	NOUN
bjp-23079	90	51	.	.	PUNCT
bjp-23079	91	1	lung	lung	NOUN
bjp-23079	91	2	cancer	cancer	NOUN
bjp-23079	91	3	.	.	PUNCT
bjp-23079	92	1	2006	2006	NUM
bjp-23079	92	2	;	;	PUNCT
bjp-23079	92	3	52	52	NUM
bjp-23079	92	4	:	:	SYM
bjp-23079	92	5	83	83	NUM
bjp-23079	92	6	-	-	SYM
bjp-23079	92	7	87	87	NUM
bjp-23079	92	8	.	.	PUNCT
bjp-23079	93	1	januchowski	januchowski	PROPN
bjp-23079	93	2	r	r	PROPN
bjp-23079	93	3	,	,	PUNCT
bjp-23079	93	4	zawierucha	zawierucha	NOUN
bjp-23079	93	5	p	p	NOUN
bjp-23079	93	6	,	,	PUNCT
bjp-23079	93	7	rucinski	rucinski	ADJ
bjp-23079	93	8	m	m	PROPN
bjp-23079	93	9	,	,	PUNCT
bjp-23079	93	10	zabel	zabel	PROPN
bjp-23079	93	11	m.	m.	PROPN
bjp-23079	93	12	microarray	microarray	PROPN
bjp-23079	93	13	-	-	PUNCT
bjp-23079	93	14	based	base	VERB
bjp-23079	93	15	detection	detection	NOUN
bjp-23079	93	16	and	and	CCONJ
bjp-23079	93	17	expression	expression	NOUN
bjp-23079	93	18	analysis	analysis	NOUN
bjp-23079	93	19	of	of	ADP
bjp-23079	93	20	extracellular	extracellular	ADJ
bjp-23079	93	21	matrix	matrix	NOUN
bjp-23079	93	22	proteins	protein	NOUN
bjp-23079	93	23	in	in	ADP
bjp-23079	93	24	drugresistant	drugresistant	ADJ
bjp-23079	93	25	ovarian	ovarian	ADJ
bjp-23079	93	26	cancer	cancer	NOUN
bjp-23079	93	27	table	table	NOUN
bjp-23079	93	28	iii	iii	NUM
bjp-23079	93	29	adverse	adverse	ADJ
bjp-23079	93	30	events	event	NOUN
bjp-23079	93	31	dose	dose	NOUN
bjp-23079	93	32	-	-	PUNCT
bjp-23079	93	33	dense	dense	ADJ
bjp-23079	93	34	treatment	treatment	NOUN
bjp-23079	93	35	(	(	PUNCT
bjp-23079	93	36	n=109	n=109	NUM
bjp-23079	93	37	)	)	PUNCT
bjp-23079	93	38	conventional	conventional	ADJ
bjp-23079	93	39	treatment	treatment	NOUN
bjp-23079	93	40	(	(	PUNCT
bjp-23079	93	41	n=112	n=112	NOUN
bjp-23079	93	42	)	)	PUNCT
bjp-23079	93	43	p	p	NOUN
bjp-23079	93	44	value	value	NOUN
bjp-23079	93	45	neutropenia	neutropenia	NOUN
bjp-23079	93	46	99	99	NUM
bjp-23079	93	47	(	(	PUNCT
bjp-23079	93	48	90.8	90.8	NUM
bjp-23079	93	49	)	)	PUNCT
bjp-23079	93	50	71	71	NUM
bjp-23079	93	51	(	(	PUNCT
bjp-23079	93	52	63	63	NUM
bjp-23079	93	53	.	.	NOUN
bjp-23079	93	54	4	4	NUM
bjp-23079	93	55	)	)	PUNCT
bjp-23079	93	56	<	<	NOUN
bjp-23079	93	57	0.01	0.01	NUM
bjp-23079	93	58	thrombocytopenia	thrombocytopenia	NOUN
bjp-23079	93	59	43	43	NUM
bjp-23079	93	60	(	(	PUNCT
bjp-23079	93	61	39.4	39.4	NUM
bjp-23079	93	62	)	)	PUNCT
bjp-23079	93	63	33	33	NUM
bjp-23079	93	64	(	(	PUNCT
bjp-23079	93	65	29.5	29.5	NUM
bjp-23079	93	66	)	)	PUNCT
bjp-23079	93	67	0.11	0.11	NUM
bjp-23079	93	68	anemia	anemia	NOUN
bjp-23079	93	69	71	71	NUM
bjp-23079	93	70	(	(	PUNCT
bjp-23079	93	71	65.1	65.1	NUM
bjp-23079	93	72	)	)	PUNCT
bjp-23079	93	73	44	44	NUM
bjp-23079	93	74	(	(	PUNCT
bjp-23079	93	75	39.3	39.3	NUM
bjp-23079	93	76	)	)	PUNCT
bjp-23079	93	77	<	<	X
bjp-23079	93	78	0.01	0.01	NUM
bjp-23079	93	79	febrile	febrile	NOUN
bjp-23079	93	80	neutropenia	neutropenia	NOUN
bjp-23079	93	81	10	10	NUM
bjp-23079	93	82	(	(	PUNCT
bjp-23079	93	83	9.2	9.2	NUM
bjp-23079	93	84	)	)	PUNCT
bjp-23079	93	85	11	11	NUM
bjp-23079	93	86	(	(	PUNCT
bjp-23079	93	87	9.8	9.8	NUM
bjp-23079	93	88	)	)	PUNCT
bjp-23079	93	89	0.93	0.93	NUM
bjp-23079	93	90	nausea	nausea	NOUN
bjp-23079	93	91	11	11	NUM
bjp-23079	93	92	(	(	PUNCT
bjp-23079	93	93	10.1	10.1	NUM
bjp-23079	93	94	)	)	PUNCT
bjp-23079	93	95	12	12	NUM
bjp-23079	93	96	(	(	PUNCT
bjp-23079	93	97	10.7	10.7	NUM
bjp-23079	93	98	)	)	PUNCT
bjp-23079	93	99	0.91	0.91	NUM
bjp-23079	93	100	vomiting	vomit	VERB
bjp-23079	93	101	2	2	NUM
bjp-23079	93	102	(	(	PUNCT
bjp-23079	93	103	1.8	1.8	NUM
bjp-23079	93	104	)	)	PUNCT
bjp-23079	93	105	3	3	NUM
bjp-23079	93	106	(	(	PUNCT
bjp-23079	93	107	2.7	2.7	NUM
bjp-23079	93	108	)	)	PUNCT
bjp-23079	93	109	0.76	0.76	NUM
bjp-23079	93	110	diarrhoea	diarrhoea	NOUN
bjp-23079	93	111	4	4	NUM
bjp-23079	93	112	(	(	PUNCT
bjp-23079	93	113	3.7	3.7	NUM
bjp-23079	93	114	)	)	PUNCT
bjp-23079	93	115	4	4	NUM
bjp-23079	93	116	(	(	PUNCT
bjp-23079	93	117	3.6	3.6	NUM
bjp-23079	93	118	)	)	PUNCT
bjp-23079	93	119	0.97	0.97	NUM
bjp-23079	93	120	fatigue	fatigue	NOUN
bjp-23079	93	121	5	5	NUM
bjp-23079	93	122	(	(	PUNCT
bjp-23079	93	123	4.6	4.6	NUM
bjp-23079	93	124	)	)	SYM
bjp-23079	93	125	5	5	NUM
bjp-23079	93	126	(	(	PUNCT
bjp-23079	93	127	4.5	4.5	NUM
bjp-23079	93	128	)	)	PUNCT
bjp-23079	93	129	0.98	0.98	NUM
bjp-23079	93	130	neuropathy	neuropathy	ADJ
bjp-23079	93	131	(	(	PUNCT
bjp-23079	93	132	motor	motor	NOUN
bjp-23079	93	133	)	)	PUNCT
bjp-23079	93	134	5	5	NUM
bjp-23079	93	135	(	(	PUNCT
bjp-23079	93	136	4.6	4.6	NUM
bjp-23079	93	137	)	)	PUNCT
bjp-23079	93	138	6	6	NUM
bjp-23079	93	139	(	(	PUNCT
bjp-23079	93	140	5.4	5.4	NUM
bjp-23079	93	141	)	)	PUNCT
bjp-23079	93	142	0.89	0.89	NUM
bjp-23079	93	143	neuropathy	neuropathy	ADJ
bjp-23079	93	144	(	(	PUNCT
bjp-23079	93	145	sensory	sensory	NOUN
bjp-23079	93	146	)	)	PUNCT
bjp-23079	93	147	7	7	NUM
bjp-23079	93	148	(	(	PUNCT
bjp-23079	93	149	6.4	6.4	NUM
bjp-23079	93	150	)	)	PUNCT
bjp-23079	93	151	6	6	NUM
bjp-23079	93	152	(	(	PUNCT
bjp-23079	93	153	5.4	5.4	NUM
bjp-23079	93	154	)	)	PUNCT
bjp-23079	93	155	0.82	0.82	NUM
bjp-23079	93	156	492	492	NUM
bjp-23079	93	157	bangladesh	bangladesh	NOUN
bjp-23079	93	158	j	j	PROPN
bjp-23079	93	159	pharmacol	pharmacol	PROPN
bjp-23079	93	160	2015	2015	NUM
bjp-23079	93	161	;	;	PUNCT
bjp-23079	93	162	10	10	NUM
bjp-23079	93	163	:	:	PUNCT
bjp-23079	93	164	489	489	NUM
bjp-23079	93	165	-	-	PUNCT
bjp-23079	93	166	493	493	NUM
bjp-23079	93	167	author	author	NOUN
bjp-23079	93	168	info	info	NOUN
bjp-23079	93	169	zhenhua	zhenhua	PROPN
bjp-23079	93	170	du	du	PROPN
bjp-23079	93	171	(	(	PUNCT
bjp-23079	93	172	principal	principal	ADJ
bjp-23079	93	173	contact	contact	NOUN
bjp-23079	93	174	)	)	PUNCT
bjp-23079	93	175	e	e	NOUN
bjp-23079	93	176	-	-	NOUN
bjp-23079	93	177	mail	mail	NOUN
bjp-23079	93	178	:	:	PUNCT
bjp-23079	93	179	zhenhuadusy@163.com	zhenhuadusy@163.com	NUM
bjp-23079	93	180	;	;	PUNCT
bjp-23079	93	181	fax	fax	NOUN
bjp-23079	93	182	:	:	PUNCT
bjp-23079	93	183	:	:	PUNCT
bjp-23079	93	184	86	86	NUM
bjp-23079	93	185	-	-	PUNCT
bjp-23079	93	186	024	024	NUM
bjp-23079	93	187	-	-	PUNCT
bjp-23079	93	188	96615	96615	NUM
bjp-23079	93	189	cell	cell	NOUN
bjp-23079	93	190	lines	line	NOUN
bjp-23079	93	191	.	.	PUNCT
bjp-23079	94	1	oncol	oncol	PROPN
bjp-23079	94	2	rep	rep	PROPN
bjp-23079	94	3	.	.	PROPN
bjp-23079	94	4	2014	2014	NUM
bjp-23079	94	5	;	;	PUNCT
bjp-23079	94	6	32	32	NUM
bjp-23079	94	7	:	:	SYM
bjp-23079	94	8	1981	1981	NUM
bjp-23079	94	9	-	-	SYM
bjp-23079	94	10	90	90	NUM
bjp-23079	94	11	.	.	PUNCT
bjp-23079	95	1	katsumata	katsumata	PROPN
bjp-23079	95	2	n	n	CCONJ
bjp-23079	95	3	,	,	PUNCT
bjp-23079	95	4	yasuda	yasuda	PROPN
bjp-23079	95	5	m	m	PROPN
bjp-23079	95	6	,	,	PUNCT
bjp-23079	95	7	isonishi	isonishi	PROPN
bjp-23079	95	8	s	s	PROPN
bjp-23079	95	9	,	,	PUNCT
bjp-23079	95	10	takahashi	takahashi	PROPN
bjp-23079	95	11	f	f	PROPN
bjp-23079	95	12	,	,	PUNCT
bjp-23079	95	13	michimae	michimae	VERB
bjp-23079	95	14	h	h	NOUN
bjp-23079	95	15	,	,	PUNCT
bjp-23079	95	16	kimura	kimura	NOUN
bjp-23079	95	17	e	e	NOUN
bjp-23079	95	18	,	,	PUNCT
bjp-23079	95	19	aoki	aoki	PROPN
bjp-23079	95	20	d	d	PROPN
bjp-23079	95	21	,	,	PUNCT
bjp-23079	95	22	jobo	jobo	PROPN
bjp-23079	95	23	t	t	PROPN
bjp-23079	95	24	,	,	PUNCT
bjp-23079	95	25	kodama	kodama	PROPN
bjp-23079	95	26	s	s	X
bjp-23079	95	27	,	,	PUNCT
bjp-23079	95	28	terauchi	terauchi	ADV
bjp-23079	95	29	f	f	NOUN
bjp-23079	95	30	,	,	PUNCT
bjp-23079	95	31	sugiyama	sugiyama	NOUN
bjp-23079	95	32	t	t	PROPN
bjp-23079	95	33	,	,	PUNCT
bjp-23079	95	34	ochiai	ochiai	PROPN
bjp-23079	95	35	k.	k.	PROPN
bjp-23079	95	36	long	long	ADJ
bjp-23079	95	37	-	-	PUNCT
bjp-23079	95	38	term	term	NOUN
bjp-23079	95	39	results	result	NOUN
bjp-23079	95	40	of	of	ADP
bjp-23079	95	41	dose	dose	NOUN
bjp-23079	95	42	-	-	PUNCT
bjp-23079	95	43	dense	dense	ADJ
bjp-23079	95	44	paclitaxel	paclitaxel	NOUN
bjp-23079	95	45	and	and	CCONJ
bjp-23079	95	46	carboplatin	carboplatin	NOUN
bjp-23079	95	47	versus	versus	ADP
bjp-23079	95	48	conventional	conventional	ADJ
bjp-23079	95	49	paclitaxel	paclitaxel	NOUN
bjp-23079	95	50	and	and	CCONJ
bjp-23079	95	51	carboplatin	carboplatin	NOUN
bjp-23079	95	52	for	for	ADP
bjp-23079	95	53	treatment	treatment	NOUN
bjp-23079	95	54	of	of	ADP
bjp-23079	95	55	advanced	advanced	ADJ
bjp-23079	95	56	epithelial	epithelial	ADJ
bjp-23079	95	57	ovarian	ovarian	NOUN
bjp-23079	95	58	,	,	PUNCT
bjp-23079	95	59	fallopian	fallopian	ADJ
bjp-23079	95	60	tube	tube	NOUN
bjp-23079	95	61	,	,	PUNCT
bjp-23079	95	62	or	or	CCONJ
bjp-23079	95	63	primary	primary	ADJ
bjp-23079	95	64	peritoneal	peritoneal	ADJ
bjp-23079	95	65	cancer	cancer	NOUN
bjp-23079	95	66	(	(	PUNCT
bjp-23079	95	67	jgog	jgog	PROPN
bjp-23079	95	68	3016	3016	NUM
bjp-23079	95	69	):	):	PUNCT
bjp-23079	95	70	a	a	DET
bjp-23079	95	71	randomised	randomise	VERB
bjp-23079	95	72	,	,	PUNCT
bjp-23079	95	73	controlled	control	VERB
bjp-23079	95	74	,	,	PUNCT
bjp-23079	95	75	open	open	ADJ
bjp-23079	95	76	-	-	PUNCT
bjp-23079	95	77	label	label	NOUN
bjp-23079	95	78	trial	trial	NOUN
bjp-23079	95	79	.	.	PUNCT
bjp-23079	96	1	lancet	lancet	PROPN
bjp-23079	96	2	oncol	oncol	PROPN
bjp-23079	96	3	.	.	PUNCT
bjp-23079	97	1	2013	2013	NUM
bjp-23079	97	2	;	;	PUNCT
bjp-23079	97	3	14	14	NUM
bjp-23079	97	4	:	:	SYM
bjp-23079	97	5	1020	1020	NUM
bjp-23079	97	6	-	-	SYM
bjp-23079	97	7	26	26	NUM
bjp-23079	97	8	.	.	PUNCT
bjp-23079	98	1	katsumata	katsumata	PROPN
bjp-23079	98	2	n	n	CCONJ
bjp-23079	98	3	,	,	PUNCT
bjp-23079	98	4	yasuda	yasuda	PROPN
bjp-23079	98	5	m	m	PROPN
bjp-23079	98	6	,	,	PUNCT
bjp-23079	98	7	takahashi	takahashi	PROPN
bjp-23079	98	8	f	f	PROPN
bjp-23079	98	9	,	,	PUNCT
bjp-23079	98	10	isonishi	isonishi	PROPN
bjp-23079	98	11	s	s	PROPN
bjp-23079	98	12	,	,	PUNCT
bjp-23079	98	13	jobo	jobo	PROPN
bjp-23079	98	14	t	t	PROPN
bjp-23079	98	15	,	,	PUNCT
bjp-23079	98	16	aoki	aoki	PROPN
bjp-23079	98	17	d	d	PROPN
bjp-23079	98	18	,	,	PUNCT
bjp-23079	98	19	tsuda	tsuda	NOUN
bjp-23079	98	20	h	h	PROPN
bjp-23079	98	21	,	,	PUNCT
bjp-23079	98	22	sugiyama	sugiyama	PROPN
bjp-23079	98	23	t	t	PROPN
bjp-23079	98	24	,	,	PUNCT
bjp-23079	98	25	kodama	kodama	PROPN
bjp-23079	98	26	s	s	PART
bjp-23079	98	27	,	,	PUNCT
bjp-23079	98	28	kimura	kimura	NOUN
bjp-23079	98	29	e	e	NOUN
bjp-23079	98	30	,	,	PUNCT
bjp-23079	98	31	ochiai	ochiai	PROPN
bjp-23079	98	32	k	k	PROPN
bjp-23079	98	33	,	,	PUNCT
bjp-23079	98	34	noda	noda	PROPN
bjp-23079	98	35	k.	k.	PROPN
bjp-23079	98	36	dose	dose	PROPN
bjp-23079	98	37	-	-	PUNCT
bjp-23079	98	38	dense	dense	ADJ
bjp-23079	98	39	paclitaxel	paclitaxel	NOUN
bjp-23079	98	40	once	once	ADV
bjp-23079	98	41	a	a	DET
bjp-23079	98	42	week	week	NOUN
bjp-23079	98	43	in	in	ADP
bjp-23079	98	44	combination	combination	NOUN
bjp-23079	98	45	with	with	ADP
bjp-23079	98	46	carboplatin	carboplatin	NOUN
bjp-23079	98	47	every	every	DET
bjp-23079	98	48	3	3	NUM
bjp-23079	98	49	weeks	week	NOUN
bjp-23079	98	50	for	for	ADP
bjp-23079	98	51	advanced	advanced	ADJ
bjp-23079	98	52	ovarian	ovarian	ADJ
bjp-23079	98	53	cancer	cancer	NOUN
bjp-23079	98	54	:	:	PUNCT
bjp-23079	98	55	a	a	DET
bjp-23079	98	56	phase	phase	NOUN
bjp-23079	98	57	3	3	NUM
bjp-23079	98	58	,	,	PUNCT
bjp-23079	98	59	open	open	ADJ
bjp-23079	98	60	-	-	PUNCT
bjp-23079	98	61	label	label	NOUN
bjp-23079	98	62	,	,	PUNCT
bjp-23079	98	63	randomised	randomise	VERB
bjp-23079	98	64	controlled	control	VERB
bjp-23079	98	65	trial	trial	NOUN
bjp-23079	98	66	.	.	PUNCT
bjp-23079	99	1	lancet	lancet	NOUN
bjp-23079	99	2	.	.	PUNCT
bjp-23079	100	1	2009	2009	NUM
bjp-23079	100	2	;	;	PUNCT
bjp-23079	100	3	374	374	NUM
bjp-23079	100	4	:	:	PUNCT
bjp-23079	100	5	1331	1331	NUM
bjp-23079	100	6	-	-	SYM
bjp-23079	100	7	38	38	NUM
bjp-23079	100	8	.	.	PUNCT
bjp-23079	101	1	kumagai	kumagai	NOUN
bjp-23079	101	2	s	s	PROPN
bjp-23079	101	3	,	,	PUNCT
bjp-23079	101	4	sugiyama	sugiyama	PROPN
bjp-23079	101	5	t	t	PROPN
bjp-23079	101	6	,	,	PUNCT
bjp-23079	101	7	shoji	shoji	PROPN
bjp-23079	101	8	t	t	PROPN
bjp-23079	101	9	,	,	PUNCT
bjp-23079	101	10	michimae	michimae	VERB
bjp-23079	101	11	h	h	PROPN
bjp-23079	101	12	,	,	PUNCT
bjp-23079	101	13	katsumata	katsumata	NOUN
bjp-23079	101	14	n	n	CCONJ
bjp-23079	101	15	,	,	PUNCT
bjp-23079	101	16	aoki	aoki	PROPN
bjp-23079	101	17	d	d	PROPN
bjp-23079	101	18	,	,	PUNCT
bjp-23079	101	19	terauchi	terauchi	ADV
bjp-23079	101	20	f	f	PROPN
bjp-23079	101	21	,	,	PUNCT
bjp-23079	101	22	jobo	jobo	PROPN
bjp-23079	101	23	t	t	PROPN
bjp-23079	101	24	,	,	PUNCT
bjp-23079	101	25	ochiai	ochiai	PROPN
bjp-23079	101	26	k	k	PROPN
bjp-23079	101	27	,	,	PUNCT
bjp-23079	101	28	yasuda	yasuda	PROPN
bjp-23079	101	29	m.	m.	PROPN
bjp-23079	101	30	does	do	AUX
bjp-23079	101	31	severe	severe	ADJ
bjp-23079	101	32	anemia	anemia	NOUN
bjp-23079	101	33	caused	cause	VERB
bjp-23079	101	34	by	by	ADP
bjp-23079	101	35	dose	dose	NOUN
bjp-23079	101	36	-	-	PUNCT
bjp-23079	101	37	dense	dense	ADJ
bjp-23079	101	38	paclitaxel	paclitaxel	NOUN
bjp-23079	101	39	-	-	PUNCT
bjp-23079	101	40	carboplatin	carboplatin	NOUN
bjp-23079	101	41	combination	combination	NOUN
bjp-23079	101	42	therapy	therapy	NOUN
bjp-23079	101	43	have	have	VERB
bjp-23079	101	44	an	an	DET
bjp-23079	101	45	effect	effect	NOUN
bjp-23079	101	46	on	on	ADP
bjp-23079	101	47	the	the	DET
bjp-23079	101	48	survival	survival	NOUN
bjp-23079	101	49	of	of	ADP
bjp-23079	101	50	patients	patient	NOUN
bjp-23079	101	51	with	with	ADP
bjp-23079	101	52	epithelial	epithelial	ADJ
bjp-23079	101	53	ovarian	ovarian	ADJ
bjp-23079	101	54	cancer	cancer	NOUN
bjp-23079	101	55	?	?	PUNCT
bjp-23079	102	1	retrospective	retrospective	ADJ
bjp-23079	102	2	analysis	analysis	NOUN
bjp-23079	102	3	of	of	ADP
bjp-23079	102	4	the	the	DET
bjp-23079	102	5	japanese	japanese	ADJ
bjp-23079	102	6	gynecologic	gynecologic	ADJ
bjp-23079	102	7	oncology	oncology	NOUN
bjp-23079	102	8	group	group	NOUN
bjp-23079	102	9	3016	3016	NUM
bjp-23079	102	10	trial	trial	NOUN
bjp-23079	102	11	.	.	PUNCT
bjp-23079	103	1	int	int	NOUN
bjp-23079	103	2	j	j	PROPN
bjp-23079	103	3	gynecol	gynecol	ADJ
bjp-23079	103	4	cancer	cancer	NOUN
bjp-23079	103	5	.	.	PUNCT
bjp-23079	104	1	2011	2011	NUM
bjp-23079	104	2	;	;	PUNCT
bjp-23079	104	3	21	21	NUM
bjp-23079	104	4	:	:	PUNCT
bjp-23079	104	5	1585	1585	NUM
bjp-23079	104	6	-	-	SYM
bjp-23079	104	7	91	91	NUM
bjp-23079	104	8	.	.	PUNCT
bjp-23079	105	1	liu	liu	PROPN
bjp-23079	105	2	x	x	PROPN
bjp-23079	105	3	,	,	PUNCT
bjp-23079	105	4	gao	gao	PROPN
bjp-23079	105	5	y	y	PROPN
bjp-23079	105	6	,	,	PUNCT
bjp-23079	105	7	lu	lu	PROPN
bjp-23079	105	8	y	y	PROPN
bjp-23079	105	9	,	,	PUNCT
bjp-23079	105	10	zhang	zhang	PROPN
bjp-23079	105	11	j	j	PROPN
bjp-23079	105	12	,	,	PUNCT
bjp-23079	105	13	li	li	PROPN
bjp-23079	105	14	l	l	PROPN
bjp-23079	105	15	,	,	PUNCT
bjp-23079	105	16	yin	yin	PROPN
bjp-23079	105	17	f.	f.	PROPN
bjp-23079	105	18	down	down	PROPN
bjp-23079	105	19	-	-	PUNCT
bjp-23079	105	20	regulation	regulation	NOUN
bjp-23079	105	21	of	of	ADP
bjp-23079	105	22	nek11	nek11	NOUN
bjp-23079	105	23	is	be	AUX
bjp-23079	105	24	associated	associate	VERB
bjp-23079	105	25	with	with	ADP
bjp-23079	105	26	drug	drug	NOUN
bjp-23079	105	27	resistance	resistance	NOUN
bjp-23079	105	28	in	in	ADP
bjp-23079	105	29	ovarian	ovarian	ADJ
bjp-23079	105	30	cancer	cancer	NOUN
bjp-23079	105	31	.	.	PUNCT
bjp-23079	106	1	int	int	NOUN
bjp-23079	106	2	j	j	PROPN
bjp-23079	106	3	oncol	oncol	ADJ
bjp-23079	106	4	.	.	PUNCT
bjp-23079	107	1	2014	2014	NUM
bjp-23079	107	2	;	;	PUNCT
bjp-23079	107	3	45	45	NUM
bjp-23079	107	4	:	:	SYM
bjp-23079	107	5	1266	1266	NUM
bjp-23079	107	6	-	-	SYM
bjp-23079	107	7	74	74	NUM
bjp-23079	107	8	.	.	PUNCT
bjp-23079	108	1	mundhenke	mundhenke	PROPN
bjp-23079	108	2	c	c	PROPN
bjp-23079	108	3	,	,	PUNCT
bjp-23079	108	4	weigel	weigel	PROPN
bjp-23079	108	5	mt	mt	PROPN
bjp-23079	108	6	,	,	PUNCT
bjp-23079	108	7	sturner	sturner	PROPN
bjp-23079	108	8	kh	kh	PROPN
bjp-23079	108	9	,	,	PUNCT
bjp-23079	108	10	roesel	roesel	PROPN
bjp-23079	108	11	f	f	PROPN
bjp-23079	108	12	,	,	PUNCT
bjp-23079	108	13	meinholdheerlein	meinholdheerlein	VERB
bjp-23079	109	1	i	i	PRON
bjp-23079	109	2	,	,	PUNCT
bjp-23079	109	3	bauerschlag	bauerschlag	PROPN
bjp-23079	109	4	do	do	VERB
bjp-23079	109	5	,	,	PUNCT
bjp-23079	109	6	schem	schem	PROPN
bjp-23079	109	7	c	c	PROPN
bjp-23079	109	8	,	,	PUNCT
bjp-23079	109	9	hilpert	hilpert	PROPN
bjp-23079	109	10	f	f	PROPN
bjp-23079	109	11	,	,	PUNCT
bjp-23079	109	12	jonat	jonat	PROPN
bjp-23079	109	13	w	w	PROPN
bjp-23079	109	14	,	,	PUNCT
bjp-23079	109	15	maass	maass	PROPN
bjp-23079	109	16	n.	n.	PROPN
bjp-23079	109	17	novel	novel	PROPN
bjp-23079	109	18	treatment	treatment	NOUN
bjp-23079	109	19	of	of	ADP
bjp-23079	109	20	ovarian	ovarian	ADJ
bjp-23079	109	21	cancer	cancer	NOUN
bjp-23079	109	22	cell	cell	NOUN
bjp-23079	109	23	lines	line	NOUN
bjp-23079	109	24	with	with	ADP
bjp-23079	109	25	imatinib	imatinib	NOUN
bjp-23079	109	26	mesylate	mesylate	NOUN
bjp-23079	109	27	combined	combine	VERB
bjp-23079	109	28	with	with	ADP
bjp-23079	109	29	paclitaxel	paclitaxel	PROPN
bjp-23079	109	30	and	and	CCONJ
bjp-23079	109	31	carboplatin	carboplatin	NOUN
bjp-23079	109	32	leads	lead	VERB
bjp-23079	109	33	to	to	ADP
bjp-23079	109	34	receptor	receptor	NOUN
bjp-23079	109	35	-	-	PUNCT
bjp-23079	109	36	mediated	mediate	VERB
bjp-23079	109	37	antiproliferative	antiproliferative	NOUN
bjp-23079	109	38	effects	effect	NOUN
bjp-23079	109	39	.	.	PUNCT
bjp-23079	110	1	j	j	PROPN
bjp-23079	110	2	cancer	cancer	NOUN
bjp-23079	110	3	res	re	VERB
bjp-23079	110	4	clin	clin	PROPN
bjp-23079	110	5	oncol	oncol	PROPN
bjp-23079	110	6	.	.	PUNCT
bjp-23079	111	1	2008	2008	NUM
bjp-23079	111	2	;	;	PUNCT
bjp-23079	111	3	134	134	NUM
bjp-23079	111	4	:	:	SYM
bjp-23079	111	5	1397	1397	NUM
bjp-23079	111	6	-	-	SYM
bjp-23079	111	7	405	405	NUM
bjp-23079	111	8	.	.	PUNCT
bjp-23079	112	1	numazaki	numazaki	PROPN
bjp-23079	112	2	r	r	PROPN
bjp-23079	112	3	,	,	PUNCT
bjp-23079	112	4	miyagi	miyagi	PROPN
bjp-23079	112	5	e	e	NOUN
bjp-23079	112	6	,	,	PUNCT
bjp-23079	112	7	onose	onose	ADJ
bjp-23079	112	8	r	r	NOUN
bjp-23079	112	9	,	,	PUNCT
bjp-23079	112	10	nakazawa	nakazawa	PROPN
bjp-23079	112	11	t	t	PROPN
bjp-23079	112	12	,	,	PUNCT
bjp-23079	112	13	sugiura	sugiura	NOUN
bjp-23079	112	14	k	k	PROPN
bjp-23079	112	15	,	,	PUNCT
bjp-23079	112	16	asukai	asukai	PROPN
bjp-23079	112	17	k	k	PROPN
bjp-23079	112	18	,	,	PUNCT
bjp-23079	112	19	nakayama	nakayama	PROPN
bjp-23079	112	20	h	h	NOUN
bjp-23079	112	21	,	,	PUNCT
bjp-23079	112	22	miyamatsu	miyamatsu	VERB
bjp-23079	112	23	a	a	PRON
bjp-23079	112	24	,	,	PUNCT
bjp-23079	112	25	okamoto	okamoto	PROPN
bjp-23079	112	26	n	n	CCONJ
bjp-23079	112	27	,	,	PUNCT
bjp-23079	112	28	hirahara	hirahara	PROPN
bjp-23079	112	29	f.	f.	PROPN
bjp-23079	112	30	historical	historical	PROPN
bjp-23079	112	31	control	control	PROPN
bjp-23079	112	32	study	study	NOUN
bjp-23079	112	33	of	of	ADP
bjp-23079	112	34	paclitaxel	paclitaxel	NOUN
bjp-23079	112	35	-	-	PUNCT
bjp-23079	112	36	carboplatin	carboplatin	NOUN
bjp-23079	112	37	(	(	PUNCT
bjp-23079	112	38	tj	tj	NOUN
bjp-23079	112	39	)	)	PUNCT
bjp-23079	112	40	versus	versus	ADP
bjp-23079	112	41	conventional	conventional	ADJ
bjp-23079	112	42	platinum	platinum	NOUN
bjp-23079	112	43	-	-	PUNCT
bjp-23079	112	44	based	base	VERB
bjp-23079	112	45	chemotherapy	chemotherapy	NOUN
bjp-23079	112	46	(	(	PUNCT
bjp-23079	112	47	cap	cap	NOUN
bjp-23079	112	48	)	)	PUNCT
bjp-23079	112	49	for	for	ADP
bjp-23079	112	50	epithelial	epithelial	ADJ
bjp-23079	112	51	ovarian	ovarian	ADJ
bjp-23079	112	52	cancer	cancer	NOUN
bjp-23079	112	53	.	.	PUNCT
bjp-23079	113	1	int	int	PROPN
bjp-23079	114	1	j	j	PROPN
bjp-23079	114	2	clin	clin	PROPN
bjp-23079	114	3	oncol	oncol	PROPN
bjp-23079	114	4	.	.	PUNCT
bjp-23079	115	1	2006	2006	NUM
bjp-23079	115	2	;	;	PUNCT
bjp-23079	115	3	11	11	NUM
bjp-23079	115	4	:	:	SYM
bjp-23079	115	5	221	221	NUM
bjp-23079	115	6	-	-	SYM
bjp-23079	115	7	28	28	NUM
bjp-23079	115	8	.	.	PUNCT
bjp-23079	116	1	pu	pu	PROPN
bjp-23079	116	2	z	z	PROPN
bjp-23079	116	3	,	,	PUNCT
bjp-23079	116	4	yuan	yuan	PROPN
bjp-23079	116	5	x	x	X
bjp-23079	116	6	,	,	PUNCT
bjp-23079	116	7	zhang	zhang	PROPN
bjp-23079	116	8	x	x	PROPN
bjp-23079	116	9	,	,	PUNCT
bjp-23079	116	10	chen	chen	PROPN
bjp-23079	117	1	q	q	PROPN
bjp-23079	117	2	,	,	PUNCT
bjp-23079	117	3	xie	xie	PROPN
bjp-23079	117	4	h.	h.	PROPN
bjp-23079	117	5	meta	meta	PROPN
bjp-23079	117	6	-	-	PUNCT
bjp-23079	117	7	analysis	analysis	NOUN
bjp-23079	117	8	on	on	ADP
bjp-23079	117	9	the	the	DET
bjp-23079	117	10	association	association	NOUN
bjp-23079	117	11	between	between	ADP
bjp-23079	117	12	cyp2d6	cyp2d6	PROPN
bjp-23079	117	13	*	*	SYM
bjp-23079	117	14	10	10	NUM
bjp-23079	117	15	gene	gene	NOUN
bjp-23079	117	16	polymorphism	polymorphism	NOUN
bjp-23079	117	17	and	and	CCONJ
bjp-23079	117	18	disease	disease	NOUN
bjp-23079	117	19	free	free	ADJ
bjp-23079	117	20	survival	survival	NOUN
bjp-23079	117	21	of	of	ADP
bjp-23079	117	22	breast	breast	NOUN
bjp-23079	117	23	cancer	cancer	NOUN
bjp-23079	117	24	patients	patient	NOUN
bjp-23079	117	25	receiving	receive	VERB
bjp-23079	117	26	tamoxifen	tamoxifen	NOUN
bjp-23079	117	27	treatment	treatment	NOUN
bjp-23079	117	28	in	in	ADP
bjp-23079	117	29	asia	asia	PROPN
bjp-23079	117	30	.	.	PUNCT
bjp-23079	118	1	bangladesh	bangladesh	PROPN
bjp-23079	118	2	j	j	PROPN
bjp-23079	118	3	pharmacol	pharmacol	PROPN
bjp-23079	118	4	.	.	PUNCT
bjp-23079	118	5	2014	2014	NUM
bjp-23079	118	6	;	;	PUNCT
bjp-23079	118	7	9	9	NUM
bjp-23079	118	8	:	:	SYM
bjp-23079	118	9	652	652	NUM
bjp-23079	118	10	-	-	SYM
bjp-23079	118	11	62	62	NUM
bjp-23079	118	12	.	.	PUNCT
bjp-23079	119	1	robinson	robinson	PROPN
bjp-23079	119	2	wr	wr	PROPN
bjp-23079	119	3	,	,	PUNCT
bjp-23079	119	4	davis	davis	PROPN
bjp-23079	119	5	n	n	PRON
bjp-23079	119	6	,	,	PUNCT
bjp-23079	119	7	rogers	roger	NOUN
bjp-23079	119	8	as	as	ADP
bjp-23079	119	9	.	.	PUNCT
bjp-23079	119	10	paclitaxel	paclitaxel	PROPN
bjp-23079	119	11	maintenance	maintenance	NOUN
bjp-23079	119	12	chemotherapy	chemotherapy	NOUN
bjp-23079	119	13	following	follow	VERB
bjp-23079	119	14	intraperitoneal	intraperitoneal	ADJ
bjp-23079	119	15	chemotherapy	chemotherapy	NOUN
bjp-23079	119	16	for	for	ADP
bjp-23079	119	17	ovarian	ovarian	ADJ
bjp-23079	119	18	cancer	cancer	NOUN
bjp-23079	119	19	.	.	PUNCT
bjp-23079	120	1	int	int	NOUN
bjp-23079	120	2	j	j	PROPN
bjp-23079	120	3	gynecol	gynecol	ADJ
bjp-23079	120	4	cancer	cancer	NOUN
bjp-23079	120	5	.	.	PUNCT
bjp-23079	120	6	2008	2008	NUM
bjp-23079	120	7	;	;	PUNCT
bjp-23079	120	8	18	18	NUM
bjp-23079	120	9	:	:	SYM
bjp-23079	120	10	891	891	NUM
bjp-23079	120	11	-	-	SYM
bjp-23079	120	12	95	95	NUM
bjp-23079	120	13	.	.	PUNCT
bjp-23079	121	1	silasi	silasi	PROPN
bjp-23079	121	2	da	da	PROPN
bjp-23079	121	3	,	,	PUNCT
bjp-23079	121	4	alvero	alvero	PROPN
bjp-23079	121	5	ab	ab	PROPN
bjp-23079	121	6	,	,	PUNCT
bjp-23079	121	7	illuzzi	illuzzi	PROPN
bjp-23079	121	8	j	j	PROPN
bjp-23079	121	9	,	,	PUNCT
bjp-23079	121	10	kelly	kelly	PROPN
bjp-23079	121	11	m	m	PROPN
bjp-23079	121	12	,	,	PUNCT
bjp-23079	121	13	chen	chen	PROPN
bjp-23079	121	14	r	r	PROPN
bjp-23079	121	15	,	,	PUNCT
bjp-23079	121	16	fu	fu	NOUN
bjp-23079	121	17	hh	hh	PROPN
bjp-23079	121	18	,	,	PUNCT
bjp-23079	121	19	schwartz	schwartz	PROPN
bjp-23079	121	20	p	p	PROPN
bjp-23079	121	21	,	,	PUNCT
bjp-23079	121	22	rutherford	rutherford	PROPN
bjp-23079	121	23	t	t	PROPN
bjp-23079	121	24	,	,	PUNCT
bjp-23079	121	25	azodi	azodi	PROPN
bjp-23079	121	26	m	m	PROPN
bjp-23079	121	27	,	,	PUNCT
bjp-23079	121	28	mor	mor	PROPN
bjp-23079	121	29	g.	g.	PROPN
bjp-23079	121	30	myd88	myd88	PROPN
bjp-23079	121	31	predicts	predict	NOUN
bjp-23079	121	32	chemoresistance	chemoresistance	VERB
bjp-23079	121	33	to	to	ADP
bjp-23079	121	34	paclitaxel	paclitaxel	PROPN
bjp-23079	121	35	in	in	ADP
bjp-23079	121	36	epithelial	epithelial	ADJ
bjp-23079	121	37	ovarian	ovarian	ADJ
bjp-23079	121	38	cancer	cancer	NOUN
bjp-23079	121	39	.	.	PUNCT
bjp-23079	122	1	yale	yale	PROPN
bjp-23079	122	2	j	j	PROPN
bjp-23079	122	3	biol	biol	PROPN
bjp-23079	122	4	med	me	VERB
bjp-23079	122	5	.	.	PUNCT
bjp-23079	123	1	2006	2006	NUM
bjp-23079	123	2	;	;	PUNCT
bjp-23079	123	3	79	79	NUM
bjp-23079	123	4	:	:	SYM
bjp-23079	123	5	153	153	NUM
bjp-23079	123	6	-	-	SYM
bjp-23079	123	7	63	63	NUM
bjp-23079	123	8	.	.	PUNCT
bjp-23079	124	1	xie	xie	PROPN
bjp-23079	124	2	y	y	PROPN
bjp-23079	124	3	,	,	PUNCT
bjp-23079	124	4	peng	peng	PROPN
bjp-23079	124	5	z	z	PROPN
bjp-23079	124	6	,	,	PUNCT
bjp-23079	124	7	shi	shi	PROPN
bjp-23079	124	8	m	m	PROPN
bjp-23079	124	9	,	,	PUNCT
bjp-23079	124	10	ji	ji	PROPN
bjp-23079	124	11	m	m	PROPN
bjp-23079	124	12	,	,	PUNCT
bjp-23079	124	13	guo	guo	PROPN
bjp-23079	124	14	h	h	PROPN
bjp-23079	124	15	,	,	PUNCT
bjp-23079	124	16	shi	shi	PROPN
bjp-23079	124	17	h.	h.	PROPN
bjp-23079	124	18	metformin	metformin	PROPN
bjp-23079	124	19	combined	combine	VERB
bjp-23079	124	20	with	with	ADP
bjp-23079	124	21	p38	p38	NOUN
bjp-23079	124	22	mapk	mapk	NOUN
bjp-23079	124	23	inhibitor	inhibitor	NOUN
bjp-23079	124	24	improves	improve	VERB
bjp-23079	124	25	cisplatin	cisplatin	NOUN
bjp-23079	124	26	sensitivity	sensitivity	NOUN
bjp-23079	124	27	in	in	ADP
bjp-23079	124	28	cisplatin	cisplatin	NOUN
bjp-23079	124	29	resistant	resistant	ADJ
bjp-23079	124	30	ovarian	ovarian	ADJ
bjp-23079	124	31	cancer	cancer	NOUN
bjp-23079	124	32	.	.	PUNCT
bjp-23079	125	1	mol	mol	ADP
bjp-23079	125	2	med	med	PROPN
bjp-23079	125	3	rep	rep	PROPN
bjp-23079	125	4	.	.	PROPN
bjp-23079	125	5	2014	2014	NUM
bjp-23079	125	6	;	;	PUNCT
bjp-23079	125	7	10	10	NUM
bjp-23079	125	8	:	:	SYM
bjp-23079	125	9	2346	2346	NUM
bjp-23079	125	10	-	-	SYM
bjp-23079	125	11	50	50	NUM
bjp-23079	125	12	.	.	PUNCT
bjp-23079	126	1	submit	submit	VERB
bjp-23079	126	2	your	your	PRON
bjp-23079	126	3	next	next	ADJ
bjp-23079	126	4	manuscript	manuscript	NOUN
bjp-23079	126	5	to	to	ADP
bjp-23079	126	6	bangladesh	bangladesh	PROPN
bjp-23079	126	7	journal	journal	PROPN
bjp-23079	126	8	of	of	ADP
bjp-23079	126	9	pharmacology	pharmacology	NOUN
bjp-23079	126	10	and	and	CCONJ
bjp-23079	126	11	take	take	VERB
bjp-23079	126	12	full	full	ADJ
bjp-23079	126	13	advantage	advantage	NOUN
bjp-23079	126	14	of	of	ADP
bjp-23079	126	15	:	:	PUNCT
bjp-23079	126	16			PRON
bjp-23079	126	17	easy	easy	ADJ
bjp-23079	126	18	online	online	ADJ
bjp-23079	126	19	submission	submission	NOUN
bjp-23079	126	20			PRON
bjp-23079	126	21	thorough	thorough	ADJ
bjp-23079	126	22	peer	peer	NOUN
bjp-23079	126	23	review	review	NOUN
bjp-23079	126	24			NOUN
bjp-23079	126	25	available	available	ADJ
bjp-23079	126	26	online	online	ADV
bjp-23079	126	27	immediately	immediately	ADV
bjp-23079	126	28	after	after	ADP
bjp-23079	126	29	acceptance	acceptance	NOUN
bjp-23079	126	30			PRON
bjp-23079	126	31	open	open	ADJ
bjp-23079	126	32	access	access	NOUN
bjp-23079	126	33			NOUN
bjp-23079	127	1	no	no	DET
bjp-23079	127	2	publication	publication	NOUN
bjp-23079	127	3	charge	charge	NOUN
bjp-23079	127	4	bangladesh	bangladesh	PROPN
bjp-23079	127	5	j	j	PROPN
bjp-23079	127	6	pharmacol	pharmacol	PROPN
bjp-23079	127	7	2015	2015	NUM
bjp-23079	127	8	;	;	PUNCT
bjp-23079	127	9	10	10	NUM
bjp-23079	127	10	:	:	PUNCT
bjp-23079	127	11	489	489	NUM
bjp-23079	127	12	-	-	SYM
bjp-23079	127	13	493	493	NUM
bjp-23079	127	14	493	493	NUM